<SEC-DOCUMENT>0001104659-23-030852.txt : 20230310
<SEC-HEADER>0001104659-23-030852.hdr.sgml : 20230310
<ACCEPTANCE-DATETIME>20230310075143
ACCESSION NUMBER:		0001104659-23-030852
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20230310
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230310
DATE AS OF CHANGE:		20230310

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COGNITION THERAPEUTICS INC
		CENTRAL INDEX KEY:			0001455365
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40886
		FILM NUMBER:		23721624

	BUSINESS ADDRESS:	
		STREET 1:		2403 SIDNEY STREET
		STREET 2:		SUITE 261
		CITY:			PITTSBURGH
		STATE:			PA
		ZIP:			15203
		BUSINESS PHONE:		412-481-2210

	MAIL ADDRESS:	
		STREET 1:		2500 WESTCHESTER AVE
		CITY:			PURCHASE
		STATE:			NY
		ZIP:			10577

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COGNITION THERAPUTICS INC
		DATE OF NAME CHANGE:	20090204
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm239035d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:cgtx="http://cogrx.com/20230310">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_030_cgtx_cogrx.com_20230310 -->
<!-- Field: Set; Name: xdx; ID: xdx_049_20230310_20230310 -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0001455365 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-03-10to2023-03-10" name="dei:EntityCentralIndexKey">0001455365</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-03-10to2023-03-10" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="cgtx-20230310.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-03-10to2023-03-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001455365</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-10</xbrli:startDate>
        <xbrli:endDate>2023-03-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b>UNITED
STATES<br />
SECURITIES AND EXCHANGE COMMISSION<br />
</b></span><b>Washington, DC 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM&#160;<span id="xdx_905_edei--DocumentType_c20230310__20230310_zmxa3LA0Sab7"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT<br />
Pursuant to Section&#160;13 or 15(d)<br />
of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event
reported):&#160;<b><span id="xdx_901_edei--DocumentPeriodEndDate_c20230310__20230310_zlXSwjLAs0Sf"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">March 10, 2023</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b><span id="xdx_907_edei--EntityRegistrantName_c20230310__20230310_zW52M3faPOi1"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" name="dei:EntityRegistrantName">Cognition
Therapeutics,&#160;Inc.</ix:nonNumeric></span><br />
</b></span>(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20230310__20230310_zIHn3f21BDd6"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_906_edei--EntityFileNumber_c20230310__20230310_zsya8yaxkhfb"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" name="dei:EntityFileNumber">001-40886</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20230310__20230310_zMbfEc8sAdae"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" name="dei:EntityTaxIdentificationNumber">13-4365359</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction of<br />
incorporation or organization)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission
File Number)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(I.R.S. Employer<br />
Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 46%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90D_edei--EntityAddressAddressLine1_c20230310__20230310_z0NCv6voMAS5"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" name="dei:EntityAddressAddressLine1">2500 Westchester Avenue</ix:nonNumeric></span><br />
<span id="xdx_907_edei--EntityAddressCityOrTown_c20230310__20230310_zwYRnX9aTkD"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" name="dei:EntityAddressCityOrTown">Purchase</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressStateOrProvince_c20230310__20230310_zDOm1TP2JBmh"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" name="dei:EntityAddressStateOrProvince">NY</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 10%">&#160;</td>
    <td style="vertical-align: bottom; width: 44%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_903_edei--EntityAddressPostalZipCode_c20230310__20230310_zdYy9GJmyYf1"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" name="dei:EntityAddressPostalZipCode">10577</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Address of principal executive offices)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code:&#160;<b>(<span id="xdx_90C_edei--CityAreaCode_c20230310__20230310_zbTXNpEuxdea"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" name="dei:CityAreaCode">412</ix:nonNumeric></span>) <span id="xdx_906_edei--LocalPhoneNumber_c20230310__20230310_zRtFjrhjBXwl"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" name="dei:LocalPhoneNumber">481-2210</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Not
Applicable<br />
</b></span>(Former name or former address, if changed since last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form&#160;8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions :</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.18in; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-family: Wingdings"><span id="xdx_902_edei--WrittenCommunications_c20230310__20230310_zrq7agcNgsCg"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-family: Wingdings"><span id="xdx_900_edei--SolicitingMaterial_c20230310__20230310_z4WqOgp8SOW6"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-family: Wingdings"><span id="xdx_906_edei--PreCommencementTenderOffer_c20230310__20230310_z2fCmt1FpC82"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-family: Wingdings"><span id="xdx_906_edei--PreCommencementIssuerTenderOffer_c20230310__20230310_zYHv36Jlz3h2"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 31%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title of Each Class</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 31%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading Symbol</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 36%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name of Exchange on Which<br />
Registered</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_edei--Security12bTitle_c20230310__20230310_z1Ab5LXaN7W"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" name="dei:Security12bTitle">Common Stock, par value $0.001 per share</ix:nonNumeric></span> </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_edei--TradingSymbol_c20230310__20230310_z8IcVEHpRRZ6"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" name="dei:TradingSymbol">CGTX</ix:nonNumeric></span></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_edei--SecurityExchangeName_c20230310__20230310_zcMuX5KElYsh"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2
of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">Emerging
growth company&#160;<span style="font-family: Wingdings"><span id="xdx_907_edei--EntityEmergingGrowthCompany_c20230310__20230310_zrpYwr5JVugk"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#120;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.&#160;<span style="font-family: Wingdings"><span id="xdx_90D_edei--EntityExTransitionPeriod_c20230310__20230310_zRyUwinSHmL2"><ix:nonNumeric contextRef="From2023-03-10to2023-03-10" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top; background-color: #FEFEFE">
    <td style="width: 10%; font-size: 10pt"><span style="font-size: 10pt"><b>Item 1.01</b></span></td>
    <td style="font-size: 10pt; width: 90%"><span style="font-size: 10pt"><b>Entry into a Material Definitive Agreement.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On March 10, 2023,
Cognition Therapeutics, Inc. (the &#8220;Company&#8221;) entered into a purchase agreement (the &#8220;Purchase Agreement&#8221;)
with Lincoln Park Capital Fund, LLC (&#8220;Lincoln Park&#8221;), which provides that, upon the terms and subject to the conditions
and limitations set forth therein, the Company has the right, but not the obligation, to sell to Lincoln Park up to $35,000,000 of
shares of the Company&#8217;s common stock (the &#8220;Purchase Shares&#8221;) from time to time over the 36-month term of the
Purchase Agreement. Concurrently with entering into the Purchase Agreement, the Company also entered into a registration rights
agreement with Lincoln Park (the &#8220;Registration Rights Agreement&#8221;) pursuant to which the Company agreed to register the
sale of the shares of the Company&#8217;s common stock that have been and may be issued to Lincoln Park under the Purchase Agreement
pursuant to the Company&#8217;s existing shelf registration statement on Form S-3 (File No. 333-268992) (the &#8220;Registration
Statement&#8221;) or a new registration statement. Upon the execution of the Purchase Agreement, the Company issued 189,856 Commitment
Shares to Lincoln Park and paid Lincoln Park $350,000, which together represents the fee for Lincoln Park&#8217;s commitment to
purchase shares of the Company&#8217;s common stock under the Purchase Agreement. Lincoln Park has agreed not to cause or engage, in
any manner whatsoever, any direct or indirect short selling or hedging of the Company&#8217;s common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">After the
Commencement Date (as defined below), on any business day selected by the Company, the Company may direct Lincoln Park to purchase
up to 100,000 shares of its common stock on such business day (or the purchase date) (a &#8220;Regular Purchase&#8221;), provided
that the closing sale price of the Company's common stock on the Nasdaq Stock Market (&#8220;Nasdaq&#8221;) on the applicable purchase date is
not below $0.20 and subject to other adjustments. A Regular Purchase may be increased to up to (i) 125,000 shares if the closing
sale price of the Company&#8217;s common stock on Nasdaq is not below $3.00 on the
applicable purchase date and (ii) 150,000 shares if the closing sale price of the
Company&#8217;s common stock on Nasdaq is not below $4.00 on the applicable purchase date. The Company may direct Lincoln Park to
purchase shares in Regular Purchases as often as every business day.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The purchase price per
share for each such Regular Purchase will be equal to the lesser of:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 4%; text-align: justify">&#160;</td>
    <td style="white-space: nowrap; width: 3%; text-align: justify"><span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 93%; text-align: justify"><span style="font-size: 10pt">the lowest sale price for the Company&#8217;s common stock on Nasdaq on the purchase date of such shares; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify">&#160;</td>
    <td style="white-space: nowrap; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify">&#160;</td>
    <td style="white-space: nowrap; text-align: justify"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the average of the three (3) lowest closing sale prices for the Company&#8217;s common stock on Nasdaq during the ten (10) consecutive business days prior to the purchase date of such shares.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In addition, the Company
may also direct Lincoln Park, on any business day on which the Company has submitted a Regular Purchase notice for the maximum amount
allowed for such Regular Purchase, to purchase an additional amount of the Company&#8217;s common stock (an &#8220;Accelerated Purchase&#8221;)
of up to the lesser of:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 4%; text-align: justify">&#160;</td>
    <td style="white-space: nowrap; width: 3%; text-align: justify"><span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 93%; text-align: justify"><span style="font-size: 10pt">three (3) times the number of shares purchased pursuant to such Regular Purchase; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify">&#160;</td>
    <td style="white-space: nowrap; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify">&#160;</td>
    <td style="white-space: nowrap; text-align: justify"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">30% of the aggregate shares of the Company&#8217;s common stock traded on Nasdaq during all or, if certain trading volume or market price thresholds specified in the Purchase Agreement are crossed on the applicable Accelerated Purchase date, the portion of the normal trading hours on the applicable Accelerated Purchase date prior to such time that any one of such thresholds is crossed (the &#8220;Accelerated Purchase Measurement Period&#8221;).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The purchase price per
share for each such Accelerated Purchase will be equal to 97% of the lower of:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 4%; text-align: justify">&#160;</td>
    <td style="white-space: nowrap; width: 3%; text-align: justify"><span style="font-family: Symbol">&#183;</span></td>
    <td style="width: 93%; text-align: justify"><span style="font-size: 10pt">the closing sale price of the Company&#8217;s common stock on Nasdaq on the applicable Accelerated Purchase date; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify">&#160;</td>
    <td style="white-space: nowrap; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify">&#160;</td>
    <td style="white-space: nowrap; text-align: justify"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the volume-weighted average price of the Company&#8217;s common stock on Nasdaq during the applicable Accelerated Purchase Measurement Period on the applicable Accelerated Purchase date.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company may also
direct Lincoln Park, on any business day on which an Accelerated Purchase has been completed and all of the shares to be purchased thereunder
have been delivered to Lincoln Park in accordance with the Purchase Agreement, to purchase an additional amount of the Company&#8217;s
common stock (an &#8220;Additional Accelerated Purchase&#8221;) as described in the Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In the case of Regular
Purchases, Accelerated Purchases and Additional Accelerated Purchases, the purchase price per share will be equitably adjusted for any
reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction occurring during the
business days used to compute the purchase price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Purchase Agreement
prohibits the Company from directing Lincoln Park to purchase any shares of common stock if those shares, when aggregated with all other
shares of Common Stock then beneficially owned by Lincoln Park (as calculated pursuant to Section 13(d) of the Securities Exchange Act
of 1934, as amended (the &#8220;Exchange Act&#8221;), and Rule 13d-3 thereunder), would result in Lincoln Park beneficially owning more
than 9.99% of the then total outstanding shares of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Under applicable
rules of Nasdaq, in no event may the Company issue or sell to Lincoln Park under the Purchase Agreement shares of its common stock,
including the Commitment Shares, in excess of 5,811,638 shares, which is equal to 19.99% of the shares of the Company&#8217;s common
stock outstanding immediately prior to the execution of the Purchase Agreement (the &#8220;Exchange Cap&#8221;) unless (i) the
Company obtains stockholder approval to issue shares of its common stock in excess of the Exchange Cap or (ii) the average price of
all shares of the Company&#8217;s common stock issued to Lincoln Park under the Purchase Agreement equals or exceeds
$1.79 per share (which represents a price equal to the lower of (a) the official closing price of the Company's common stock on Nasdaq immediately preceding the signing of the Purchase Agreement and (b) the average of the official closing prices of the Company's common stock on Nasdaq for the five (5) trading days immediately preceding the signing of the Purchase Agreement), such that the
transactions contemplated by the Purchase Agreement are exempt from the Exchange Cap limitation under applicable Nasdaq rules. In
any event, the Purchase Agreement specifically provides that the Company may not issue or sell any shares of its common stock under
the Purchase Agreement if such issuance or sale would breach any applicable rules or regulations of the Nasdaq.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Purchase Agreement
contains customary representations, warranties, covenants, closing conditions and indemnification and termination provisions. Sales under
the Purchase Agreement may commence only after certain conditions have been satisfied, the date on which all requisite conditions have
been satisfied (the &#8220;Commencement Date&#8221;), which conditions include the delivery to Lincoln Park of a prospectus supplement
covering the shares of the Company&#8217;s common stock issued or sold by the Company to Lincoln Park under the Purchase Agreement, approval
for listing on Nasdaq of the shares of the Company&#8217;s common stock issued or sold by the Company to Lincoln Park under the Purchase
Agreement, the issuance of the Commitment Shares to Lincoln Park under the Purchase Agreement, and the receipt by Lincoln Park of a customary
opinion of counsel and other certificates and closing documents. The Purchase Agreement may be terminated by the Company at any time,
at its sole discretion, without any cost or penalty, however, the Commitment Shares will not be returned to the Company. There are no
limitations on use of proceeds, financial or business covenants, restrictions on future financings (other than restrictions on the Company&#8217;s
ability to enter into additional &#8220;equity line&#8221; whereby an investor is irrevocably bound to purchase securities over a period
of time from the Company at a price based on the market price of the Company&#8217;s common stock at the time of such purchase), rights
of first refusal, participation rights, penalties or liquidated damages in the Purchase Agreement. The Company may deliver purchase notices
under the Purchase Agreement, subject to market conditions, and in light of the Company&#8217;s capital needs, from time to time and under
the limitations contained in the Purchase Agreement. Any proceeds that the Company receives under the Purchase Agreement are expected
to be used for working capital and general corporate purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The issuance of the
Purchase Shares and Commitment Shares have been registered pursuant to the Registration
Statement and the related base prospectus included in the Registration Statement, as supplemented by a prospectus supplement
filed on March 10, 2023. A copy of the legal opinion as to the validity of the shares of the Company&#8217;s common stock subject to
the Purchase Agreement is filed as Exhibit 5.1 attached hereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The foregoing is a summary
description of certain terms of the Purchase Agreement and the Registration Rights Agreement and, by its nature, is incomplete. Copies
of the Purchase Agreement and the Registration Rights Agreement are filed as Exhibits 10.1 and 10.2 attached hereto. The foregoing descriptions
of the Purchase Agreement and the Registration Rights Agreement are qualified in their entirety by reference to such exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Purchase Agreement
and Registration Rights Agreement contain customary representations and warranties, covenants and indemnification provisions that the
parties made to, and solely for the benefit of, each other in the context of all of the terms and conditions of such agreements and in
the context of the specific relationship between the parties thereto. The provisions of the Purchase Agreement and Registration Rights
Agreement, including any representations and warranties contained therein, are not for the benefit of any party other than the parties
thereto and are not intended as documents for investors and the public to obtain factual information about the current state of affairs
of the parties thereto. Rather, investors and the public should look to other disclosures contained in the Company&#8217;s annual, quarterly
and current reports the Company may file with the Securities and Exchange Commission (the &#8220;SEC&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The information contained
in this Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the shares of the Company&#8217;s
common stock discussed herein, nor shall there be any offer, solicitation or sale of the shares in any jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 10%"><span style="font-size: 10pt"><b>Item 2.02</b></span></td>
    <td style="width: 90%; text-align: justify"><span style="font-size: 10pt"><b>Results of Operations and Financial Condition.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">Preliminary unaudited operating results for the
year ended December 31, 2022 and certain preliminary financial condition information as of December 31, 2022 are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse"><tr style="vertical-align: top; text-align: justify">
<td style="width: 4%"></td><td style="width: 3%; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 93%">Net loss for the year ended December 31, 2022 is expected to
be approximately $21.4 million.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-indent: -4.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse"><tr style="vertical-align: top; text-align: justify">
<td style="width: 4%"></td><td style="width: 3%; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; width: 93%">As of December 31, 2022, the Company had approximately $41.6
million in cash and cash equivalents.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The above information is preliminary financial information
for the year ended December 31, 2022 and is subject to completion. The unaudited, estimated results for the year ended December 31, 2022
are preliminary and were prepared by the Company&#8217;s management, based upon the Company&#8217;s estimates, a number of assumptions
and currently available information, and are subject to revision based upon, among other things, year-end closing procedures and/or adjustments,
the completion of the Company&#8217;s audited financial statements and other operational procedures. This preliminary financial information
is the responsibility of management and has been prepared in good faith on a consistent basis with prior periods. However, the Company
has not completed its audited financial statements for the year ended December 31, 2022, and its actual results could be materially different
from this preliminary financial information, which preliminary information should not be regarded as a representation by the Company,
its management, or the underwriter as to its actual results for the year ended December 31, 2022. In addition, the Company&#8217;s independent
registered public accounting firm has not completed its audit procedures with respect to this preliminary financial information and does
not express an opinion or any other form of assurance with respect to this preliminary financial information. During the course of the
preparation of the Company&#8217;s financial statements and related notes as of and for the year ended December 31, 2022, the Company
may identify items that would require it to make material adjustments to this preliminary financial information. As a result, prospective
investors should exercise caution in relying on this information and should not draw any inferences from this information. This preliminary
financial information should not be viewed as a substitute for full financial statements prepared in accordance with United States generally
accepted accounting principles and audited by the Company&#8217;s auditors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #212529">The information disclosed under
Item 2.02 is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of
1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, and shall not be deemed to
be incorporated by reference in any filing under the&#160;Securities Act of 1933, as amended, or the&#160;Exchange Act, except as expressly
set forth by specific reference in such filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top; background-color: #FEFEFE">
    <td style="width: 10%"><span style="font-size: 10pt"><b>Item 9.01</b></span></td>
    <td style="width: 90%"><span style="font-size: 10pt"><b>Financial Statements and Exhibits.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(d) Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-size: 10pt"><b>Exhibit<br />
    No.</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Document</b></span></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm239035d1_ex5-1.htm"><span style="font-size: 10pt">5.1</span></a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm239035d1_ex5-1.htm"><span style="font-size: 10pt">Opinion of Goodwin Procter LLP</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm239035d1_ex10-1.htm"><span style="font-size: 10pt">10.1</span></a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm239035d1_ex10-1.htm"><span style="font-size: 10pt">Purchase Agreement, dated as of March 10, 2023, by and between Cognition
    Therapeutics, Inc. and Lincoln Park Capital Fund, LLC</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm239035d1_ex10-2.htm"><span style="font-size: 10pt">10.2</span></a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm239035d1_ex10-2.htm"><span style="font-size: 10pt">Registration Rights Agreement, dated as of March 10, 2023, by and between
    Cognition Therapeutics, Inc. and Lincoln Park Capital Fund, LLC</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm239035d1_ex5-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">23.1</span></a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm239035d1_ex5-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Consent of Goodwin Procter LLP (contained in Exhibit 5.1)</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">The cover page from this Current Report on Form 8-K, formatted in Inline XBRL</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-size: 10pt"><b>COGNITION THERAPEUTICS, INC.</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 5%"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; width: 45%"><span style="font-size: 10pt">/s/ Lisa Ricciardi</span></td>
    <td style="width: 50%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">Name:</span></td>
    <td><span style="font-size: 10pt">Lisa Ricciardi</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">Title:</span></td>
    <td><span style="font-size: 10pt">President and Chief Executive Officer</span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: March 10, 2023</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5ltpUitI3LSpiFSkivka7lWCbLZv4dyRvaWwRl4VlmflmhBiIJS10jQzHWZHDHpu2Vg6hwAoZzRm9I1utU/C3wIu2jpVx3fsDM/IMeiYJZXTyQme9a4tlClIO5WQYS4iSdDSG6UYEXz0jU+kSjdOqBmVK2DG1rNEpfvUJe/UkQ82rqzogW03Gx4VRL78hjmQMW7qrB/HVQp5nIhh0E4gl06391tysowbmNTa+y/bof4MPEEFJPA== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>tm239035d1_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font-weight: bold; text-align: right; margin: 0">Exhibit 5.1</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="5" STYLE="width: 80%; font-size: 10pt"><IMG SRC="tm239035d1_ex5-1img01.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 20%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwin Procter
    LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; font-size: 10pt">292 Arch Street Suit #1700<BR>
    Philadelphia, PA 19104</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; font-size: 10pt">goodwinlaw.com</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+1 (445) 207-7800</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">March 10, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cognition Therapeutics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2500 Westchester Ave.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Purchase, NY 10577</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Re:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Securities Registered under Registration Statement on Form
S-3</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have acted as counsel to you in connection with your filing of a
Registration Statement on Form&nbsp;S-3 (File No.&nbsp;333-268992) (as amended or supplemented, the &ldquo;Registration Statement&rdquo;)
filed on December 23, 2022 with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) pursuant to the Securities Act of
1933, as amended (the &ldquo;Securities Act&rdquo;), relating to the registration of the offer of any combination of securities of the
types specified therein of Cognition Therapeutics, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), having an aggregate offering
price of up to $200,000,000. The Registration Statement was declared effective by the Commission on January 3, 2023. We are delivering
this supplemental opinion letter in connection with the prospectus supplement (the &ldquo;Prospectus Supplement&rdquo;) filed on March
10, 2023 by the Company with the Commission pursuant to Rule&nbsp;424 under the Securities Act. The Prospectus Supplement relates to the
offering of (i) 189,856 shares of the Company&rsquo;s common stock, par value $0.001, of the Company (the &ldquo;Common Stock&rdquo;)
and (ii) subject to certain conditions, additional shares of Common Stock having an aggregate gross purchase price up to $35,000,000 from
time to time (together, the &ldquo;Shares&rdquo;). The Shares are being sold to Lincoln Park Capital Fund, LLC (the &ldquo;Purchaser&rdquo;)
pursuant to a Purchase Agreement to be entered into between the Company and the Purchaser (the &ldquo;Purchase Agreement&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have reviewed such documents and made such examination of law as
we have deemed appropriate to give the opinion set forth below. We have relied, without independent verification, on certificates of public
officials and, as to matters of fact material to the opinion set forth below, on certificates of officers of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">For purposes of our opinion set forth below, we have
assumed (i) approval by the Company's board of directors (or a duly authorized committee thereof) of each issuance of Shares, (ii) that the Shares
are issued for a price per share equal to or greater than the minimum price, if any, authorized by the Company's board of directors (or
a duly authorized committee thereof) prior to the date of issuance (the "Minimum Price") and (iii) that no
event occurs that causes the number of authorized shares of Common Stock available for issuance by the Company to be less than the number
of then unissued Shares that may be issued for the Minimum Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The opinion set forth below is limited to the Delaware General Corporation
Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cognition Therapeutics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 10, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Based on the foregoing, we are of the opinion that the Shares have
been duly authorized and, subject to issuance by the Company at a price not less than the Minimum Price, when delivered and paid for in
accordance with the Purchase Agreement and in accordance with any reservation of shares or other restrictions or limitations imposed by
the Company&rsquo;s board of directors (or a duly authorized committee thereof) on sales of Shares by the Company under the Purchase Agreement,
will be validly issued, fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This opinion letter and the opinion it contains shall be interpreted
in accordance with the Core Opinion Principles as published in 74 <I>Business Lawyer</I> 815 (Summer 2019).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We hereby consent to the inclusion of this opinion as Exhibit&nbsp;5.1
to the Registration Statement and to the references to our firm under the caption &ldquo;Legal Matters&rdquo; in the Registration Statement.
In giving our consent, we do not admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities
Act or the rules and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Goodwin Procter LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">GOODWIN PROCTER <FONT STYLE="font-size: 10pt">LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>tm239035d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0; margin-right: 0; margin-bottom: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin-top: 0; margin-right: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">PURCHASE
AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>THIS
PURCHASE AGREEMENT</B> (the &quot;<U>Agreement</U>&quot;), dated as of March 10, 2023, is made by and between <FONT STYLE="text-transform: uppercase"><B>Cognition
Therapeutics, Inc.</B></FONT>, a Delaware corporation (the &quot;<U>Company</U>&quot;), and <B>LINCOLN PARK CAPITAL FUND, LLC</B>, an
Illinois limited liability company (the &quot;<U>Investor</U>&quot;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center"><B>WHEREAS:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">Subject
to the terms and conditions set forth in this Agreement, the Company wishes to sell to the Investor, and the Investor wishes to buy from
the Company, up to Thirty-Five Million Dollars ($35,000,000) of the Company&rsquo;s common stock, $0.001 par value per share (the &quot;<U>Common
Stock</U>&quot;). The shares of Common Stock to be purchased hereunder are referred to herein as the &quot;<U>Purchase Shares</U>.&quot;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">NOW
THEREFORE, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the Company and the Investor hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">1.</FONT></TD><TD>CERTAIN DEFINITIONS.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">For
purposes of this Agreement, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>&quot;<U>Accelerated
Purchase Date</U>&quot; means, with respect to any Accelerated Purchase made pursuant to <U>Section 2(b)</U> hereof, the Business Day
immediately following the applicable Purchase Date with respect to the corresponding Regular Purchase referred to in <U>Section 2(b)
</U>hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>&quot;<U>Accelerated
Purchase Minimum Price Threshold</U>&quot; means, with respect to any Accelerated Purchase made pursuant to <U>Section 2(b)</U> hereof,
any minimum per share price threshold set forth by the Company in the applicable Accelerated Purchase Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Accelerated Purchase Notice</U>&quot; means, with respect to any Accelerated Purchase made pursuant to <U>Section
2(b) </U>hereof, an irrevocable written notice from the Company to the Investor directing the Investor to purchase the applicable Accelerated
Purchase Share Amount at the Accelerated Purchase Price on the Accelerated Purchase Date for such Accelerated Purchase in accordance
with this Agreement, and specifying any Accelerated Purchase Minimum Price Threshold determined by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Accelerated Purchase Price</U>&quot; means, with respect to any Accelerated Purchase made pursuant to <U>Section
2(b)</U> hereof, the lower of ninety-seven percent (97%) of (i) the VWAP for the period beginning at 9:30:01 a.m., Eastern time, on the
applicable Accelerated Purchase Date, or such other time publicly announced by the Principal Market as the official open (or commencement)
of trading on the Principal Market on such applicable Accelerated Purchase Date (the &quot;<U>Accelerated Purchase Commencement Time</U>&quot;),
and ending at the earliest of (A) 4:00:00 p.m., Eastern time, on such applicable Accelerated Purchase Date, or such other time publicly
announced by the Principal Market as the official close of trading on the Principal Market on such applicable Accelerated Purchase Date,
(B) such time, from and after the Accelerated Purchase Commencement Time for such Accelerated Purchase, that the total number (or volume)
of shares of Common Stock traded on the Principal Market has exceeded the applicable Accelerated Purchase Share Volume Maximum, and (C)
such time, from and after the Accelerated Purchase Commencement Time for such Accelerated Purchase, that the Sale Price has fallen below
the applicable Accelerated Purchase Minimum Price Threshold (such earliest of (i)(A), (i)(B) and (i)(C) above, the &quot;<U>Accelerated
Purchase Termination Time</U>&quot;), and (ii) the Closing Sale Price of the Common Stock on such applicable Accelerated Purchase Date
(to be appropriately adjusted for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other
similar transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Accelerated Purchase Share Amount</U>&quot; means, with respect to any Accelerated Purchase made pursuant to <U>Section
2(b)</U> hereof, the number of Purchase Shares directed by the Company to be purchased by the Investor in an Accelerated Purchase Notice,
which number of Purchase Shares shall not exceed the lesser of (i) 300% of the number of Purchase Shares directed by the Company to be
purchased by the Investor pursuant to the corresponding Regular Purchase Notice for the corresponding Regular Purchase referred to in
<U>Section 2(b)</U> hereof (subject to the Purchase Share limitations contained in <U>Section 2(a)</U> hereof) and (ii) an amount equal
to (A) the Accelerated Purchase Share Percentage multiplied by (B) the total number (or volume) of shares of Common Stock traded on the
Principal Market during the period on the applicable Accelerated Purchase Date beginning at the Accelerated Purchase Commencement Time
for such Accelerated Purchase and ending at the Accelerated Purchase Termination Time for such Accelerated Purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Accelerated Purchase Share Percentage</U>&quot; means, with respect to any Accelerated Purchase made pursuant
to <U>Section 2(b)</U> hereof, thirty percent (30%).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Accelerated Purchase Share Volume Maximum</U>&quot; means, with respect to any Accelerated Purchase made pursuant
to <U>Section 2(b)</U> hereof, a number of shares of Common Stock equal to (i) the applicable Accelerated Purchase Share Amount properly
directed by the Company to be purchased by the Investor in the applicable Accelerated Purchase Notice for such Accelerated Purchase,
divided by (ii) the Accelerated Purchase Share Percentage (to be appropriately adjusted for any reorganization, recapitalization, non-cash
dividend, stock split, reverse stock split or other similar transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Additional Accelerated Purchase Date</U>&quot; means, with respect to any Additional Accelerated Purchase made
pursuant to <U>Section 2(c)</U> hereof, the Business Day (i) that is the Accelerated Purchase Date with respect to the corresponding
Accelerated Purchase referred to in <U>Section 2(b)</U> hereof and (ii) on which the Investor receives, prior to 1:00 p.m., Eastern time,
on such Business Day, a valid Additional Accelerated Purchase Notice for such Additional Accelerated Purchase in accordance with this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT> &quot;<U>Additional Accelerated Purchase Minimum Price Threshold</U>&quot; means, with respect to any Additional Accelerated
Purchase made pursuant to <U>Section 2(c)</U> hereof, any minimum per share price threshold set forth by the Company in the applicable
Additional Accelerated Purchase Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Additional Accelerated Purchase Notice</U>&quot; means, with respect to any Additional Accelerated Purchase made
pursuant to <U>Section 2(c)</U> hereof, an irrevocable written notice from the Company to the Investor directing the Investor to purchase
the applicable Additional Accelerated Purchase Share Amount at the Additional Accelerated Purchase Price for such Additional Accelerated
Purchase in accordance with this Agreement, and specifying any Additional Accelerated Purchase Minimum Price Threshold determined by
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Additional Accelerated Purchase Price</U>&quot; means, with respect to any Additional Accelerated Purchase made
pursuant to <U>Section 2(c)</U> hereof, the lower of ninety-seven percent (97%) of (i) the VWAP for the period on the applicable Additional
Accelerated Purchase Date, beginning at the latest of (A) the applicable Accelerated Purchase Termination Time with respect to the corresponding
Accelerated Purchase referred to in <U>Section 2(c)</U> hereof on such Additional Accelerated Purchase Date, (B) the applicable Additional
Accelerated Purchase Termination Time with respect to the most recently completed prior Additional Accelerated Purchase on such Additional
Accelerated Purchase Date, as applicable, and (C) the time at which all Purchase Shares subject to all prior Accelerated Purchases and
Additional Accelerated Purchases (as applicable), including, without limitation, those that have been effected on the same Business Day
as the applicable Additional Accelerated Purchase Date with respect to which the applicable Additional Accelerated Purchase relates,
have theretofore been received by the Investor as DWAC Shares in accordance with this Agreement (such latest of (i)(A), (i)(B) and (i)(C)
above, the &quot;<U>Additional Accelerated Purchase Commencement Time</U>&quot;), and ending at the earliest of (X) 4:00 p.m., Eastern
time, on such Additional Accelerated Purchase Date, or such other time publicly announced by the Principal Market as the official close
of trading on the Principal Market on such Additional Accelerated Purchase Date, (Y) such time, from and after the Additional Accelerated
Purchase Commencement Time for such Additional Accelerated Purchase, that the total number (or volume) of shares of Common Stock traded
on the Principal Market has exceeded the applicable Additional Accelerated Purchase Share Volume Maximum, and (Z) such time, from and
after the Additional Accelerated Purchase Commencement Time for such Additional Accelerated Purchase, that the Sale Price has fallen
below the applicable Additional Accelerated Purchase Minimum Price Threshold (such earliest of (i)(X), (i)(Y) and (i)(Z) above, the &quot;<U>Additional
Accelerated Purchase Termination Time</U>&quot;), and (ii) the Closing Sale Price of the Common Stock on such Additional Accelerated
Purchase Date (to be appropriately adjusted for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split
or other similar transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Additional Accelerated Purchase Share Amount</U>&quot; means, with respect to any Additional Accelerated Purchase
made pursuant to <U>Section 2(c)</U> hereof, the number of Purchase Shares directed by the Company to be purchased by the Investor on
an Additional Accelerated Purchase Notice, which number of Purchase Shares shall not exceed the lesser of (i) 300% of the number of Purchase
Shares directed by the Company to be purchased by the Investor pursuant to the corresponding Regular Purchase Notice for the corresponding
Regular Purchase referred to in <U>Section 2(c)</U> hereof (subject to the Purchase Share limitations contained in <U>Section 2(a)</U>
hereof) and (ii) an amount equal to (A) the Additional Accelerated Purchase Share Percentage multiplied by (B) the total number (or volume)
of shares of Common Stock traded on the Principal Market during the period on the applicable Additional Accelerated Purchase Date beginning
at the Additional Accelerated Purchase Commencement Time for such Additional Accelerated Purchase and ending at the Additional Accelerated
Purchase Termination Time for such Additional Accelerated Purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Additional Accelerated Purchase Share Percentage</U>&quot; means, with respect to any Additional Accelerated Purchase
made pursuant to <U>Section 2(c)</U> hereof, thirty percent (30%).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Additional Accelerated Purchase Share Volume Maximum</U>&quot; means, with respect to any Additional Accelerated
Purchase made pursuant to <U>Section 2(c)</U> hereof, a number of shares of Common Stock equal to (i) the applicable Additional Accelerated
Purchase Share Amount properly directed by the Company to be purchased by the Investor in the applicable Additional Accelerated Purchase
Notice for such Additional Accelerated Purchase, divided by (ii) the Additional Accelerated Purchase Share Percentage (to be appropriately
adjusted for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><FONT STYLE="background-color: white">&quot;<U>Alternate Adjusted Regular Purchase Share Limit</U>&quot; means, with respect
to a Regular Purchase made pursuant to <U>Section 2(a)</U> hereof, the maximum number of Purchase Shares which, taking into account the
applicable per share Purchase Price therefor calculated in accordance with this Agreement, would enable the Company to deliver to the
Investor, on the applicable Purchase Date for such Regular Purchase, a Regular Purchase Notice for a Purchase Amount equal to, or as
closely approximating without exceeding, One Hundred Fifty Thousand ($150,000).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(p)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Applicable Laws</U>&quot; means, with respect to any Person, the common law and any federal, provincial, state,
territorial, local, foreign, multinational or international laws, statutes, codes, treaties, standards, rules and regulations, guidelines,
ordinances, orders, judgments, writs, injunctions, decrees or settlement agreements (including administrative or judicial precedents
or authorities) and the interpretation or administration thereof by, and other determinations, directives, requirements or requests of,
any governmental authority, in each case whether or not having the force of law and, in each case, that are applicable to or binding
upon such Person or any of its property or to which such Person or any of its property is subject.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(q)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Available Amount</U>&quot; means, initially, Thirty-Five Million Dollars ($35,000,000) in the aggregate, which
amount shall be reduced by the Purchase Amount each time the Investor purchases shares of Common Stock pursuant to <U>Section 2</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(r)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Bankruptcy Law</U>&quot; means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(s)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Base Prospectus</U>&quot; means the Company&rsquo;s final base prospectus, dated January 3, 2023, including the
documents incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(t)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Business Day</U>&quot; means any day on which the Principal Market is open for trading, including any day on which
the Principal Market is open for trading for a period of time less than the customary time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(u)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Bylaws</U>&quot; means the Company&rsquo;s Amended and Restated Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Charter</U>&quot; means the Company&rsquo;s Third Amended and Restated Certificate of Incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(w)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Closing Sale Price</U>&quot; means, for any security as of any date, the last closing sale price for such security
on the Principal Market as reported by the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Confidential Information</U>&quot; means any information disclosed by either party to the other party, either
directly or indirectly, in writing, orally or by inspection of tangible objects (including, without limitation, documents, prototypes,
samples, plant and equipment), which by its nature is confidential or proprietary and would be judged so under a reasonable standard
or is disclosed or provided under circumstances reasonably indicating it is confidential or proprietary, regardless of whether the information
is designated, either orally or in writing, as &quot;Confidential,&quot; &quot;Proprietary&quot; or some similar designation. Confidential
Information may also include information disclosed to a disclosing party by third parties. Confidential Information shall not, however,
include any information which (i) was publicly known and made generally available in the public domain prior to the time of disclosure
by the disclosing party; (ii) becomes publicly known and made generally available after disclosure by the disclosing party to the receiving
party through no action or inaction of the receiving party; (iii) is already in the possession of the receiving party without confidential
restriction at the time of disclosure by the disclosing party as shown by the receiving party&rsquo;s files and records immediately prior
to the time of disclosure; (iv) is obtained by the receiving party from a third party and is not known by the receiving party to be a
breach of such third party&rsquo;s obligations of confidentiality; or (v) is independently developed by the receiving party without use
of or reference to the disclosing party&rsquo;s Confidential Information, as shown by documents and other competent evidence in the receiving
party&rsquo;s possession.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(y)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Custodian</U>&quot; means any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy
Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(z)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>DTC</U>&quot; means The Depository Trust Company, or any successor performing substantially the same function
for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(aa)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>DWAC Shares</U>&quot; means shares of Common Stock that are (i) issued in electronic form, (ii) freely tradable
and transferable and without restriction on resale and (iii) timely credited by the Company, once a DWAC notice is received, to the Investor&rsquo;s
or its designee&rsquo;s specified Deposit/Withdrawal at Custodian (DWAC) account with DTC under its Fast Automated Securities Transfer
(FAST) Program, or any similar program hereafter adopted by DTC performing substantially the same function.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(bb)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Exchange Act</U>&quot; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(cc)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT> &quot;<U>Fully Adjusted Regular Purchase Share Limit</U>&quot; means, with respect to any reorganization, recapitalization,
non-cash dividend, stock split or other similar transaction from and after the date of this Agreement, the Regular Purchase Share Limit
(as defined in <U>Section 2(a)</U> hereof) in effect on the applicable date of determination, after giving effect to the full proportionate
adjustment thereto made pursuant to <U>Section 2(a)</U> hereof for or in respect of such reorganization, recapitalization, non-cash dividend,
stock split or other similar transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(dd)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
 &#8239;&#8239;&#8239;</FONT></FONT>&quot;<U>Initial Prospectus Supplement</U>&quot; means the prospectus supplement of the Company relating
to the Securities, including the accompanying Base Prospectus, to be prepared and filed by the Company with the SEC pursuant to Rule
424(b)(5) under the Securities Act and in accordance with <U>Section 5(a)</U> hereof, together with all documents and information incorporated
therein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(ee)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&#8239;&quot;<U>Material Adverse Effect</U>&quot; means any material adverse effect on (i) the enforceability of any Transaction
Document, (ii) the results of operations, operations, assets, business or financial condition of the Company and its Subsidiaries, taken
as a whole, other than any material adverse effect that resulted exclusively from (A) any change in the United States or foreign economies
or securities or financial markets in general that does not have a disproportionate effect on the Company and its Subsidiaries, taken
as a whole, (B) any change that generally affects the industry in which the Company and its Subsidiaries operate that does not have a
disproportionate effect on the Company and its Subsidiaries, taken as a whole, (C) any change arising in connection with earthquakes,
hostilities, acts of war, civil unrest, sabotage or terrorism or military actions or any escalation or material worsening of any such
hostilities, acts of war, civil unrest, sabotage or terrorism or military actions existing as of the date hereof, (D) any action taken
by the Investor, its affiliates or its or their successors and assigns with respect to the transactions contemplated by this Agreement,
(E) the effect of any change in Applicable Laws or accounting rules that does not have a disproportionate effect on the Company and its
Subsidiaries, taken as a whole, or (F) any change resulting from compliance with terms of this Agreement or the consummation of the transactions
contemplated by this Agreement, or (iii) the Company&rsquo;s ability to perform in any material respect on a timely basis its obligations
under any Transaction Document to be performed as of the date of determination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(ff)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Maturity Date</U>&quot; means the first day of the month immediately following the thirty-six (36) month anniversary
of the Commencement Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(gg)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>PEA Period</U>&quot; means the period commencing at 9:30 a.m., Eastern time, on the tenth (10<SUP>th</SUP>) Business
Day immediately prior to the filing of any post-effective amendment to the Registration Statement (as defined herein) or New Registration
Statement (as such term is defined in the Registration Rights Agreement), and ending at 9:30 a.m., Eastern time, on the Business Day
immediately following, the effective date of any post-effective amendment to the Registration Statement (as defined herein) or New Registration
Statement (as such term is defined in the Registration Rights Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(hh)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Person</U>&quot; means an individual or entity including but not limited to any limited liability company, a partnership,
a joint venture, a corporation, a trust, an unincorporated organization and a government or any department or agency thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Principal Market</U>&quot; means The Nasdaq Global Market (or any nationally recognized successor thereto); provided,
however, that in the event the Company&rsquo;s Common Stock is at any time not listed on The Nasdaq Global Market (or any nationally
recognized successor thereto) but is listed or traded on The Nasdaq Capital Market, The Nasdaq Global Select Market, the New York Stock
Exchange, the NYSE American, the NYSE Arca, the OTC Bulletin Board, or the OTCQX or OTCQB operated by the OTC Markets Group, Inc. (or
any nationally recognized successor to any of the foregoing), then the &quot;Principal Market&quot; shall mean such other market or exchange
which then constitutes the principal trading market for the Company&rsquo;s Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(jj)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Prospectus</U>&quot; means the Base Prospectus, as supplemented from time to time by any Prospectus Supplement
(including the Initial Prospectus Supplement), including the documents and information incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(kk)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Prospectus Supplement</U>&quot; means any prospectus supplement to the Base Prospectus (including the Initial
Prospectus Supplement) filed with the SEC pursuant to Rule 424(b) under the Securities Act in connection with the transactions contemplated
by this Agreement, including the documents and information incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(ll)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT> &quot;<U>Purchase Amount</U>&quot; means, with respect to any Regular Purchase, any Accelerated Purchase, or any Additional
Accelerated Purchase made hereunder, as applicable, the portion of the Available Amount to be purchased by the Investor pursuant to <U>Section
2</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(mm)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Purchase Date</U>&quot; means, with respect to a Regular Purchase made pursuant to <U>Section 2(a)</U> hereof,
the Business Day on which the Investor receives, after 4:00 p.m., Eastern time, but prior to 10:00 p.m., Eastern time, on such Business
Day, a valid Regular Purchase Notice for such Regular Purchase in accordance with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(nn)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Purchase Price</U>&quot; means, with respect to a Regular Purchase made pursuant to <U>Section 2(a)</U> hereof,
the lower of: (i) the lowest Sale Price on the Purchase Date for such Regular Purchase and (ii) the arithmetic average of the three (3)
lowest Closing Sale Prices for the Common Stock during the ten (10) consecutive Business Days ending on the Business Day immediately
preceding such Purchase Date for such Regular Purchase (in each case, to be appropriately adjusted for any reorganization, recapitalization,
non-cash dividend, stock split or other similar transaction that occurs on or after the date of this Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(oo)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>&quot;<U>Registration
Rights Agreement</U>&quot; means that certain Registration Rights Agreement, of even date herewith between the Company and the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(pp)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Registration Statement</U>&quot; has the meaning set forth in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(qq)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Regular Purchase Notice</U>&quot; means, with respect to a Regular Purchase pursuant to <U>Section 2(a)</U> hereof,
an irrevocable written notice from the Company to the Investor directing the Investor to buy a specified number of Purchase Shares (subject
to the Purchase Share limitations contained in <U>Section 2(a)</U> hereof) at the applicable Purchase Price for such Regular Purchase
in accordance with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(rr)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Sale Price</U>&quot; means any trade price for the shares of Common Stock on the Principal Market as reported
by the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(ss)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>SEC</U>&quot; means the U.S. Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(tt)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Securities</U>&quot; means, collectively, the Purchase Shares and the Commitment Shares (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(uu)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>&quot;<U>Securities
Act</U>&quot; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(vv)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Shelf Registration Statement</U>&quot; means the Company&rsquo;s existing registration statement on Form S-3 (File
No. 333-268992), initially filed on December 23, 2022 and declared effective by order of the SEC on January 3, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(ww)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Subsidiary</U>&quot; means any Person the Company wholly-owns or controls, or in which the Company, directly or
indirectly, owns a majority of the voting stock or similar voting interest, in each case that would be disclosable pursuant to Item 601(b)(21)
of Regulation S-K promulgated under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(xx)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT> &quot;<U>Transaction Documents</U>&quot; means, collectively, this Agreement and the schedules and exhibits hereto, the
Registration Rights Agreement and the schedules and exhibits thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(yy)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>Transfer Agent</U>&quot; means American Stock Transfer &amp; Trust Company, LLC, or such other Person who is then
serving as the transfer agent for the Company in respect of the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(zz)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&quot;<U>VWAP</U>&quot; means in respect of an Accelerated Purchase Date and an Additional Accelerated Purchase Date, as
applicable, the volume weighted average price of the Common Stock on the Principal Market, as reported on the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">2.</FONT></TD><TD>PURCHASE OF COMMON STOCK.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">Subject
to the terms and conditions set forth in this Agreement, the Company has the right, but not the obligation to sell to the Investor, in
the Company&rsquo;s sole and absolute discretion, and the Investor has the obligation to purchase from the Company, Purchase Shares as
follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Commencement of Regular Sales of Common Stock</U>. Beginning one (1) Business Day following the satisfaction of the
conditions set forth in Sections 7 and 8 hereof (the &quot;<U>Closing</U>&quot; and the date of satisfaction of such conditions the &quot;<U>Commencement
Date</U>&quot;) and thereafter, the Company shall have the right, but not the obligation, to direct the Investor, by its delivery to
the Investor of a Regular Purchase Notice from time to time, to purchase up to One Hundred Thousand (100,000) Purchase Shares, provided
that the Closing Sale Price of the Common Stock on the applicable Purchase Date is not below $0.20 and subject to adjustment as set forth
below in this Section 2(a) (such maximum number of Purchase Shares, as may be adjusted from time to time, the &quot;<U>Regular Purchase
Share Limit</U>&quot;), at the Purchase Price on the Purchase Date (each such purchase a &quot;<U>Regular Purchase</U>&quot;); <U>provided</U>,
<U>however</U>, that the Regular Purchase Share Limit shall be increased to: (i) One Hundred Twenty-Five Thousand (125,000) Purchase
Shares, if the Closing Sale Price of the Common Stock on the applicable Purchase Date is not below $3.00 and (ii) One Hundred Fifty Thousand
(150,000) Purchase Shares, if the Closing Sale Price of the Common Stock on the applicable Purchase Date is not below $4.00 (all of which
share and dollar amounts shall be appropriately proportionately adjusted for any reorganization, recapitalization, non-cash dividend,
stock split or other similar transaction); <U>provided</U> that if, after giving effect to the full proportionate adjustment to the Regular
Purchase Share Limit therefor, the Fully Adjusted Regular Purchase Share Limit then in effect would preclude the Company from delivering
to the Investor a Regular Purchase Notice hereunder for a Purchase Amount (calculated by multiplying (X) the number of Purchase Shares
equal to the Fully Adjusted Regular Purchase Share Limit, by (Y) the Purchase Price per Purchase Share covered by such Regular Purchase
Notice on the applicable Purchase Date therefor) equal to or greater than the Alternate Adjusted Regular Purchase Share Limit, the Regular
Purchase Share Limit for such Regular Purchase Notice shall not be fully adjusted to equal the applicable Fully Adjusted Regular Purchase
Share Limit, but rather the Regular Purchase Share Limit for such Regular Purchase Notice shall be adjusted to equal the applicable Alternate
Adjusted Regular Purchase Share Limit as of the applicable Purchase Date for such Regular Purchase Notice; and <U>provided</U>, <U>further</U>,
<U>however</U>, that the Investor&rsquo;s committed obligation under any single Regular Purchase, other than any Regular Purchase with
respect to which an Alternate Adjusted Regular Purchase Share Limit shall apply, shall not exceed One Million Five Hundred Thousand Dollars
($1,500,000) and <U>provided</U>, <U>further</U>, <U>however</U>, that the parties may mutually agree at any time to increase the dollar
amount of any Regular Purchase on any Purchase Date to a dollar amount greater than the limit then in effect. If the Company delivers
any Regular Purchase Notice for a Purchase Amount in excess of the limitations contained in the immediately preceding sentence, such
Regular Purchase Notice shall be void ab initio only with respect to the extent of the amount by which the number of Purchase Shares
set forth in such Regular Purchase Notice exceeds the number of Purchase Shares which the Company is permitted to include in such Purchase
Notice in accordance herewith, and the Investor shall have no obligation to purchase such excess Purchase Shares in respect of such Regular
Purchase Notice; provided, however, that the Investor shall remain obligated to purchase the number of Purchase Shares which the Company
is permitted to include in such Regular Purchase Notice. The Company may deliver a single Regular Purchase Notice to the Investor on
any Business Day, provided the Company has not failed to deliver Purchase Shares for the most recent prior Regular Purchase. Notwithstanding
the foregoing, the Company shall not deliver any Regular Purchase Notices during the PEA Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Accelerated Purchases</U>. Subject to the terms and conditions of this Agreement, from and after one (1) Business Day
following the Commencement Date, in addition to purchases of Purchase Shares as described in <U>Section 2(a)</U> above, the Company shall
also have the right, but not the obligation, to direct the Investor, by its delivery to the Investor of an Accelerated Purchase Notice
from time to time in accordance with this Agreement, to purchase the applicable Accelerated Purchase Share Amount at the Accelerated
Purchase Price on the Accelerated Purchase Date therefor in accordance with this Agreement (each such purchase, an &quot;<U>Accelerated
Purchase</U>&quot;); <U>provided however</U>, that the parties may mutually agree to increase the Accelerated Purchase Share Amount for
any Accelerated Purchase. The Company may deliver an Accelerated Purchase Notice to the Investor only on a Purchase Date on which the
Company also properly submitted a Regular Purchase Notice providing for a Regular Purchase of a number of Purchase Shares not less than
the Regular Purchase Share Limit then in effect on such Purchase Date in accordance with this Agreement (including, without limitation,
giving effect to any automatic increase to the Regular Purchase Share Limit as a result of the Closing Sale Price of the Common Stock
exceeding certain thresholds set forth in <U>Section 2(a)</U> above on such Purchase Date and any other adjustments to the Regular Purchase
Share Limit, in each case pursuant to <U>Section 2(a)</U> above). If the Company delivers any Accelerated Purchase Notice directing the
Investor to purchase an amount of Purchase Shares that exceeds the Accelerated Purchase Share Amount that the Company is then permitted
to include in such Accelerated Purchase Notice, such Accelerated Purchase Notice shall be void <I>ab initio</I> only with respect to
the extent of the amount by which the number of Purchase Shares set forth in such Accelerated Purchase Notice exceeds the Accelerated
Purchase Share Amount that the Company is then permitted to include in such Accelerated Purchase Notice (which shall be confirmed in
an Accelerated Purchase Confirmation), and the Investor shall have no obligation to purchase such excess Purchase Shares in respect of
such Accelerated Purchase Notice; <U>provided</U>, <U>however</U>, that the Investor shall remain obligated to purchase the Accelerated
Purchase Share Amount which the Company is permitted to include in such Accelerated Purchase Notice. Within one (1) Business Day after
completion of each Accelerated Purchase Date for an Accelerated Purchase, the Investor will provide to the Company a written confirmation
of such Accelerated Purchase setting forth the applicable Accelerated Purchase Share Amount and Accelerated Purchase Price for such Accelerated
Purchase (each, an &quot;<U>Accelerated Purchase Confirmation</U>&quot;). Notwithstanding the foregoing, the Company shall not deliver
any Accelerated Purchase Notices during the PEA Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Additional Accelerated Purchases</U>. Subject to the terms and conditions of this Agreement, from and after one (1)
Business Day following the Commencement Date, in addition to purchases of Purchase Shares as described in <U>Section 2(a)</U> and <U>Section
2(b)</U> above, the Company shall also have the right, but not the obligation, to direct the Investor, by its timely delivery to the
Investor of an Additional Accelerated Purchase Notice on an Additional Accelerated Purchase Date in accordance with this Agreement, to
purchase the applicable Additional Accelerated Purchase Share Amount at the applicable Additional Accelerated Purchase Price therefor
in accordance with this Agreement (each such purchase, an &quot;<U>Additional Accelerated Purchase</U>&quot;); <U>provided however</U>,
that the parties may mutually agree to increase the Additional Accelerated Purchase Share Amount for any Additional Accelerated Purchase.
The Company may deliver multiple Additional Accelerated Purchase Notices to the Investor on an Additional Accelerated Purchase Date;
<U>provided</U>, <U>however</U>, that the Company may deliver an Additional Accelerated Purchase Notice to the Investor only (i) on a
Business Day that is also the Accelerated Purchase Date for an Accelerated Purchase with respect to which the Company properly submitted
to the Investor an Accelerated Purchase Notice in accordance with this Agreement on the applicable Purchase Date for a Regular Purchase
of a number of Purchase Shares not less than the Regular Purchase Share Limit then in effect in accordance with this Agreement (including,
without limitation, giving effect to any automatic increase to the Regular Purchase Share Limit as a result of the Closing Sale Price
of the Common Stock exceeding certain thresholds set forth in <U>Section 2(a)</U> above on such Purchase Date and any other adjustments
to the Regular Purchase Share Limit, in each case pursuant to <U>Section 2(a)</U> above), and (ii) if all Purchase Shares subject to
all prior Regular Purchases, Accelerated Purchases and Additional Accelerated Purchases, including, without limitation, those that have
been effected on the same Business Day as the applicable Additional Accelerated Purchase Date with respect to which the applicable Additional
Accelerated Purchase relates, in each case have theretofore been received by the Investor as DWAC Shares in accordance with this Agreement.
If the Company delivers any Additional Accelerated Purchase Notice directing the Investor to purchase an amount of Purchase Shares that
exceeds the Additional Accelerated Purchase Share Amount that the Company is then permitted to include in such Additional Accelerated
Purchase Notice, such Additional Accelerated Purchase Notice shall be void <I>ab initio </I>only with respect to the extent of the amount
by which the number of Purchase Shares set forth in such Additional Accelerated Purchase Notice exceeds the Additional Accelerated Purchase
Share Amount that the Company is then permitted to include in such Additional Accelerated Purchase Notice (which shall be confirmed in
an Additional Accelerated Purchase Confirmation), and the Investor shall have no obligation to purchase such excess Purchase Shares in
respect of such Additional Accelerated Purchase Notice; <U>provided</U>, <U>however</U>, that the Investor shall remain obligated to
purchase the Additional Accelerated Purchase Share Amount which the Company is permitted to include in such Additional Accelerated Purchase
Notice. Within one (1) Business Day after completion of each Additional Accelerated Purchase Date, the Investor will provide to the Company
a written confirmation of each Additional Accelerated Purchase on such Additional Accelerated Purchase Date setting forth the applicable
Additional Accelerated Purchase Share Amount and Additional Accelerated Purchase Price for each such Additional Accelerated Purchase
on such Additional Accelerated Purchase Date (each, an &quot;<U>Additional Accelerated Purchase Confirmation</U>&quot;). Notwithstanding
the foregoing, the Company shall not deliver any Additional Accelerated Purchase Notices during the PEA Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; </FONT></FONT><U>Compliance
with Principal Market Rules</U>. Notwithstanding anything in this Agreement to the contrary, and in addition to the limitations set
forth in <U>Section 2(e)</U>, the Company shall not issue more than 5,811,638 shares (including the Commitment Shares) of Common
Stock (the &quot;<U>Exchange Cap</U>&quot;) under this Agreement, which equals 19.99% of the Company&rsquo;s outstanding shares of
Common Stock as of the date hereof, unless stockholder approval is obtained to issue in excess of the Exchange Cap; <U>provided</U>, <U>however</U>,
that the foregoing limitation shall not apply if at any time the Exchange Cap is reached and at all times thereafter the average
price paid for all shares of Common Stock issued under this Agreement is equal to or greater than $1.79 (the &quot;<U>Minimum
Price</U>&quot;), a price equal to the lower of (i) the Nasdaq Official Closing Price immediately preceding the execution of this
Agreement and (ii) the arithmetic average of the five (5) Nasdaq Official Closing Prices for the Common Stock immediately preceding
the execution of this Agreement, as calculated in accordance with the rules of the Principal Market (in such circumstance, for
purposes of the Principal Market, the transaction contemplated hereby would not be &quot;below market&quot; and the Exchange Cap
would not apply). Notwithstanding the foregoing, the Company shall not be required or permitted to issue, and the Investor shall not
be required to purchase, any shares of Common Stock under this Agreement if such issuance would violate the rules or regulations of
the Principal Market. The Company may, in its sole discretion, determine whether to obtain stockholder approval to issue more than
19.99% of its outstanding shares of Common Stock hereunder if such issuance would require stockholder approval under the rules or
regulations of the Principal Market. The Exchange Cap shall be reduced, on a share-for-share basis, by the number of shares of
Common Stock issued or issuable that may be aggregated with the transactions contemplated by this Agreement under applicable rules
of the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Payment for Purchase Shares.</U> For each Regular Purchase, the Investor shall pay to the Company an amount equal to
the Purchase Amount with respect to such Regular Purchase, as applicable, as full payment for such Purchase Shares via wire transfer
of immediately available funds on the same Business Day that the Investor receives such Purchase Shares, if such Purchase Shares are
received by the Investor before 1:00 p.m., Eastern time, or, if such Purchase Shares are received by the Investor after 1:00 p.m., Eastern
time, the next Business Day. For each Accelerated Purchase and each Additional Accelerated Purchase, the Investor shall pay to the Company
an amount equal to the Purchase Amount with respect to such Accelerated Purchase and Additional Accelerated Purchase, respectively, as
full payment for such Purchase Shares via wire transfer of immediately available funds on the second Business Day following the date
that the Investor receives such Purchase Shares. If the Company or the Transfer Agent shall fail for any reason or for no reason to electronically
transfer any Purchase Shares as DWAC Shares with respect to any Regular Purchase, Accelerated Purchase or Additional Accelerated Purchase
(as applicable) within two (2) Business Days following the receipt by the Company of the Purchase Price, Accelerated Purchase Price or
Additional Accelerated Purchase Price, respectively, therefor in compliance with this <U>Section 2(e)</U>, and if on or after such Business
Day the Investor purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by
the Investor of such Purchase Shares that the Investor anticipated receiving from the Company in respect of such Regular Purchase, Accelerated
Purchase or Additional Accelerated Purchase (as applicable), then the Company shall, within two (2) Business Days after the Investor&rsquo;s
request, either (i) pay cash to the Investor in an amount equal to the Investor&rsquo;s total purchase price (including customary brokerage
commissions, if any) for the shares of Common Stock so purchased (the &quot;<U>Cover Price</U>&quot;), at which point the Company&rsquo;s
obligation to deliver such Purchase Shares as DWAC Shares shall terminate, or (ii) promptly honor its obligation to deliver to the Investor
such Purchase Shares as DWAC Shares and pay cash to the Investor in an amount equal to the excess (if any) of the Cover Price over the
total Purchase Amount paid by the Investor pursuant to this Agreement for all of the Purchase Shares to be purchased by the Investor
in connection with such purchases. The Company shall not issue any fraction of a share of Common Stock upon any Regular Purchase, Accelerated
Purchase or Additional Accelerated Purchase. If the issuance would result in the issuance of a fraction of a share of Common Stock, the
Company shall round such fraction of a share of Common Stock up or down to the nearest whole share (with a fractional share of 0.5 or
higher rounded up to the next whole share). All payments made under this Agreement shall be made in lawful money of the United States
of America or wire transfer of immediately available funds to such account as the Company may from time to time designate by written
notice in accordance with the provisions of this Agreement. Whenever any amount expressed to be due by the terms of this Agreement is
due on any day that is not a Business Day, the same shall instead be due on the next succeeding day that is a Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Beneficial Ownership Limitation.</U> Notwithstanding anything to the contrary contained in this Agreement, the Company
shall not issue or sell, and the Investor shall not purchase or acquire, any shares of Common Stock under this Agreement which, when
aggregated with all other shares of Common Stock then beneficially owned by the Investor and its affiliates (as calculated pursuant to
Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder), would result in the beneficial ownership by the Investor and
its affiliates of more than 9.99% of the then issued and outstanding shares of Common Stock (the &quot;<U>Beneficial Ownership Limitation</U>&quot;).
Upon the written or oral request of the Investor, the Company shall promptly (but not later than one (1) Business Day) confirm orally
or in writing to the Investor the number of shares of Common Stock then outstanding. The Investor and the Company shall each cooperate
in good faith in the determinations required hereby and the application hereof. The Investor shall promptly (but no later than one (1)
Business Day after obtaining such ownership) confirm to the Company when the total number of shares beneficially held by it and/or its
affiliates exceeds 9.0% of the total outstanding amount of Common Stock then outstanding. The Investor&rsquo;s written certification
to the Company of the applicability of the Beneficial Ownership Limitation, and the resulting effect thereof hereunder at any time, shall
be conclusive with respect to the applicability thereof and such result absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">3.</FONT></TD><TD>INVESTOR&rsquo;S REPRESENTATIONS
                                            AND WARRANTIES.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">The
Investor represents and warrants to the Company that as of the date hereof and as of the Commencement Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Organization, Authority</U>. Investor is an entity duly organized, validly existing and in good standing under the laws
of the jurisdiction of its organization, with the requisite power and authority to enter into and to consummate the transactions contemplated
by this Agreement and the other Transaction Documents to which it is a party and otherwise to carry out its obligations hereunder and
thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Investment Purpose</U>. The Investor is acquiring the Securities as principal for its own account for investment only
and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any
applicable state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or
any applicable state securities law and has no direct or indirect arrangement or understandings with any other Persons to distribute
or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation
and warranty not limiting the Investor&rsquo;s right to sell the Securities at any time pursuant to the Registration Statement described
herein or otherwise in compliance with applicable federal and state securities laws). The Investor is acquiring the Securities hereunder
in the ordinary course of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Accredited Investor Status</U>. The Investor is an &quot;accredited investor&quot; as that term is defined in Rule 501(a)(3)
of Regulation D promulgated under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Information</U>. The Investor understands that its investment in the Securities involves a high degree of risk. The
Investor (i) is able to bear the economic risk of an investment in the Securities including a total loss thereof, (ii) has such knowledge
and experience in financial and business matters that it is capable of evaluating the merits and risks of the proposed investment in
the Securities and (iii) has had an opportunity to ask questions of and receive answers from the officers of the Company concerning the
financial condition and business of the Company and other matters related to an investment in the Securities. Neither such inquiries
nor any other due diligence investigations conducted by the Investor or its representatives shall modify, amend or affect the Investor&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in <U>Section 4</U> below. The Investor has sought such
accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition
of the Securities and is not relying on any accounting, legal tax or other advice from the Company or its officers, employees or representatives.
The Investor acknowledges and agrees that the Company neither makes nor has made any representations or warranties with respect to the
transactions contemplated hereby other than those specifically set forth in <U>Section 4</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>No Governmental Review</U>. The Investor understands that no U.S. federal or state agency or any other government or
governmental agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of an investment
in the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Validity;
Enforcement</U>. This Agreement and the other Transaction Documents have been duly and validly authorized, executed and delivered on
behalf of the Investor and each is a valid and binding agreement of the Investor enforceable against the Investor in accordance with
its terms, subject as to enforceability to general principles of equity and to applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable creditors&rsquo; rights and remedies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Residency</U>. The Investor&rsquo;s principal place of business is located in of the State of Illinois.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>No Short Selling</U>. The Investor represents and warrants to the Company that at no time prior to the date of this
Agreement has any of the Investor, its agents (in their capacities as such), representatives or affiliates (in their capacities as such)
engaged in or effected, in any manner whatsoever, directly or indirectly, any (i) &quot;short sale&quot; (as such term is defined in
Rule 200 of Regulation SHO of the Exchange Act) of the Common Stock or (ii) hedging transaction that establishes a net short position
with respect to the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">4.</FONT></TD><TD>REPRESENTATIONS AND WARRANTIES
                                            OF THE COMPANY.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">The
Company represents and warrants to the Investor that, as of the date hereof and as of the Commencement Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Organization and Qualification</U>. The Company and each of its Subsidiaries is an entity duly incorporated or otherwise
organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite
corporate power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the
Company nor any of its Subsidiaries is in violation or default of any of the provisions of its respective certificate or articles of
formation or incorporation, bylaws or other organizational or charter documents, except as would not be expected to result in a Material
Adverse Effect. Each of the Company and its Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation
or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary,
and no proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail
such power and authority or qualification, except where the failure to be so qualified or in good standing or such proceeding, as the
case may be, would not reasonably be expected to result in a Material Adverse Effect. The Company has no Subsidiaries except for the
subsidiaries set forth on Exhibit 21.1 to the Company&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Authorization; Enforcement; Validity</U>. (i) The Company has the requisite corporate power and authority to enter into
and perform its obligations under this Agreement and each of the other Transaction Documents, and to issue the Securities in accordance
with the terms hereof and thereof, (ii) the execution and delivery of the Transaction Documents by the Company and the consummation by
it of the transactions contemplated hereby and thereby, including without limitation, the issuance of the Commitment Shares (as defined
below in <U>Section 5(f)</U>), the reservation for issuance and the issuance of the Purchase Shares issuable under this Agreement, have
been duly authorized by the Company&rsquo;s board of directors, or a validly authorized committee thereof (collectively, the &quot;<U>Board
of Directors</U>&quot;), and no further consent or authorization is required by the Company, its Board of Directors or any committee
thereof, or its stockholders (save to the extent provided in this Agreement), (iii) this Agreement has been, and each other Transaction
Document shall be on the Commencement Date, duly executed and delivered by the Company and (iv) this Agreement constitutes, and each
other Transaction Document upon its execution on behalf of the Company, shall constitute, the valid and binding obligations of the Company
enforceable against the Company in accordance with their terms, except as such enforceability may be limited by general principles of
equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally,
the enforcement of creditors&rsquo; rights and remedies. The Board of Directors of the Company has approved the resolutions (the &quot;<U>Signing
Resolutions</U>&quot;) substantially in the form attached hereto as <B><U>Exhibit A</U></B> to authorize this Agreement and the transactions
contemplated hereby. The Signing Resolutions are valid, in full force and effect and have not been modified or supplemented in any respect.
The Company has delivered to the Investor a true and correct copy of a unanimous written consent adopting the Signing Resolutions executed
by all of the members of the Board of Directors of the Company. Except as set forth in this Agreement, no other approvals or consents
of the Board of Directors, any other authorized committee thereof, and/or stockholders is necessary under applicable laws and the Company&rsquo;s
Charter and/or Bylaws to authorize the execution and delivery of this Agreement or any of the transactions contemplated hereby, including,
but not limited to, the issuance of the Commitment Shares and the issuance of the Purchase Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Capitalization</U>. As of the date hereof, the authorized capital stock of the Company consists of 250,000,000 shares
of $0.001 par value Common Stock and 10,000,000 shares of $0.001 par value preferred stock. Except as disclosed in the SEC Documents
(as defined below), (i) no shares of the Company&rsquo;s capital stock are subject to preemptive rights or any other similar rights or
any liens or encumbrances suffered or permitted by the Company, (ii) there are no outstanding debt securities, (iii) there are no outstanding
options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights
convertible into, any shares of capital stock of the Company or any of its Subsidiaries, or contracts, commitments, understandings or
arrangements by which the Company or any of its Subsidiaries is or may become bound to issue additional shares of capital stock of the
Company or any of its Subsidiaries or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever
relating to, or securities or rights convertible into, any shares of capital stock of the Company or any of its Subsidiaries, (iv) there
are no agreements or arrangements under which the Company or any of its Subsidiaries is obligated to register the sale of any of their
securities under the Securities Act (except the Registration Rights Agreement and those registration rights for which a registration
statement has been filed and is effective), (v) there are no outstanding securities or instruments of the Company or any of its Subsidiaries
which contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which
the Company or any of its Subsidiaries is or may become bound to redeem a security of the Company or any of its Subsidiaries, (vi) there
are no securities or instruments containing anti-dilution or similar provisions that will be triggered by the issuance of the Securities
as described in this Agreement and (vii) the Company does not have any stock appreciation rights or &quot;phantom stock&quot; plans or
agreements or any similar plan or agreement. To the extent not filed as an exhibit to the Company&rsquo;s Exchange Act reports, the Company
has furnished to the Investor true and correct copies of the Charter and the Bylaws, each as in effect on the date hereof, and copies
of any documents containing the material rights of holders of securities convertible or exercisable for Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp; </FONT></FONT><U>Issuance
of Securities</U>. Upon issuance and payment therefor in accordance with the terms and conditions of this Agreement, the Purchase
Shares shall be validly issued, fully paid and nonassessable and free from all taxes, liens, charges, restrictions, rights of first
refusal and preemptive rights with respect to the issue thereof, with the holders being entitled to all rights accorded to a holder
of Common Stock.  6,284,374 shares of Common Stock have been duly authorized and reserved for issuance upon purchase under this
Agreement as Purchase Shares. 189,856 shares of Common Stock (subject to equitable adjustment for any reorganization,
recapitalization, non-cash dividend, stock split or other similar transaction) have been duly authorized and reserved for issuance
as Commitment Shares (as defined below in <U>Section 5(f)</U>) in accordance with this Agreement. Upon issuance in accordance with
the terms and conditions of this Agreement, each of the Purchase Shares and the Commitment Shares shall be validly issued, fully
paid and nonassessable and free from all taxes, Liens, charges, restrictions, rights of first refusal and preemptive rights with
respect to the issue thereof, with the holders being entitled to all rights accorded to a holder of Common Stock. The Securities are
being issued pursuant to the Registration Statement. Upon receipt of the Purchase Shares and the Commitment Shares, the Investor
will have good and marketable title to such Securities and such Securities will be immediately freely tradeable on the Principal
Market by any holder who is not an &ldquo;affiliate&rdquo; of the Company under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT></FONT><U>No Conflicts</U>. The execution, delivery and performance of the Transaction Documents by the Company and the consummation
by the Company of the transactions contemplated hereby and thereby (including, without limitation, the reservation for issuance and issuance
of the Purchase Shares and the Commitment Shares) will not (i) result in a violation of the Charter, any certificate of designations,
preferences and rights of any outstanding series of preferred stock of the Company or the Bylaws or (ii) conflict with, or constitute
a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Company or any of its Subsidiaries is
a party, or result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws
and regulations and the rules and regulations of the Principal Market applicable to the Company or any of its Subsidiaries) or by which
any property or asset of the Company or any of its Subsidiaries is bound or affected, except in the case of conflicts, defaults, terminations,
amendments, accelerations, cancellations and violations under clause (ii), which would not reasonably be expected to result in a Material
Adverse Effect. Neither the Company nor its Subsidiaries is in violation of any term of or in default under its Certificate of Incorporation,
any certificate of designation, preferences and rights of any outstanding series of preferred stock of the Company or Bylaws or their
organizational charter or bylaws, respectively. Neither the Company nor any of its Subsidiaries is in violation of any term of or is
in default under any material contract, agreement, mortgage, indebtedness, indenture, instrument, judgment, decree or order or any statute,
rule or regulation applicable to the Company or its Subsidiaries, except for possible conflicts, defaults, terminations or amendments
that would not reasonably be expected to have a Material Adverse Effect. The business of the Company and its Subsidiaries is not being
conducted, and shall not be conducted, in violation of any law, ordinance or regulation of any governmental entity, except for possible
violations, the sanctions for which either individually or in the aggregate would not reasonably be expected to have a Material Adverse
Effect. Except as specifically contemplated by this Agreement and as required under the Securities Act or applicable state securities
laws and the rules and regulations of the Principal Market, the Company is not required to obtain any consent, authorization or order
of, or make any filing or registration with, any court or governmental agency or any regulatory or self-regulatory agency in order for
it to execute, deliver or perform any of its obligations under or contemplated by the Transaction Documents in accordance with the terms
hereof or thereof. Except as set forth elsewhere in this Agreement, (i) all consents, authorizations, orders, filings and registrations
which the Company is required to obtain pursuant to the preceding sentence on or prior to the date hereof or on or prior to the Commencement
Date shall have been obtained or effected on or prior to the date hereof and on or prior to the Commencement Date, respectively, and
(ii) all consents, authorizations, orders, filings and registrations which the Company is required to obtain pursuant to the preceding
sentence with respect to the Commencement shall be obtained or effected on or prior to the Commencement Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>SEC Documents; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents
required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof,
for the twelve months preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such
material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with each
Prospectus, being collectively referred to herein as the &quot;<U>SEC Documents</U>&quot;) on a timely basis or has received a valid
extension of such time of filing and has filed any such SEC Documents prior to the expiration of any such extension. As of their respective
dates, the SEC Documents complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable.
None of the SEC Documents, when filed, contained any untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading. The financial statements of the Company included in the SEC Documents comply in all material respects with applicable
accounting requirements and the rules and regulations of the SEC with respect thereto as in effect at the time of filing. Such financial
statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis
during the periods involved (&quot;<U>GAAP</U>&quot;), except as may be otherwise specified in such financial statements or the notes
thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material
respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations
and cash flows for the periods presented, subject, in the case of unaudited financial statements, to normal, immaterial, year-end audit
adjustments. Except as publicly available through the SEC&rsquo;s Electronic Data Gathering, Analysis, and Retrieval system (EDGAR),
the Company has received no notices or correspondence from the SEC for the one year preceding the date hereof other than SEC comment
letters relating to the Company&rsquo;s filings under the Exchange Act and the Securities Act. There are no SEC comments that have not
been resolved to the satisfaction of the SEC staff. To the Company&rsquo;s knowledge, the SEC has not commenced any enforcement proceedings
against the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT></FONT><U>Absence of Certain Changes</U>. Except as disclosed in the SEC Documents, since September 30, 2022, there has been no
material adverse change in the business, properties, operations, financial condition or results of operations of the Company or its Subsidiaries.
For the avoidance of doubt, neither a decrease in cash or cash equivalents or in the market price of the Common Stock nor losses incurred
in the ordinary course of the Company&rsquo;s business shall be deemed or considered material adverse changes (it being understood and
agreed that any events, changes, effects, circumstances, facts, developments or occurrences giving rise to or contributing to such decreases
or losses may be taken into account in determining whether there has been, or would reasonably be expected to be, a material adverse
change). The Company has not taken any steps, and does not currently expect to take any steps, to seek protection pursuant to any Bankruptcy
Law nor does the Company or any of its Subsidiaries have any knowledge or reason to believe that its creditors intend to initiate involuntary
bankruptcy or insolvency proceedings. The Company is financially solvent and is generally able to pay its debts as they become due.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT></FONT><U>Absence of Litigation</U>. Except as disclosed in the SEC Documents, there is no action, suit, proceeding, inquiry or
investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge
of the Company or any of its Subsidiaries, threatened against the Company, the Common Stock or any of the Company&rsquo;s or its Subsidiaries&rsquo;
officers or directors in their capacities as such, which could reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Acknowledgment Regarding Investor&rsquo;s Status</U>. The Company acknowledges and agrees that the Investor is acting
solely in the capacity of arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated hereby
and thereby. The Company further acknowledges that the Investor is not acting as a financial advisor or fiduciary of the Company (or
in any similar capacity) with respect to the Transaction Documents and the transactions contemplated hereby and thereby and any advice
given by the Investor or any of its representatives or agents in connection with the Transaction Documents and the transactions contemplated
hereby and thereby is merely incidental to the Investor&rsquo;s purchase of the Securities. The Company further represents to the Investor
that the Company&rsquo;s decision to enter into the Transaction Documents has been based solely on the independent evaluation by the
Company and its representatives and advisors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>No Aggregated Offering</U>. Neither the Company, nor any of its affiliates, nor any Person acting on its or their behalf
has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances
that would cause this offering of the Securities to be integrated or aggregated with prior offerings by the Company in a manner that
would require stockholder approval pursuant to the rules of the Principal Market on which any of the securities of the Company are listed
or designated. The issuance and sale of the Commitment Shares hereunder does not, and subject to the terms of this Agreement, the issuance
and sale of the additional Purchase Shares will not, contravene the rules and regulations of the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT></FONT><U>Intellectual Property Rights</U>. The Company and its Subsidiaries own or possess adequate rights or licenses to use
all material trademarks, trade names, service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions,
licenses, approvals, governmental authorizations, trade secrets and rights necessary to conduct their respective businesses as now conducted,
except as such failure to own, possess or acquire such rights would not reasonably be expected, individually, or in the aggregate, to
result in a Material Adverse Effect. None of the Company&rsquo;s material trademarks, trade names, service marks, service mark registrations,
service names, patents, patent rights, copyrights, inventions, licenses, approvals, government authorizations, trade secrets or other
intellectual property rights have expired or terminated, or, by the terms and conditions thereof, could expire or terminate within two
years from the date of this Agreement, except as would not reasonably be expected to have a Material Adverse Effect. Except as set forth
in the SEC Documents, the Company and its Subsidiaries do not have any knowledge of any infringement by the Company or its Subsidiaries
of any material trademark, trade name rights, patents, patent rights, copyrights, inventions, licenses, service names, service marks,
service mark registrations, trade secret or other similar rights of others, or of any such development of similar or identical trade
secrets or technical information by others, and there is no claim, action or proceeding that has been brought against, or to the Company&rsquo;s
knowledge, being threatened against, the Company or its Subsidiaries regarding trademark, trade name, patents, patent rights, invention,
copyright, license, service names, service marks, service mark registrations, trade secret or other infringement, which would reasonably
be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Environmental Laws</U>. The Company and its Subsidiaries (i) are in compliance with any and all applicable foreign,
federal, state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or
toxic substances or wastes, pollutants or contaminants (&quot;<U>Environmental Laws</U>&quot;), (ii) have received all permits, licenses
or other approvals required of them under applicable Environmental Laws to conduct their respective businesses and (iii) are in compliance
with all terms and conditions of any such permit, license or approval, except where, in each of the three foregoing clauses, the failure
to so comply would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Title</U>. Except as set forth in the SEC Documents, the Company and its Subsidiaries have good and marketable title
in fee simple to all real property owned by them and good and marketable title in all personal property owned by them that is material
to the business of the Company and its Subsidiaries, taken as a whole, in each case free and clear of all liens, encumbrances and defects
(&quot;<U>Liens</U>&quot;) and, except for Liens as do not materially affect the value of such property and do not materially interfere
with the use made and proposed to be made of such property by the Company and its Subsidiaries and Liens for the payment of federal,
state or other taxes, the payment of which is neither delinquent nor subject to penalties, and Liens that would not reasonably be expected,
individually or in the aggregate, to result in a Material Adverse Effect. Any real property and facilities held under lease by the Company
and its Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and its Subsidiaries are
in compliance with such exceptions as are not material and do not interfere with the use made and proposed to be made of such property
and buildings by the Company and its Subsidiaries, taken as a whole, except for such interference which would not reasonably be expected
to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Insurance</U>. The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility
against such losses and risks and in such amounts as management of the Company believes to be prudent and customary in the businesses
in which the Company and its Subsidiaries are engaged (including in respect of directors and officers liability insurance). Neither the
Company nor any such Subsidiary has been refused any insurance coverage sought or applied for and neither the Company nor any such Subsidiary
has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its business at a cost that would not materially and adversely
affect the condition, financial or otherwise, or the earnings, business or operations of the Company and its Subsidiaries, taken as a
whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Regulatory
Permits</U>. Except as disclosed in the SEC Documents, the Company and its Subsidiaries possess all material certificates, authorizations
and permits issued by the appropriate federal, state or foreign regulatory authorities necessary to conduct their respective businesses
as currently conducted, except where the failure to possess such certificates, authorizations or permits would not reasonably be expected
to have a Material Adverse Effect, and neither the Company nor any such Subsidiary has received any notice of proceedings relating to
the revocation or modification of any such material certificate, authorization or permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(p)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Compliance with Laws</U>. The Company is not in violation of any Applicable Law, except as would not reasonably be expected
to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(q)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Tax
Status</U>. Except as disclosed in the SEC Documents, the Company and each of its Subsidiaries has made or filed all federal, state,
local or foreign income and all other material tax returns, reports and declarations required by any jurisdiction to which it is subject
(unless and only to the extent that the Company and each of its Subsidiaries has set aside on its books provisions reasonably adequate
for the payment of all unpaid and unreported taxes) and has paid all taxes and other governmental assessments and charges that are material
in amount, shown or determined to be due on such returns, reports and declarations, except those being contested in good faith and has
set aside on its books provision reasonably adequate for the payment of all taxes for periods subsequent to the periods to which such
returns, reports or declarations apply, and except as would not reasonably be expected to have a Material Adverse Effect. To the Company&rsquo;s
knowledge, there are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(r)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Transactions With Affiliates</U>. Except as disclosed <FONT STYLE="background-color: white">in the SEC Documents, none
of the Company&rsquo;s stockholders, officers or directors or any family member or affiliate of any of the foregoing, has either directly
or indirectly an interest in, or is a party to, any transaction that would be required to be disclosed as a related party transaction
pursuant to Item 404 of Regulation S-K promulgated under the Securities Act</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(s)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Application
of Takeover Protections</U>. The Company and its board of directors have taken or will take prior to the Commencement Date all necessary
action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or other similar anti-takeover provision under the Charter or the laws of the state of its incorporation which
is or could become applicable to the Investor as a result of the transactions contemplated by this Agreement, including, without limitation,
the Company&rsquo;s issuance of the Securities and the Investor&rsquo;s ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(t)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents or any other agreements to be entered into by the Company and the Investor that, in each case, which shall be timely publicly
disclosed by the Company, the Company confirms that neither it nor any other Person acting on its behalf has provided the Investor or
its agents or counsel with any information that the Company believes constitutes or might constitute material, non-public information
which is not otherwise disclosed in the Registration Statement or the SEC Documents. The Company understands and confirms that the Investor
will rely on the foregoing representation in effecting purchases and sales of securities of the Company. All of the disclosure furnished
by or on behalf of the Company to the Investor regarding the Company, its business and the transactions contemplated hereby, including
the disclosure schedules to this Agreement, is true and correct in all material respects and does not contain any untrue statement of
a material fact or omit to state any material fact necessary in order to make the statements made therein, in light of the circumstances
under which they were made, not misleading. The press releases disseminated by the Company during the twelve (12) months preceding the
date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made and
when made, not misleading. The Company acknowledges and agrees that the Investor neither makes nor has made any representations or warranties
with respect to the transactions contemplated hereby other than those specifically set forth in <U>Section 3</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(u)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Foreign Corrupt Practices</U>. Neither the Company nor any of its Subsidiaries nor any director or officer, nor, to
the knowledge of the Company, any agent, employee or affiliate of the Company or any Subsidiary is aware of or has taken any action,
directly or indirectly, that would result in a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and
the rules and regulations thereunder (the &quot;<U>FCPA</U>&quot;), including, without limitation, making use of the mails or any means
or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment
of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any &quot;foreign official&quot;
(as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office,
in contravention of the FCPA; and the Company, each of its Subsidiaries and, to the knowledge of the Company, its affiliates have conducted
their businesses in compliance with the FCPA and have instituted and maintain policies and procedures designed to ensure, and which are
reasonably expected to continue to ensure, continued compliance therewith. The operations of the Company and each of its Subsidiaries
are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements and the money
laundering statutes and the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered
or enforced by any applicable governmental agency, including, without limitation, Title 18 U.S. Code section 1956 and 1957, the Patriot
Act, the Bank Secrecy Act, and international anti-money laundering principles or procedures by an intergovernmental group or organization,
such as the Financial Action Task Force on Money Laundering, of which the United States is a member and with which designation the United
States representative to the group or organization continues to concur, all as amended, and any Executive order, directive or regulation
pursuant to the authority of any of the foregoing, or any orders or licenses issued thereunder (collectively, the &quot;<U>Money Laundering
Laws</U>&quot;), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Company or any of its Subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company,
threatened. Neither the Company nor any of its Subsidiaries, nor to the knowledge of the Company any of the directors, officers or employees,
agents, affiliates or representatives of the Company or each of its Subsidiaries, is an individual or entity that is, or is owned or
controlled by an individual or entity that is: (i) the subject of any sanctions administered or enforced by the U.S. Department of Treasury&rsquo;s
Office of Foreign Assets Control, the United Nations Security Council, the European Union, Her Majesty&rsquo;s Treasury, or other relevant
sanctions authority (collectively, &quot;<U>Sanctions</U>&quot;), nor (ii) located, organized or resident in a country or territory that
is the subject of Sanctions (including, without limitation, the Balkans, Belarus, Burma/Myanmar, Cote D&rsquo;Ivoire, Cuba, Democratic
Republic of Congo, Iran, Iraq, Liberia, Libya, North Korea, Russia, Sudan, Syria, Venezuela and Zimbabwe). Neither the Company nor any
of its Subsidiaries will, directly or indirectly, use the proceeds of the transactions contemplated hereby, or lend, contribute or otherwise
make available such proceeds to any subsidiary, joint venture partner or other individual or entity: (i) to fund or facilitate any activities
or business of or with any individual or entity or in any country or territory that, at the time of such funding or facilitation, is
the subject of Sanctions or (ii) in any other manner that will result in a violation of Sanctions by any individual or entity (including
any individual or entity participating in the transactions contemplated hereby, whether as underwriter, advisor, investor or otherwise).
For the past five years, neither the Company nor any of its Subsidiaries has knowingly engaged in, and is not now knowingly engaged in,
any dealings or transactions with any individual or entity, or in any country or territory, that at the time of the dealing or transaction
is or was the subject of Sanctions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>DTC Eligibility</U>. The Company, through the Transfer Agent, currently participates in the DTC Fast Automated Securities
Transfer (FAST) Program and the Common Stock can be transferred electronically to third parties via the DTC Fast Automated Securities
Transfer (FAST) Program. The Common Stock is not subject to any DTC &ldquo;chill,&rdquo; freeze or similar restriction with respect to
any DTC services, including the clearing of shares of Common Stock through DTC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(w)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Sarbanes-Oxley</U>. The Company is in material compliance with all provisions of the Sarbanes-Oxley Act of 2002, as
amended, which are applicable to it as of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Certain Fees</U>. No brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company to any broker,
financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated
by the Transaction Documents. The Investor shall have no obligation with respect to any fees or with respect to any claims made by or
on behalf of other Persons for fees of a type contemplated in this <U>Section 4(w)</U> that may be due in connection with the transactions
contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(y)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Investment
Company</U>. The Company is not required to be registered as, and immediately after receipt of any payment for the Purchase Shares will
not be required to be registered as, an &quot;investment company&quot; within the meaning of the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(z)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Listing
and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act, and the Company has taken
no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock pursuant
to the Exchange Act nor has the Company received any notification that the SEC is currently contemplating terminating such registration.
The Securities have been approved for listing on the Principal Market prior to issuance. The Company has taken no action designed to,
or likely to have the effect of, delisting the Common Stock from the Principal Market, nor has the Company received any notice from any
Person to the effect that the Company is not in compliance with the listing or maintenance requirements of the Principal Market. The
Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing
and maintenance requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(aa)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Accountants</U>.
The Company&rsquo;s accountants are set forth in the SEC Documents and, to the knowledge of the Company, such accountants are an independent
registered public accounting firm as required by the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(bb)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>No
Market Manipulation</U>. The Company has not, and to its knowledge no Person acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company in connection with the transactions contemplated in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(cc)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Shell
Company Status</U>. The Company is not, and has never been, an issuer identified in Rule 144(i)(1) under the Securities Act and has filed
with the SEC current &quot;Form 10 information&quot; (as defined in Rule 144(i)(3) under the Securities Act) at least 12 calendar months
prior to the date of this Agreement reflecting its status as an entity that is not an issuer identified in Rule 144(i)(1) under the Securities
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(dd)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>No
Disqualification Events</U>. None of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other
officer of the Company participating in the offering contemplated hereby, any beneficial owner of 20% or more of the Company&rsquo;s
outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405
under the Securities Act) connected with the Company in any capacity at the time of sale (each, an &quot;<U>Issuer Covered Person</U>&quot;)
is subject to any of the &quot;Bad Actor&quot; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a
 &quot;<U>Disqualification Event</U>&quot;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3) under the Securities
Act. The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(ee)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Registration
Statement</U>. The Company has prepared and filed the Shelf Registration Statement with the SEC in accordance with the Securities Act.
The Shelf Registration Statement was declared effective by order of the SEC on January 3, 2023. The Shelf Registration Statement is effective
pursuant to the Securities Act and available for the issuance of the Securities thereunder. No stop order suspending the effectiveness
of the Shelf Registration Statement has been issued by the SEC, and no proceeding for that purpose or pursuant to Section 8A of the Securities
Act against the Company or related to the offering of the Securities has been initiated or, to the knowledge of the Company, threatened
by the SEC. The &quot;Plan of Distribution&quot; section of the Prospectus permits the issuance of the Securities under the terms of
this Agreement. At the time the Shelf Registration Statement and any amendments thereto became effective, at the date of this Agreement
and at each deemed effective date thereof pursuant to Rule 430B(f)(2) of the Securities Act, the Shelf Registration Statement and any
amendments thereto complied and will comply in all material respects with the requirements of the Securities Act and did not and will
not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to
make the statements therein not misleading; and the Base Prospectus and any Prospectus Supplement thereto, at the time such Base Prospectus
or such Prospectus Supplement thereto was issued and on the Commencement Date, complied and will comply in all material respects with
the requirements of the Securities Act and did not and will not contain an untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading; provided
that this representation and warranty does not apply to statements in or omissions from any Prospectus Supplement made in reliance upon
and in conformity with information relating to the Investor furnished to the Company in writing by or on behalf of the Investor expressly
for use therein. The Company meets all of the requirements for the use of a registration statement on Form S-3 pursuant to the Securities
Act for the offering and sale of the Securities contemplated by this Agreement in reliance on General Instruction I.B.1., and the SEC
has not notified the Company of any objection to the use of the form of the Registration Statement pursuant to Rule 401(g)(1) of the
Securities Act. The Company hereby confirms that the issuance of the Securities to the Investor in accordance with this Agreement would
not result in non-compliance with the Securities Act or any of the General Instructions to Form S-3. The Registration Statement, as of
its effective date, meets the requirements set forth in Rule 415(a)(1)(x) pursuant to the Securities Act. At the earliest time after
the filing of the Registration Statement that the Company or another offering participant made a bona fide offer (within the meaning
of Rule 164(h)(2) of the Securities Act) relating to any of the Securities, the Company was, and as of the date of this Agreement the
Company is, not an Ineligible Issuer (as defined in Rule 405 of the Securities Act). The Company has not distributed any offering material
in connection with the offering, issuance and sale of any of the Securities, other than the Shelf Registration Statement or any amendment
thereto, the Prospectus or any Prospectus Supplement required pursuant to Applicable Law or the Transaction Documents. The Company has
not made an offer relating to the Securities that would constitute a &quot;free writing prospectus&quot; as defined in Rule 405 under
the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Options: NewSection; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(ff)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Absence
of Schedules</U>. In the event that on the date hereof, or the Commencement Date, the Company does not deliver any disclosure schedule
contemplated by this Agreement, the Company hereby acknowledges and agrees that each such undelivered disclosure schedule shall be deemed
to read as follows: &quot;Nothing to Disclose.&quot;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="color: #010000">5.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;COVENANTS.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Filing
of Current Report and Initial Prospectus Supplement</U>. The Company agrees that it shall, within the time required under the Exchange
Act, file with the SEC a Current Report on Form 8-K relating to the transactions contemplated by, and describing the material terms and
conditions of, the Transaction Documents (the &quot;<U>Current Report</U>&quot;). The Company further agrees that it shall, within the
time required under Rule 424(b) under the Securities Act, file with the SEC the Initial Prospectus Supplement pursuant to Rule 424(b)
under the Securities Act specifically relating to the transactions contemplated by, and describing the material terms and conditions
of, the Transaction Documents, containing information previously omitted at the time of effectiveness of the Shelf Registration Statement
in reliance on Rule 430B under the Securities Act, and disclosing all information relating to the transactions contemplated hereby required
to be disclosed in the Shelf Registration Statement and the Prospectus as of the date of the Initial Prospectus Supplement, including,
without limitation, information required to be disclosed in the section captioned &quot;Plan of Distribution&quot; in the Prospectus.
The Investor acknowledges that it will be identified in the Initial Prospectus Supplement as an underwriter within the meaning of Section
2(a)(11) of the Securities Act. The Company shall permit the Investor to review and comment upon the Current Report and the Initial Prospectus
Supplement at least two (2) Business Days prior to their filing with the SEC, the Company shall give due consideration to all such comments.
The Investor shall use its reasonable best efforts to provide any comments upon the Current Report and the Initial Prospectus Supplement
within one (1) Business Day from the date the Investor receives a substantially complete draft thereof from the Company. The Investor
shall furnish to the Company such information regarding itself, the Securities held by it and the intended method of distribution thereof,
including any arrangement between the Investor and any other Person relating to the sale or distribution of the Securities, as shall
be reasonably requested by the Company in connection with the preparation and filing of the Current Report and the Initial Prospectus
Supplement, and shall otherwise cooperate with the Company as reasonably requested by the Company in connection with the preparation
and filing of the Current Report and the Initial Prospectus Supplement with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Blue
Sky</U>. The Company shall take all such action, if any, as is reasonably necessary in order to obtain an exemption for or to register
or qualify (i) the issuance and the sale of the Securities to the Investor under this Agreement and (ii) any subsequent resale of all
Commitment Shares and all Purchase Shares by the Investor, in each case, under applicable securities or &quot;Blue Sky&quot; laws of
the states of the United States in such states as is reasonably requested by the Investor from time to time, and shall provide evidence
of any such action so taken to the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Listing/DTC</U>.
The Company shall use commercially reasonable efforts to maintain, so long as any shares of Common Stock shall be so listed, such listing
of all Purchase Shares and Commitment Shares from time to time issuable hereunder. The Company shall use commercially reasonable efforts
to maintain the listing of the Common Stock on the Principal Market and shall use commercially reasonable efforts to comply in all respects
with the Company&rsquo;s reporting, filing and other obligations under the Exchange Act, or rules and regulations of the Principal Market.
The Company shall not take any action that would reasonably be expected to result in the delisting or suspension of the Common Stock
on the Principal Market. The Company shall promptly, and in no event later than the following Business Day, provide to the Investor copies
of any notices it receives from any Person regarding the continued eligibility of the Common Stock for listing on the Principal Market;
provided, however, that the Company shall not be required to provide the Investor copies of any such notice that the Company reasonably
believes constitutes material non-public information that the Company would not be required to contemporaneously publicly disclose in
any report or statement filed with the SEC under the Exchange Act or the Securities Act. The Company shall pay all fees and expenses
in connection with satisfying its obligations under this <U>Section 5(c)</U>. The Company shall take all commercially reasonable action
necessary to ensure that its Common Stock can be transferred electronically as DWAC Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Prohibition
of Short Sales and Hedging Transactions</U>. The Investor agrees that beginning on the date of this Agreement and ending on the date
of termination of this Agreement as provided in Section 11, the Investor and its agents (in their capacities as such), representatives
(in their capacities as such) and affiliates shall not in any manner whatsoever enter into or effect, directly or indirectly, any (i)
 &quot;short sale&quot; (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of the Common Stock or (ii) hedging
transaction, which establishes a net short position with respect to the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Payment
of Commitment Fee</U>. In consideration for the Investor&rsquo;s execution and delivery of this Agreement, the Company shall cause to
be paid to the Investor a commitment fee of $350,000 (the &ldquo;<U>Commitment Fee</U>&rdquo;) on the date of this Agreement and shall
deliver the Commitment Fee in full to the Investor by wire transfer of immediately available funds to an account designated by the Investor
by written notice to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Issuance
of Commitment Shares</U>. In consideration for the Investor&rsquo;s execution and delivery of this Agreement, the Company shall cause
the Transfer Agent to issue 189,856 shares of Common Stock (the &quot;<U>Commitment Shares</U>&quot;) directly to the Investor in accordance
with <U>Section 6</U> hereto and the Irrevocable Transfer Agent Instructions. For the avoidance of doubt, all of the Commitment Shares
shall be fully earned as of the date of this Agreement, whether or not the Commencement shall occur or any Purchase Shares are purchased
by the Investor under this Agreement and irrespective of any termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Due
Diligence; Non-Public Information</U>. During the term of this Agreement, the Investor shall have the right, from time to time as the
Investor may reasonably deem appropriate, and upon reasonable advance notice to the Company, to perform reasonable due diligence on the
Company during normal business hours. The Company and its officers and employees shall provide material information and reasonably cooperate
with the Investor in connection with any reasonable request by the Investor related to the Investor&rsquo;s due diligence of the Company.
Each party hereto agrees not to disclose any Confidential Information of the other party to any third party and shall not use the Confidential
Information for any purpose other than in connection with, or in furtherance of, the transactions contemplated hereby. Each party hereto
acknowledges that the Confidential Information shall remain the property of the disclosing party and agrees that it shall take all reasonable
measures to protect the secrecy of any Confidential Information disclosed by the other party. The receiving party may disclose Confidential
Information to the extent such information is required to be disclosed by law, regulation or order of a court of competent jurisdiction
or regulatory authority, provided that the receiving party shall promptly notify the disclosing party when such requirement to disclose
arises, and shall cooperate with the disclosing party so as to enable the disclosing party to: (i) seek an appropriate protective order;
and (ii) make any applicable claim of confidentiality in respect of such Confidential Information; and provided, further, that the receiving
party shall disclose Confidential Information only to the extent required by the protective order or other similar order, if such an
order is obtained, and, if no such order is obtained, the receiving party shall disclose only the minimum amount of such Confidential
Information required to be disclosed in order to comply with the applicable law, regulation or order. In addition, any such Confidential
Information disclosed pursuant to this section shall continue to be deemed Confidential Information. Notwithstanding anything in this
Agreement to the contrary, (x) the Company shall not be obligated to provide the Investor with any information that constitutes or may
reasonably be considered to constitute material, non-public information pursuant to a request for information hereunder, and the Company
and the Investor agree that neither the Company nor any other Person acting on its behalf shall provide the Investor or its agents or
counsel with any information that constitutes or may reasonably be considered to constitute material, non-public information, unless
a simultaneous public announcement thereof is made by the Company in the manner contemplated by Regulation FD, and (y) in the event that
the Company believes that a notice or communication to the Investor or any of its affiliates, attorneys, agents or representatives pursuant
to this Agreement or any other Transaction Document contains any material, nonpublic information, the Company shall so indicate to the
Investor prior to delivery of such notice or communication, and such indication shall provide the Investor the means to refuse to receive
such notice or communication; and in the absence of any such indication, the Investor and its affiliates, agents and representatives
shall be allowed to presume that all matters relating to such notice or communication do not constitute material, nonpublic information.
In the event of any breach of the foregoing covenants by the Company or any Person acting on its behalf (as determined in the reasonable
good faith judgment of the Investor), in addition to any other remedy provided herein or in the other Transaction Documents, if the Investor
is holding any Securities at the time of the disclosure of such material non-public information, the Investor shall have the right to
make a public disclosure, in the form of a press release, public advertisement or otherwise, of such material, non-public information
without the prior approval by the Company; provided the Investor shall have first provided notice to the Company that it believes it
has received information that constitutes material, non-public information; and the Company shall have at least two (2) Business Days
from such notice to either publicly disclose such material, non-public information or to demonstrate to the Investor that such information
does not constitute material, non-public information, and (assuming the Investor and Investor&rsquo;s counsel disagree in their reasonable
good faith judgment with the Company&rsquo;s determination) prior to any such disclosure by the Investor; and the Company shall have
failed to publicly disclose such material, non-public information. The Investor shall not have any liability to the Company, any of its
Subsidiaries, or any of their respective directors, officers, employees, stockholders or agents, for any such disclosure in accordance
with this <U>Section 5(g)</U>. The Company understands and confirms that the Investor shall be relying on the foregoing covenants in
effecting transactions in securities of the Company. The Company hereby acknowledges and agrees that, notwithstanding the provisions
of this Section 5(g), if there is a breach or violation of any representation, covenant, provision or agreement of the Company set forth
in this Section 5(g) or Section 5(a) resulting in the Investor obtaining or otherwise possessing material nonpublic information, neither
the Investor nor any of the Investor&rsquo;s affiliates, attorneys, agents or representatives shall have any duty of trust or confidence
(including any obligation under any confidentiality or non-disclosure agreement entered into by the Investor with the Company) with respect
to, or obligation not to trade in any securities while aware of, such material nonpublic information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Purchase
Records</U>. The Investor and the Company shall each maintain records showing the remaining Available Amount at any given time and the
dates and Purchase Amounts for each Regular Purchase, Accelerated Purchase and Additional Accelerated Purchase or shall use such other
method, reasonably satisfactory to the Investor and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Taxes.
</U>The Company shall pay any and all transfer, stamp or similar taxes that may be payable with respect to the issuance and delivery
of any shares of Common Stock to the Investor made under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Use
of Proceeds</U>. The Company will use the net proceeds from the offering for any corporate purpose at the sole discretion of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Other
Transactions</U>. The Company shall not enter into, announce or recommend to its stockholders any agreement, plan, arrangement or transaction
in or of which the terms thereof would restrict, materially delay, conflict with or impair the ability or right of the Company to perform
its obligations under the Transaction Documents, including, without limitation, the obligation of the Company to deliver the Commitment
Shares to the Investor in accordance with the terms of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Aggregation</U>.&nbsp;From
and after the date of this Agreement, neither the Company, nor or any of its affiliates will, and the Company shall use its commercially
reasonable efforts to ensure that no Person acting on their behalf will, directly or indirectly, make any offers or sales of any security
or solicit any offers to buy any security, under circumstances that would cause this offering of the Securities by the Company to the
Investor to be aggregated with other offerings by the Company in a manner that would require stockholder approval pursuant to the rules
of the Principal Market on which any of the securities of the Company are listed or designated, unless stockholder approval is obtained
before the closing of such subsequent transaction in accordance with the rules of such Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Limitation
on Variable Rate Transactions.</U> From and after the date of this Agreement until the thirty-six (36) month anniversary of the date
of this Agreement (irrespective of any earlier termination of this Agreement), the Company shall be prohibited from effecting or entering
into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock involving a Variable Rate Transaction
other than with the Investor. &quot;<U>Variable Rate Transaction</U>&quot; includes, without limitation, an &quot;equity line of credit&quot;
or any similar transaction whereby an investor is irrevocably bound to purchase securities over a period of time from the Company at
a price based on the market price of the Company&rsquo;s Common Stock at the time of each such purchase; provided, however, that this
Section 5(m) shall not be deemed to prohibit the issuance and sale of Common Stock pursuant to an &quot;at-the-market offering&quot;
by the Company exclusively through a registered broker-dealer acting as agent of the Company pursuant to a written agreement between
the Company and such registered broker-dealer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="color: #010000">6.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;TRANSFER
AGENT INSTRUCTIONS.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Commitment
Shares</U>. On the date of this Agreement, the Company shall issue to the Transfer Agent (and any subsequent transfer agent) irrevocable
instructions, in the form agreed to prior to the date hereof (the &quot;<U>Irrevocable Transfer Agent Instructions</U>&quot;), to issue
the Commitment Shares in accordance with the terms of this Agreement. All Commitment Shares to be issued to or for the benefit of the
Investor pursuant to this Agreement shall be issued as DWAC Shares. The Company warrants to the Investor that, while the Agreement is
effective, no instruction other than the Irrevocable Transfer Agent Instructions referred to in this <U>Section 6</U> will be given by
the Company to the Transfer Agent with respect to the Commitment Shares, and the Commitment Shares shall otherwise be freely transferable
on the books and records of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Purchase
Shares</U>. On the date of the Initial Prospectus Supplement, the Company shall issue to the Transfer Agent, and any subsequent transfer
agent, irrevocable instructions in the form agreed to prior to the date hereof (the &quot;<U>Commencement Irrevocable Transfer Agent
Instructions</U>&quot;) to issue the Purchase Shares in accordance with the terms of this Agreement and the Registration Rights Agreement.
All Purchase Shares to be issued from and after Commencement to or for the benefit of the Investor pursuant to this Agreement shall be
issued only as DWAC Shares. The Company represents and warrants to the Investor that, while this Agreement is effective, no instruction
other than as contemplated by the Commencement Irrevocable Transfer Agent Instructions and any Notice of Effectiveness of Registration
Statement (as defined in the Registration Rights Agreement) will be given by the Company to the Transfer Agent with respect to the Purchase
Shares from and after Commencement, and no instruction or other communication to the Transfer Agent with respect to the issuance of the
Purchase Shares shall be made without the approval of the Investor. The Company shall provide confirmation of receipt by the Transfer
Agent of all instructions pursuant to the Commencement Irrevocable Transfer Agent Instructions with respect to Purchase Shares within
one (1) Business Day of delivery of any Purchase Notice. The Purchase Shares covered by the Registration Statement shall otherwise be
freely transferable on the books and records of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="color: #010000">7.
</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;CONDITIONS TO THE COMPANY&rsquo;S RIGHT TO
COMMENCE SALES OF SHARES OF COMMON STOCK.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The right of the Company
hereunder to commence sales of Purchase Shares is subject to the satisfaction, or where legally permissible, the waiver of each of the
following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>The
Investor shall have executed each of the Transaction Documents and delivered the same to the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>The
representations and warranties of the Investor shall be true and correct in all material respects as of the date hereof and as of the
Commencement Date as though made at that time; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>No
stop order with respect to the Registration Statement shall be pending or threatened by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="color: #010000">8.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;CONDITIONS
TO THE INVESTOR&rsquo;S OBLIGATION TO PURCHASE SHARES OF COMMON STOCK.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The obligation of the Investor
to buy Purchase Shares under this Agreement is subject to the satisfaction or, where legally permissible, the waiver of each of the following
conditions on or prior to the Commencement Date and, once such conditions have been initially satisfied, there shall not be any ongoing
obligation to satisfy such conditions after the Commencement has occurred:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>The
Company shall have executed each of the Transaction Documents and delivered the same to the Investor;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>The
Company shall have issued or caused to be issued to the Investor a number of shares of Common Stock equal to the number of Commitment
Shares as DWAC Shares, in each case in accordance with <U>Section 6</U>, and shall have paid the Commitment Fee to the Investor;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>The
Common Stock shall be listed on the Principal Market, and the Company shall have filed with The Nasdaq Stock Market a Notification Form:
Listing of Additional Shares for the listing of the Securities, and Nasdaq shall have raised no objection to the consummation of the
transactions contemplated by this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>The
Investor shall have received the opinion and negative assurances letter of the Company&rsquo;s legal counsel dated as of the Commencement
Date substantially in the forms agreed prior to the date of this Agreement by the Company&rsquo;s legal counsel and the Investor&rsquo;s
legal counsel;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>The
representations and warranties of the Company shall be true and correct in all material respects (except to the extent that any of such
representations and warranties is already qualified as to materiality in <U>Section 4</U> above, in which case, such representations
and warranties shall be true and correct without further qualification) as of the date hereof and as of the Commencement Date as though
made at that time (except for representations and warranties that speak as of a specific date, which shall be true and correct in all
material respects as of such date) and the Company shall have performed, satisfied and complied in all material respects with the covenants,
agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with by the Company at or prior
to the Commencement Date. The Investor shall have received a certificate, executed by the CEO, President or CFO of the Company, dated
as of the Commencement Date, to the foregoing effect in the form attached hereto as <B><U>Exhibit B</U></B>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>The
Board of Directors of the Company shall have adopted Signing Resolutions, which shall be in full force and effect without any amendment
or supplement thereto as of the Commencement Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>As
of the Commencement Date, the Company shall have reserved out of its authorized and unissued Common Stock, solely for the purpose of
effecting purchases of Purchase Shares hereunder, 6,284,374 shares of Common Stock;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>Each
of the Irrevocable Transfer Agent Instructions and the Commencement Irrevocable Transfer Agent Instructions shall have been delivered
to and acknowledged in writing by the Company and the Transfer Agent (or any successor transfer agent);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>The
Company shall have delivered to the Investor a certificate of good standing of the Company in the State of Delaware issued by the Secretary
of State of the State of Delaware and a certificate or its equivalent evidencing the good standing of the Company as a foreign corporation
in any other jurisdiction where the Company is duly qualified to conduct business, in each case, as of a date within ten (10) Business
Days of the Commencement Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>The
Company shall have delivered to the Investor a certified copy of the Charter as certified by the Secretary of State of the State of Delaware
within ten (10) Business Days of the Commencement Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>The
Company shall have delivered to the Investor a secretary&rsquo;s certificate executed by the Secretary of the Company, dated as of the
Commencement Date, in the form attached hereto as <B><U>Exhibit C</U></B>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>The
Shelf Registration Statement shall continue to be effective and no stop order with respect to the Shelf Registration Statement shall
be pending or threatened by the SEC. The Company shall have a maximum dollar amount of Common Stock registered under the Shelf Registration
Statement which is sufficient to issue to the Investor not less than (i) the full Available Amount worth of Purchase Shares plus (ii)
all of the Commitment Shares. The Current Report and the Initial Prospectus Supplement each shall have been filed with the SEC, as required
pursuant to <U>Section 5(a)</U>, and copies of the Prospectus shall have been delivered to the Investor in accordance with the terms
of the Registration Rights Agreement. The Prospectus shall be current and available for issuances and sales of all of the Securities
by the Company to the Investor. Any other Prospectus Supplements required to have been filed by the Company with the SEC under the Securities
Act at or prior to the Commencement Date shall have been filed with the SEC within the applicable time periods prescribed for such filings
under the Securities Act. All reports, schedules, registrations, forms, statements, information and other documents required to have
been filed by the Company with the SEC at or prior to the Commencement Date pursuant to the reporting requirements of the Exchange Act
shall have been filed with the SEC within the applicable time periods prescribed for such filings under the Exchange Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>No
Event of Default (as defined below) shall have occurred, and no event which, after notice and/or lapse of time, would reasonably be expected
to become an Event of Default shall have occurred;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>The
Exchange Cap shall not have been reached (to the extent the Exchange Cap is applicable pursuant to Section 2(d) hereof);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>All
federal, state and local governmental laws, rules and regulations applicable to the transactions contemplated by the Transaction Documents
and necessary for the execution, delivery and performance of the Transaction Documents and the consummation of the transactions contemplated
thereby in accordance with the terms thereof shall have been complied with, and all consents, authorizations and orders of, and all filings
and registrations with, all federal, state and local courts or governmental agencies and all federal, state and local regulatory or self-regulatory
agencies necessary for the execution, delivery and performance of the Transaction Documents and the consummation of the transactions
contemplated thereby in accordance with the terms thereof shall have been obtained or made, including, without limitation, in each case
those required under the Securities Act, the Exchange Act, applicable state securities or &quot;Blue Sky&quot; laws or applicable rules
and regulations of the Principal Market, or otherwise required by the SEC, the Principal Market or any state securities regulators;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(p)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>No
statute, regulation, order, decree, writ, ruling or injunction shall have been enacted, entered, promulgated, threatened or endorsed
by any federal, state or local or foreign court or governmental authority of competent jurisdiction which prohibits the consummation
of or which would materially modify or delay any of the transactions contemplated by the Transaction Documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(q)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>No
action, suit or proceeding before any federal, state, local or foreign arbitrator or any court or governmental authority of competent
jurisdiction shall have been commenced or threatened, and no inquiry or investigation by any federal, state, local or foreign governmental
authority of competent jurisdiction shall have been commenced or threatened, against the Company, or any of the officers, directors or
affiliates of the Company, seeking to restrain, prevent or change the transactions contemplated by the Transaction Documents, or seeking
material damages in connection with such transactions; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(r)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>The
Company shall have provided the Investor with the information requested by the Investor in connection with its due diligence requests
in accordance with the terms of Section 5(g) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="color: #010000">9.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;INDEMNIFICATION.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In consideration of the Investor&rsquo;s
execution and delivery of the Transaction Documents and acquiring the Purchase Shares hereunder and in addition to all of the Company&rsquo;s
other obligations under the Transaction Documents, the Company shall defend, protect, indemnify and hold harmless the Investor and all
of its affiliates, equityholders, members, managers, officers, directors and employees and any of the foregoing Person&rsquo;s agents
or other representatives (including, without limitation, those retained in connection with the transactions contemplated by this Agreement)
(collectively, the &quot;<U>Indemnitees</U>&quot;) from and against any and all actions, causes of action, suits, claims, losses, costs,
penalties, fees, liabilities and damages, and reasonable expenses in connection therewith (irrespective of whether any such Indemnitee
is a party to the action for which indemnification hereunder is sought), and including reasonable and documented attorneys&rsquo; fees
and disbursements (the &quot;<U>Indemnified Liabilities</U>&quot;), incurred by any Indemnitee as a result of, or arising out of, or
relating to (a) any misrepresentation or breach of any representation or warranty made by the Company in the Transaction Documents or
any other certificate, instrument or document executed by the Company contemplated hereby or thereby, (b) any breach of any covenant,
agreement or obligation of the Company contained in the Transaction Documents or any other certificate, instrument or document executed
by the Company contemplated hereby or thereby, (c) any cause of action, suit or claim brought or made against such Indemnitee and arising
out of or resulting from the execution, delivery, performance or enforcement of the Transaction Documents or any other certificate, instrument
or document contemplated hereby or thereby, other than, in the case of clause (c) with respect to Indemnified Liabilities which result
from the fraud, gross negligence or willful misconduct of an Indemnitee. The indemnity in this <U>Section 9</U> shall not apply to amounts
paid in settlement of any claim if such settlement is effected without the prior written consent of the Company, which consent shall
not be unreasonably withheld, conditioned or delayed. To the extent that the foregoing undertaking by the Company may be unenforceable
for any reason, the Company shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities
which is permissible under applicable law. Payment under this indemnification shall be made within thirty (30) days from the date the
Investor makes written request for it. A certificate containing reasonable detail as to the amount of such indemnification submitted
to the Company by the Investor shall be conclusive evidence, absent manifest error, of the amount due from the Company to the Investor,
provided that the Indemnitee shall undertake to repay any amounts paid to it hereunder if it is ultimately determined, by a final and
non-appealable order of a court of competent jurisdiction, that the Indemnitee is not entitled to be indemnified against such Indemnified
Liabilities by the Company pursuant to this Agreement. If any action shall be brought against any Indemnitee in respect of which indemnity
may be sought pursuant to this Agreement, such Indemnitee shall promptly notify the Company in writing, and the Company shall have the
right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Indemnitee. Any Indemnitee shall have
the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel
shall be at the expense of such Indemnitee, except to the extent that (i) the employment thereof has been specifically authorized by
the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or
(iii) in such action there is, in the reasonable opinion of such separate counsel, a material conflict on any material issue between
the position of the Company and the position of such Indemnitee, in which case the Company shall be responsible for the reasonable fees
and expenses of no more than one such separate counsel (plus local counsel). The Company shall not, without the consent of the Indemnitee,
consent to the entry of any judgment or enter into any settlement or other compromise which does not include as an unconditional term
thereof the giving by the claimant or plaintiff to such Indemnitee of a release from all liability in respect to such claim or litigation
or which includes any admission as to fault, culpability or failure to act on the part of such Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="color: #010000">10.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;EVENTS
OF DEFAULT.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An &quot;<U>Event of Default</U>&quot;
shall be deemed to have occurred at any time as any of the following events occurs:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT></FONT>the effectiveness of a Registration Statement registering the sale or resale of the Securities lapses for any reason (including,
without limitation, the issuance of a stop order or similar order) or such registration statement (or the prospectus forming a part thereof)
is unavailable to the Investor for sale or resale of any or all of the Securities to be issued to the Investor under the Transaction
Documents that are required to be included therein, and such lapse or unavailability continues for a period of ten (10) consecutive Business
Days or for more than an aggregate of thirty (30) Business Days in any 365-day period, but excluding a lapse or unavailability where
(i) the Company terminates a Registration Statement after the Investor has confirmed in writing that all of the Securities covered thereby
have been resold or (ii) the Company supersedes one Registration Statement with another Registration Statement, including (without limitation)
by terminating a prior Registration Statement when it is effectively replaced with a new Registration Statement covering Securities (provided
in the case of this clause (ii), that all of the Securities covered by the superseded (or terminated) Registration Statement that have
not theretofore been resold are included in the superseding (or new) Registration Statement);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>the
suspension of the Common Stock from trading on the Principal Market for a period of at least one (1) Business Day; provided that the
Company may not direct the Investor to purchase any shares of Common Stock during any such suspension;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>the
delisting of the Common Stock from The Nasdaq Global Market; provided, however, that the Common Stock is not immediately thereafter trading
on The Nasdaq Capital Market, The Nasdaq Global Select Market, the New York Stock Exchange, the NYSE American, the NYSE Arca, the OTC
Bulletin Board, or the OTCQB or the OTCQX operated by the OTC Markets Group, Inc. (or any nationally recognized successor to any of the
foregoing);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>the
failure for any reason by the Transfer Agent to issue Purchase Shares to the Investor within two (2) Business Days after the applicable
Purchase Date, Accelerated Purchase Date or Additional Accelerated Purchase Date (as applicable) on which the Investor is entitled to
receive such Purchase Shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>the
Company breaches any representation, warranty, covenant or other term or condition under this Agreement, any other Transaction Document
or any other certificate, instrument or document executed by the Company contemplated hereby or thereby, if such breach would reasonably
be expected to have a Material Adverse Effect and except, in the case of a breach of a covenant which is reasonably curable, only if
such breach continues for a period of at least five (5) Business Days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>if
any Person commences a proceeding against the Company pursuant to or within the meaning of any Bankruptcy Law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>if
the Company is at any time insolvent, or, pursuant to or within the meaning of any Bankruptcy Law, (i) commences a voluntary case, (ii)
consents to the entry of an order for relief against it in an involuntary case, (iii) consents to the appointment of a Custodian of it
or for all or substantially all of its property, or (iv) makes a general assignment for the benefit of its creditors or is generally
unable to pay its debts as the same become due;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>a
court of competent jurisdiction enters an order or decree under any Bankruptcy Law that (i) is for relief against the Company in an involuntary
case, (ii) appoints a Custodian of the Company or for all or substantially all of its property, or (iii) orders the liquidation of the
Company; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>if
at any time the Company is not eligible to transfer its Common Stock electronically as DWAC Shares or if the Company fails to maintain
the service of its Transfer Agent (or a successor Transfer Agent) with respect to the issuance of Purchase Shares under this Agreement,
including but not limited to, maintaining the effectiveness of the Commencement Irrevocable Transfer Instructions, payment of all fees
owed to the Transfer Agent and satisfaction of all conditions required by the Transfer Agent to issue Purchase Shares pursuant to the
Commencement Irrevocable Transfer Agent Instructions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to any other
rights and remedies under applicable law and this Agreement, so long as (i) an Event of Default has occurred and is continuing, or if
any event that, after notice and/or lapse of time, would reasonably be expected to become an Event of Default, has occurred and is continuing
or (ii) if at any time after the Commencement Date, the Exchange Cap is reached (to the extent the Exchange Cap is applicable pursuant
to Section 2(d) hereof), the Company shall not deliver to the Investor any Regular Purchase Notice, Accelerated Purchase Notice or Additional
Accelerated Purchase Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="color: #010000">11.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;TERMINATION</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement may be terminated
only as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>If
pursuant to or within the meaning of any Bankruptcy Law, the Company commences a voluntary case or any Person commences a proceeding
against the Company, a Custodian is appointed for the Company or for all or substantially all of its property, or the Company makes a
general assignment for the benefit of its creditors (any of which would be an Event of Default as described in <U>Sections 10(f)</U>,
<U>10(g)</U> and <U>10(h)</U> hereof), this Agreement shall automatically terminate without any liability or payment to the Company (except
as set forth below) without further action or notice by any Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>At
any time after the Commencement Date, the Company shall have the option to terminate this Agreement for any reason or for no reason by
delivering notice (a &quot;<U>Company Termination Notice</U>&quot;) to the Investor electing to terminate this Agreement without any
liability whatsoever of any party to any other party under this Agreement (except as set forth below). The Company Termination Notice
shall not be effective until one (1) Business Day after it has been received by the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>This
Agreement shall automatically terminate on the date that the Company sells and the Investor purchases the full Available Amount as provided
herein, without any action or notice on the part of any party and without any liability whatsoever of any party to any other party under
this Agreement (except as set forth below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT>If,
for any reason or for no reason, the full Available Amount has not been purchased in accordance with <U>Section 2</U> of this Agreement
by the Maturity Date, this Agreement shall automatically terminate on the Maturity Date, without any action or notice on the part of
any party and without any liability whatsoever of any party to any other party under this Agreement (except as set forth below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as set forth in <U>Sections
11(a)</U> (in respect of an Event of Default under <U>Sections 10(f)</U>, <U>10(g)</U> and <U>10(h)</U>), and <U>11(d)</U>, any termination
of this Agreement pursuant to this <U>Section 11</U> shall be effected by written notice from the Company to the Investor, or the Investor
to the Company, as the case may be, setting forth the basis for the termination hereof. The representations and warranties and covenants
of the Company and the Investor contained in <U>Sections 3</U>, <U>4</U>, <U>5</U>, and <U>6</U> hereof, the indemnification provisions
set forth in <U>Section 9</U> hereof and the agreements and covenants set forth in <U>Sections 10</U>, <U>11</U> and <U>12</U> shall
survive the execution and delivery of this Agreement and any termination of this Agreement. No termination of this Agreement shall (i)
affect the Company&rsquo;s or the Investor&rsquo;s rights or obligations under (A) this Agreement with respect to any pending Regular
Purchases, Accelerated Purchases, or Additional Accelerated Purchases, and the Company and the Investor shall complete their respective
obligations with respect to any pending Regular Purchases, Accelerated Purchases and Additional Accelerated Purchases under this Agreement
and (B) the Registration Rights Agreement, which shall survive any such termination in accordance with its terms, or (ii) be deemed to
release the Company or the Investor from any liability for intentional misrepresentation or willful breach of any of the Transaction
Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="color: #010000">12.
</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;MISCELLANEOUS.</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Governing
Law; Jurisdiction; Jury Trial</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement
and the other Transaction Documents shall be governed by the internal laws of the State of New York, without giving effect to any choice
of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of and venue in the U.S. District Court for the Southern District of New York or, if that court does not have subject matter jurisdiction,
in any state court located in the City and County of New York, for the adjudication of any dispute hereunder or under the other Transaction
Documents or in connection herewith or therewith, or with any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding
is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit,
action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that
such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to
limit in any way any right to serve process in any manner permitted by law. <B>EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY
HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT
OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Counterparts</U>.
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and delivered to the other party. Signatures transmitted by Adobe
Sign, DocuSign, RightSignature, electronic mail, or other digital or electronic means will be treated as original signatures for all
purposes hereunder, each of which shall be of the same legal effect, validity, and enforceability as a manually executed signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Headings</U>.
The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 31; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Severability</U>.
If any provision of this Agreement shall be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall not
affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability of any
provision of this Agreement in any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Entire
Agreement</U>. The Transaction Documents supersede all other prior oral or written agreements between the Investor, the Company, their
affiliates and Persons acting on their behalf with respect to the subject matter thereof, and this Agreement, the other Transaction Documents
and the instruments referenced herein contain the entire understanding of the parties with respect to the matters covered herein and
therein and, except as specifically set forth herein or therein, neither the Company nor the Investor makes any representation, warranty,
covenant or undertaking with respect to such matters. The Company acknowledges and agrees that it has not relied on, in any manner whatsoever,
any representations or statements, written or oral, other than as expressly set forth in the Transaction Documents. The Investor acknowledges
and agrees that it has not relied on, in any manner whatsoever, any representations or statements, written or oral, other than as expressly
set forth in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Notices</U>.
Any notices, consents or other communications required or permitted to be given under the terms of this Agreement must be in writing
and will be deemed to have been delivered: (i) upon receipt when delivered personally; (ii) upon receipt when sent by facsimile or email
(provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending party); or (iii) one
(1) Business Day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party
to receive the same. The addresses for such communications shall be:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Cognition Therapeutics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">2500 Westchester Ave.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Purchase, NY 10577</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">E-mail: [***]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention: [***]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">With a copy to (which shall not constitute
notice or service of process):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Goodwin Procter LLP<BR>
Rachael M. Bushey</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">2929 Arch Street Suite #1700<BR>
Philadelphia,&nbsp;Pennsylvania&nbsp;19104&nbsp;United States</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Telephone: &nbsp;(445) 207-7800</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Email: RBushey@goodwinlaw.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention: Rachael M. Bushey</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If to the Investor:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Lincoln Park Capital Fund, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">440 North Wells, Suite 410</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Chicago, IL 60654</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Telephone:&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[***]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Facsimile:&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[***]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">E-mail:&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[***]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention:&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[***]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 32; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">With a copy to (which shall not constitute
notice or service of process):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Katten Muchin Rosenman LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">525 W. Monroe St.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Chicago, IL 60661</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Telephone:&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;(312)
902-5493</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">E-mail: &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;mark.wood@katten.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention:&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Mark
D. Wood, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If to the Transfer Agent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">American Stock Transfer &amp; Trust Company, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">6201 15<SUP>th</SUP> Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Brooklyn, NY 11219</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Telephone:&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[***]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Email: &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[***]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention:&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[***]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">or at such other address, email address and/or
facsimile number and/or to the attention of such other Person as the recipient party has specified by written notice given to each other
party three (3) Business Days prior to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient of
such notice, consent or other communication, (B) mechanically or electronically generated by the sender&rsquo;s facsimile machine or
email account containing the time, date, and recipient facsimile number or email address, as applicable, or (C) provided by a nationally
recognized overnight delivery service, shall be rebuttable evidence of personal service, receipt by facsimile or email or deposit with
a nationally recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns.
The Company shall not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Investor,
including by merger or consolidation. The Investor may not assign its rights or obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>No
Third Party Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective permitted successors
and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Publicity</U>.
The Company shall afford the Investor and its counsel with the opportunity to review and comment upon, shall consult with the Investor
and its counsel on the form and substance of, and shall give due consideration to all such comments from the Investor or its counsel
on, the Prospectus Supplement, any press release or any Current Report on Form 8-K by or on behalf of the Company relating to the Investor,
its purchases hereunder or any aspect to the Transaction Documents or the transactions contemplated thereby, not less than 24 hours prior
to the issuance, filing or public disclosure thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 33; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Further
Assurances</U>. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute
and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request in order to
consummate and make effective, as soon as reasonably possible, the Commencement, and to carry out the intent and accomplish the purposes
of this Agreement and the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>No
Financial Advisor, Placement Agent, Broker or Finder</U>. The Company represents and warrants to the Investor that it has not engaged
any financial advisor, placement agent, broker or finder in connection with the transactions contemplated hereby. The Investor represents
and warrants to the Company that it has not engaged any financial advisor, placement agent, broker or finder in connection with the transactions
contemplated hereby. The Company shall be responsible for the payment of any fees or commissions, if any, of any financial advisor, placement
agent, broker or finder relating to or arising out of the transactions contemplated hereby. The Company shall pay, and hold the Investor
harmless against, any liability, loss or expense (including, without limitation, reasonable attorneys&rsquo; fees and out of pocket expenses)
arising in connection with any such claim made by a third party for any such fees or commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>No
Strict Construction; Rule of Construction</U>. The language used in this Agreement will be deemed to be the language chosen by the parties
to express their mutual intent, and no rules of strict construction will be applied against any party. For the purposes of this Agreement,
except to the extent that the context otherwise requires: (i) when a reference is made in this Agreement to an Article, Section, Exhibit
or Schedule, such reference is to an Article or Section of, or an Exhibit or Schedule to, this Agreement unless otherwise indicated;
(ii) headings for this Agreement are for reference purposes only and do not affect in any way the meaning or interpretation of this Agreement;
(iii) whenever the words &ldquo;include,&rdquo; &ldquo;includes&rdquo; or &ldquo;including&rdquo; (or similar terms) are used in this
Agreement, they are deemed to be followed by the words &ldquo;without limitation&rdquo;; (iv) the words &ldquo;hereof,&rdquo; &ldquo;herein&rdquo;
and &ldquo;hereunder&rdquo; and words of similar import, when used in this Agreement, refer to this Agreement as a whole and not to any
particular provision of this Agreement; (v) the definitions contained in this Agreement are applicable to the singular as well as the
plural forms of such terms;; (vi) references to a Person are also to its permitted successors and assigns; and (vii) the use of &ldquo;or&rdquo;
is not intended to be exclusive unless expressly indicated otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Remedies, Other Obligations, Breaches and Injunctive Relief</U>. The Investor&rsquo;s remedies provided in this Agreement,
including, without limitation, the Investor&rsquo;s remedies provided in <U>Section 9</U>, shall be cumulative and in addition to all
other remedies available to the Investor under this Agreement, at law or in equity (including a decree of specific performance and/or
other injunctive relief). No remedy of the Investor contained herein shall be deemed a waiver of compliance with the provisions giving
rise to such remedy and nothing herein shall limit the Investor&rsquo;s right to pursue actual damages for any failure by the Company
to comply with the terms of this Agreement. The Company acknowledges that a material breach by it of its obligations hereunder will cause
irreparable harm to the Investor and that the remedy at law for any such material breach may be inadequate. The Company therefore agrees
that, in the event of any such material breach or threatened material breach, the Investor shall be entitled, in addition to all other
available remedies, to an injunction restraining any material breach, without the necessity of showing economic loss and without any
bond or other security being required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Enforcement
Costs</U>. If: (i) this Agreement is placed by the Investor in the hands of an attorney for enforcement or is enforced by the Investor
through any legal proceeding; (ii) an attorney is retained to represent the Investor in any bankruptcy, reorganization, receivership
or other proceedings affecting creditors&rsquo; rights and involving a claim under this Agreement; or (iii) subject to <U>Section 9</U>,
an attorney is retained to represent the Investor in any other proceedings whatsoever in connection with this Agreement, then the Company
shall pay to the Investor, as incurred by the Investor, all reasonable costs and expenses including attorneys&rsquo; fees incurred in
connection therewith, in addition to all other amounts due hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></FONT><U>Amendment
and Waiver; Failure or Indulgence Not Waiver</U>. No provision of this Agreement (i) may be amended other than by a written instrument
signed by both parties hereto and (ii) may be waived other than in a written instrument signed by the party against whom enforcement
of such waiver is sought. No failure or delay in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof,
nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other
right, power or privilege.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">* * * * *</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 34; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF,</B>
the Investor and the Company have caused this Purchase Agreement to be duly executed as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><U>THE COMPANY:</U></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase"><FONT STYLE="font-size: 10pt">Cognition Therapeutics,
    Inc.</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 211.5pt; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%">/s/ Lisa Ricciardi</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Lisa Ricciardi</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 211.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><U>THE INVESTOR:</U></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">LINCOLN PARK CAPITAL FUND, LLC</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">BY: LINCOLN PARK CAPITAL, LLC</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">BY:</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%">/s/ Josh Scheinfeld</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Josh Scheinfeld</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">President</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 35; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBITS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exhibit A&#9;Signing Resolutions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exhibit B&#9;Form of Officer&rsquo;s Certificate</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exhibit C&#9;Form of Secretary&rsquo;s Certificate</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Split-Segment; Name: 2 -->
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>EXHIBIT A</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM OF COMPANY RESOLUTIONS</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOR SIGNING PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Omitted pursuant to Regulation S-K, Item 601(a)(5). We agree to furnish supplementally a copy of such omitted materials to the SEC upon
request.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT B</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM OF OFFICER&rsquo;S CERTIFICATE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-style: normal; font-weight: normal">[Omitted
pursuant to Regulation S-K, Item 601(a)(5). We agree to furnish supplementally a copy of such omitted materials to the SEC upon request.]</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in"></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT C</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM OF SECRETARY&rsquo;S CERTIFICATE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-style: normal; font-weight: normal">[Omitted
pursuant to Regulation S-K, Item 601(a)(5). We agree to furnish supplementally a copy of such omitted materials to the SEC upon request.]</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>tm239035d1_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION RIGHTS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>THIS REGISTRATION RIGHTS
AGREEMENT</B> (this &ldquo;<U>Agreement</U>&rdquo;), dated as of March 10, 2023, is entered into by and between <B>COGNITION THERAPEUTICS,
INC.</B>, a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and <B>LINCOLN PARK CAPITAL FUND, LLC</B>, an Illinois limited liability
company (together with its permitted assigns, the &ldquo;<U>Investor</U>&rdquo;).&nbsp;Capitalized terms used herein and not otherwise
defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the
date hereof (as amended, restated, supplemented or otherwise modified from time to time, the &ldquo;<U>Purchase Agreement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WHEREAS:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>Upon the terms and subject to the conditions of the Purchase Agreement, (i)&nbsp;the Company has agreed to issue to the Investor,
and the Investor has agreed to purchase,&nbsp;up to Thirty-Five Million Dollars ($35,000,000) of the Company's common stock, par value
$0.001 per share (the &ldquo;<U>Common Stock</U>&rdquo;), pursuant to the Purchase Agreement (such shares, the &ldquo;<U>Purchase Shares</U>&rdquo;),
and (ii)&nbsp;the Company has agreed to issue to the Investor such number of shares of Common Stock as is required pursuant to the Purchase
Agreement (the &ldquo;<U>Commitment Shares</U>&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>To induce the Investor to enter into the Purchase Agreement, the Company has agreed to provide certain registration rights under
the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, the
 &ldquo;<U>Securities Act</U>&rdquo;), and applicable state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE,</B> in
consideration of the promises and the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the Company and the Investor hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">1.</TD><TD>DEFINITIONS.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">For purposes of this Agreement,
the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>&ldquo;<U>Register</U>,&rdquo; &ldquo;<U>Registered</U>,&rdquo; and &ldquo;<U>Registration</U>&rdquo; refer to a registration effected
by preparing and filing one or more registration statements of the Company in compliance with the Securities Act and pursuant to Rule
415 under the Securities Act or any successor rule providing for offering securities on a continuous basis (&ldquo;<U>Rule 415</U>&rdquo;),
and the declaration or ordering of effectiveness of such registration statement(s) by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>&ldquo;<U>Registrable Securities</U>&rdquo; means the Purchase Shares that may from time to time be issued or issuable to the Investor
upon purchases of the Available Amount under the Purchase Agreement (without regard to any limitation or restriction on purchases), the
Commitment Shares issued or issuable to the Investor, and any Common Stock issued or issuable with respect to the Purchase Shares, the
Commitment Shares or the Purchase Agreement as a result of any stock split, stock dividend, recapitalization, exchange or similar event,
without regard to any limitation on purchases under the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>&ldquo;<U>Registration Statement</U>&rdquo; means the Shelf Registration Statement and any other registration statement of the
Company that Registers Registrable Securities, including a New Registration Statement, as amended when each became effective, including
all documents filed as part thereof or incorporated by reference therein, and including any information contained in a Prospectus subsequently
filed with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>&ldquo;<U>Shelf Registration Statement</U>&rdquo; has the meaning set forth in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>REGISTRATION.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Mandatory Registration</U></FONT>.&nbsp;The Company agrees that it
shall, within the time required under Rule 424(b) under the Securities Act, file with the SEC the Initial Prospectus Supplement pursuant
to Rule 424(b) under the Securities Act specifically relating to the transactions contemplated by, and describing the material terms and
conditions of, the Transaction Documents, containing information previously omitted at the time of effectiveness of the Registration Statement
in reliance on Rule 430B under the Securities Act, and disclosing all information relating to the transactions contemplated hereby required
to be disclosed in the Registration Statement and the Prospectus as of the date of the Initial Prospectus Supplement, including, without
limitation, information required to be disclosed in the section captioned &ldquo;Plan of Distribution&rdquo; in the Prospectus. The Investor
acknowledges that it will be identified in the Initial Prospectus Supplement as an underwriter within the meaning of Section 2(a)(11)
of the Securities Act. The Company shall permit the Investor to review and comment upon the Initial Prospectus Supplement at least two
(2) Business Days prior to its filing with the SEC, the Company shall give due consideration to all such comments, and the Company shall
not file the Initial Prospectus Supplement with the SEC in a form to which the Investor reasonably objects. The Investor shall use its
commercially reasonable efforts to comment upon the Initial Prospectus Supplement within one (1) Business Day from the date the Investor
receives a substantially complete draft thereof from the Company. The Investor shall furnish to the Company such information regarding
itself, the Securities held by it and the intended method of distribution thereof, including any arrangement between the Investor and
any other Person relating to the sale or distribution of the Securities, as shall be reasonably requested by the Company in connection
with the preparation and filing of the Initial Prospectus Supplement, and shall otherwise cooperate with the Company as reasonably requested
by the Company in connection with the preparation and filing of the Initial Prospectus Supplement with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Effectiveness</U></FONT>. The Company shall use its commercially reasonable
efforts to keep the Registration Statement effective pursuant to Rule 415 promulgated under the Securities Act, and to keep the Registration
Statement and the Prospectus current and available for issuances and sales of all possible Registrable Securities by the Company to the
Investor, and for the resale of all of the Registrable Securities by the Investor, at all times until the earlier of (i) the date on which
the Investor shall have sold all the Securities and no Available Amount remains under the Purchase Agreement and (ii) 180 days following
the earlier of termination of the Purchase Agreement and the Maturity Date (the &quot;<U>Registration Period</U>&quot;). Without limiting
the generality of the foregoing, during the Registration Period, the Company shall (a) take all action necessary to cause the Common Stock
to continue to be Registered as a class of securities under Section 12(b) of the Exchange Act and shall not take any action or file any
document (whether or not permitted by the Exchange Act) to terminate or suspend such registration and (b) file or furnish on or before
their respective due dates all reports and other documents required to be filed or furnished by the Company pursuant to Sections 13(a),
13(c), 14, 15(d) or any other provision of or under the Exchange Act, and shall not take any action or file any document (whether or not
permitted by the Exchange Act) to terminate or suspend its reporting and filing obligations under the Exchange Act. The Registration Statement
(including any amendments or supplements thereto and the Base Prospectus, the Prospectus Supplements and any other prospectuses and prospectus
supplements contained therein or related thereto and any documents incorporated therein) shall not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Prospectus Amendments or Supplements</U></FONT>. Except as provided
in this Agreement and other than periodic and current reports required to be filed pursuant to the Exchange Act, the Company shall not
file with the SEC any amendment to the Registration Statement or any supplement to the Base Prospectus that refers to the Investor, the
Transaction Documents or the transactions contemplated thereby (including, without limitation, any Prospectus Supplement filed in connection
with the transactions contemplated by the Transaction Documents), in each case with respect to which (a) the Investor shall not previously
have been advised and afforded the opportunity to review and comment thereon at least two (2) Business Days prior to filing with the SEC,
as the case may be, (b) the Company shall not have given due consideration to any comments thereon received from the Investor or its counsel,
or (c) the Investor shall reasonably object, unless the Company reasonably has determined that it is necessary to amend the Registration
Statement or make any supplement to the Prospectus to comply with the Securities Act or any other applicable law or regulation, in which
case (i) the Company shall promptly (but in no event later than 24 hours) so inform the Investor, (ii) the Investor shall be provided
with a reasonable opportunity to review and comment upon any disclosure referring to the Investor, the Transaction Documents or the transactions
contemplated thereby, as applicable, and (iii) the Company shall expeditiously furnish to the Investor a copy thereof. In addition, for
so long as, in the reasonable opinion of counsel for the Investor, the Prospectus is required to be delivered in connection with any acquisition
or sale of Securities by the Investor, the Company shall not file any Prospectus Supplement with respect to the Securities without furnishing
to the Investor as many copies of such Prospectus Supplement, together with the Prospectus, as the Investor may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Sufficient Number of Shares Registered</U></FONT>.&nbsp;In the event
the number of shares available under the Shelf Registration Statement at any time is insufficient to cover the Registrable Securities,
the Company shall, to the extent necessary and permissible, amend the Shelf Registration Statement or file a new registration statement
(together with any prospectuses or prospectus supplements thereunder, a &ldquo;<U>New Registration Statement</U>&rdquo;), so as to cover
all of such Registrable Securities as soon as reasonably practicable, but in any event not later than ten (10) Business Days after the
necessity therefor arises, subject to any limits that may be imposed by the SEC pursuant to Rule 415.&nbsp;The Company shall use its commercially
reasonable efforts to have such amendment and/or New Registration Statement become effective as soon as reasonably practicable following
the filing thereof. &#8239;&#8239;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Offering</U></FONT>. If the SEC seeks to characterize any offering
pursuant to a Registration Statement filed pursuant to this Agreement as constituting an offering of securities that does not permit such
Registration Statement to become effective and be used by the Investor under Rule 415 at then-prevailing market prices (and not fixed
prices), or if after the filing of the Initial Prospectus Supplement with the SEC pursuant to <U>Section 2(a)</U>, the Company is otherwise
required by the Staff or the SEC to reduce the number of Registrable Securities included in such initial Registration Statement, then
the Company shall reduce the number of Registrable Securities to be included in such initial Registration Statement until such time as
the SEC shall so permit such Registration Statement to become effective and be used as aforesaid; provided, however, that prior to filing
such amendment or New Registration Statement, the Company shall be obligated to use its commercially reasonable efforts to advocate with
the SEC for the registration of all of the Registrable Securities in accordance with any publicly available written or oral guidance,
comments, requirements or requests of the SEC staff (the &ldquo;<U>SEC Guidance</U>&rdquo;), including without limitation, the Manual
of Publicly Available Telephone Interpretations D.29. The Investor shall have the right to participate or have its legal counsel participate
in any meetings or discussions with the SEC regarding the SEC&rsquo;s position and to comment or have its counsel comment on any written
submission made to the SEC with respect thereto. No such written submission shall be made to the SEC to which the Investor&rsquo;s counsel
reasonably objects. In the event of any reduction in Registrable Securities pursuant to this paragraph, the Company shall file one or
more New Registration Statements in accordance with <U>Section 2(d)</U> until such time as all Registrable Securities have been included
in Registration Statements that have been declared effective and the prospectuses contained therein are available for use by the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>RELATED OBLIGATIONS.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With respect to the Registration
Statement and whenever any Registrable Securities are to be Registered pursuant to <U>Section 2</U>, including on the Shelf Registration
Statement or on any New Registration Statement, the Company shall use its commercially reasonable efforts to effect the registration of
the Registrable Securities in accordance with the intended method of disposition thereof and, pursuant thereto, the Company shall have
the following obligations:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Notifications</U></FONT>. The Company will notify the Investor promptly
of the time when any subsequent amendment to the Shelf Registration Statement or any New Registration Statement, other than documents
incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any
subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration
Statement, any New Registration Statement or any Prospectus or for additional information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Amendments.</U></FONT> The Company will prepare and file with the SEC,
promptly upon the Investor&rsquo;s request, any amendments or supplements to the Shelf Registration Statement, any New Registration Statement
or any Prospectus, as applicable, that, in the reasonable opinion of the Investor and the Company, may be necessary or advisable in connection
with any acquisition or sale of Registrable Securities by the Investor (provided, however, that the failure of the Investor to make such
request shall not relieve the Company of any obligation or liability hereunder).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Investor Review</U></FONT>. The Company will not file any amendment
or supplement to the Registration Statement, any New Registration Statement or any Prospectus, other than documents incorporated by reference,
relating to the Investor, the Registrable Securities or the transactions contemplated hereby unless (A) the Investor shall have been advised
and afforded the opportunity to review and comment thereon at least two (2) Business Days prior to filing with the SEC, (B) the Company
shall have given due consideration to any comments thereon received from the Investor or its counsel, and (C) the Investor has not reasonably
objected thereto (provided, however, that the failure of the Investor to make such objection shall not relieve the Company of any obligation
or liability hereunder), and the Company will furnish to the Investor at the time of filing thereof a copy of any document that upon filing
is deemed to be incorporated by reference into the Registration Statement or any Prospectus, except for those documents available via
EDGAR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Form S-3</U></FONT>. The Company will cause each amendment or supplement
to the Prospectus, other than documents incorporated by reference, to be filed with the SEC as required pursuant to the rules of Form
S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Copies Available</U></FONT>. The Company will furnish to the Investor
and its counsel (at the expense of the Company) copies of the Registration Statement, the Prospectus (including all documents incorporated
by reference therein), any Prospectus Supplement, any New Registration Statement and all amendments and supplements to the Registration
Statement, the Prospectus or any New Registration Statement that are filed with the SEC during the Registration Period (including all
documents filed with or furnished to the SEC during such period that are deemed to be incorporated by reference therein), in each case
as soon as reasonably practicable upon the Investor&rsquo;s request and in such quantities as the Investor may from time to time reasonably
request and, at the Investor&rsquo;s request, will also furnish copies of the Prospectus to each exchange or market on which sales of
the Registrable Securities may be made; provided, however, that the Company shall not be required to furnish any document (other than
the Prospectus) to the Investor to the extent such document is available on EDGAR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Qualification</U></FONT>. The Company shall take all such action, if
any, as is reasonably necessary in order to obtain an exemption for or to qualify (i) the issuance of the Commitment Shares and the sale
of the Purchase Shares to the Investor under this Agreement and (ii) any subsequent resale of all Commitment Shares and all Purchase Shares
by the Investor, in each case, under applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States in such states
as is reasonably requested by the Investor during the Registration Period, and shall provide evidence of any such action so taken to the
Investor.&nbsp;During the Registration Period, the Company shall promptly notify the Investor of the receipt by the Company of any notification
with respect to the suspension of the registration or qualification of any of the Registrable Securities for sale under the securities
or &ldquo;blue sky&rdquo; laws of any jurisdiction in the United States or its receipt of actual notice of the initiation or threat of
any proceeding for such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Notification of Stop Orders; Material Changes</U></FONT>. The Company
shall advise the Investor promptly (but in no event later than 24 hours) and shall confirm such advice in writing, in each case: (i) of
the Company&rsquo;s receipt of notice of any request by the SEC or any other federal or state governmental authority for amendment of
or a supplement to the Registration Statement or any Prospectus or for any additional information; (ii) of the Company&rsquo;s receipt
of notice of the issuance by the SEC or any other federal or state governmental authority of any stop order suspending the effectiveness
of the Registration Statement or prohibiting or suspending the use of the Prospectus or Prospectus Supplement, or any New Registration
Statement, or of the Company&rsquo;s receipt of any notification of the suspension of qualification of the Registrable Securities for
offering or sale in any jurisdiction or the initiation or contemplated initiation of any proceeding for such purpose; and (iii) of the
Company becoming aware of the happening of any event, which makes any statement of a material fact made in the Registration Statement
or any Prospectus untrue or which requires the making of any additions to or changes to the statements then made in the Registration Statement
or any Prospectus in order to state a material fact required by the Securities Act to be stated therein or necessary in order to make
the statements then made therein (in the case of any Prospectus or Prospectus Supplement, in light of the circumstances under which they
were made) not misleading, or of the necessity to amend the Registration Statement or any Prospectus to comply with the Securities Act
or any other law. If at any time the SEC, or any other federal or state governmental authority shall issue any stop order suspending the
effectiveness of the Registration Statement or prohibiting or suspending the use of the Prospectus or Prospectus Supplement, the Company
shall use its commercially reasonable efforts to obtain the withdrawal of such order at the earliest practicable time. The Company shall
furnish to the Investor, without charge and upon request, a copy of any correspondence from the SEC or the staff of the SEC, or any other
federal or state governmental authority to the Company or its representatives relating to the Shelf Registration Statement, any New Registration
Statement or any Prospectus, or Prospectus Supplement as the case may be. The Company shall not deliver to the Investor any Regular Purchase
Notice, Accelerated Purchase Notice or Additional Accelerated Purchase Notice, and the Investor shall not be obligated to purchase any
shares of Common Stock under the Purchase Agreement, during the continuation or pendency of any of the foregoing events. If at any time
the SEC shall issue any stop order suspending the effectiveness of the Registration Statement or prohibiting or suspending the use of
any Prospectus or any Prospectus Supplement, the Company shall use its commercially reasonable efforts to obtain the withdrawal of such
order at the earliest practicable time. The Company shall furnish to the Investor, without charge and upon request, a copy of any correspondence
from the SEC or the staff of the SEC to the Company or its representatives relating to the Registration Statement or the Prospectus, as
the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Listing on the Principal Market</U></FONT>. The Company shall promptly
secure the listing, or conditional listing as applicable, of all of the Purchase Shares and Commitment Shares to be issued to the Investor
hereunder on the Principal Market (subject to standard listing conditions, if any, for transactions of this nature, official notice of
issuance and the Exchange Cap) and upon each other national securities exchange, automated quotation system or trading market, if any,
upon which the Common Stock are then listed, quoted or traded, and shall maintain, so long as any Common Stock shall be so listed, such
listing of all such Registrable Securities from time to time issuable hereunder. The Company shall use its commercially reasonable efforts
to maintain the listing of the Common Stock on the Principal Market and shall comply in all respects with the Company&rsquo;s reporting,
filing and other obligations under the bylaws or rules and regulations of the Principal Market. The Company shall not take any action
that would reasonably be expected to result in the delisting or suspension of the Common Stock on the Principal Market. The Company shall
promptly, and in no event later than the following Business Day, provide to the Investor copies of any notices it receives from any Person
regarding the continued eligibility of the Common Stock for listing on the Principal Market; provided, however, that the Company shall
not provide the Investor copies of any such notice that the Company reasonably believes constitutes material non-public information and
that the Company would not be required to publicly disclose such notice in any report or statement filed with the SEC under the Exchange
Act (including on Form 8-K) or the Securities Act. The Company shall pay all fees and expenses in connection with satisfying its obligations
under this <U>Section 3(h)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Delivery of Shares</U></FONT>. The Company shall cooperate with the
Investor to facilitate the timely preparation and delivery of DWAC Shares (not bearing any restrictive legend) representing the Registrable
Securities to be offered pursuant to the Shelf Registration Statement or any New Registration Statement and enable such DWAC Shares to
be in such denominations or amounts as the Investor may reasonably request and registered in such names as the Investor may request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Transfer Agent</U></FONT>. The Company shall at all times maintain
the services of the Transfer Agent with respect to its Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Approvals</U></FONT>. The Company shall use its commercially reasonable
efforts to cause the Registrable Securities covered by any Registration Statement to be Registered with or approved by such other governmental
agencies or authorities in the United States as may be necessary to consummate the disposition of such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Confirmation of Effectiveness</U></FONT>. If reasonably requested by
the Investor at any time, the Company shall deliver to the Investor a written confirmation from Company&rsquo;s counsel of whether or
not the effectiveness of such Registration Statement has lapsed at any time for any reason (including, without limitation, the issuance
of a stop order) and whether or not the Registration Statement is currently effective and available to the Company for sale of all of
the Registrable Securities. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Further Assurances</U></FONT>. The Company agrees to use its commercially
reasonable efforts to take all other reasonable actions as necessary and reasonably requested by the Investor to expedite and facilitate
disposition by the Investor of Registrable Securities pursuant to any Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Suspension of Sales</U></FONT>. The Investor agrees that, upon receipt
of any notice from the Company of the existence of any suspension or stop order as set forth in <U>Section 3(f)</U> or <U>3(g)</U>, the
Investor will immediately discontinue disposition of Registrable Securities pursuant to any Registration Statement covering such Registrable
Securities until the Investor's receipt of the copies of a notice regarding the resolution or withdrawal of the suspension or stop order
as contemplated by <U>Section 3(f)</U> or <U>3(g)</U>. Notwithstanding anything to the contrary, the Company shall cause its transfer
agent to promptly deliver to the Investor DWAC Shares without any restrictive legend in accordance with the terms of the Purchase Agreement
in connection with any sale of Registrable Securities with respect to which the Investor has entered into a contract for sale prior to
the Investor&rsquo;s receipt of a notice from the Company of the happening of any event of the kind described in <U>Section 3(f)</U> or
<U>3(g)</U> and for which the Investor has not yet settled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Transfer Agent Instructions</U></FONT>. On or before the date the Initial
Prospectus Supplement is filed with the SEC, the Company shall issue to the Transfer Agent the Commencement Irrevocable Transfer Agent
Instructions in the form agreed to prior to the date hereof, and on the date the Initial Prospectus Supplement is filed with the SEC,
the Company shall deliver, and shall cause legal counsel for the Company to deliver, to the Transfer Agent for such Registrable Securities
(with copies to the Investor) confirmation that such Registration Statement has been declared effective by the SEC in the form attached
as an exhibit to the Commencement Irrevocable Transfer Agent Instructions. Thereafter, if requested by the Investor at any time, the Company
shall require its legal counsel to deliver to the Investor a written confirmation whether or not the effectiveness of such Registration
Statement has lapsed at any time for any reason (including, without limitation, the issuance of a stop order) and whether or not the Registration
Statement is current and available to the Investor for sale of all of the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">4.</TD><TD>OBLIGATIONS OF THE INVESTOR.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Investor Information</U></FONT>. The Investor has furnished to the
Company in <U>Exhibit A </U>hereto such information regarding itself, the Registrable Securities held by it, and the intended method of
disposition thereof, including any arrangement between the Investor and any other Person relating to the sale or distribution of the Securities,
as required to effect the registration of such Registrable Securities and shall execute such documents in connection with such registration
as the Company may reasonably request. The Company shall notify the Investor in writing of any other information the Company reasonably
requires from the Investor in connection with any Registration Statement hereunder. The Investor will as promptly as practicable notify
the Company of any material change in the information set forth in <U>Exhibit A</U>, other than changes in its ownership of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Investor Cooperation</U></FONT>. The Investor agrees to cooperate with
the Company as reasonably requested by the Company in connection with the preparation and filing of any amendments and supplements to
any Registration Statement or New Registration Statement hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">5.</TD><TD>EXPENSES OF REGISTRATION.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">All reasonable expenses of the
Company, other than sales or brokerage commissions and fees and disbursements of counsel for, and other expenses of, the Investor, incurred
in connection with registrations, filings or qualifications pursuant to <U>Sections 2</U> and <U>3</U>, including, without limitation,
all registration, listing and qualifications fees, printers and accounting fees, and fees and disbursements of counsel for the Company,
shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">6.</TD><TD>INDEMNIFICATION.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>To the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend the Investor, each
Person, if any, who controls the Investor, the members, the directors, officers, partners, equityholders, employees, members, managers,
agents and representatives of the Investor and each Person, if any, who controls the Investor within the meaning of the Securities Act
or the Exchange Act (each, an &ldquo;<U>Indemnified Person</U>&rdquo;), against any losses, claims, damages, liabilities, judgments, fines,
penalties, charges, costs, reasonable attorneys&rsquo; fees, amounts paid in settlement (with the consent of the Company, such consent
not to be unreasonably withheld) or reasonable expenses, (collectively, &ldquo;<U>Claims</U>&rdquo;) reasonably incurred in investigating,
preparing or defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any
court or governmental, administrative or other regulatory agency or body or the SEC, whether pending or threatened, whether or not an
indemnified party is or may be a party thereto (&ldquo;<U>Indemnified Damages</U>&rdquo;), to which any of them may become subject insofar
as such Claims (or actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon: (i) any
untrue statement or alleged untrue statement of a material fact in the Shelf Registration Statement, any New Registration Statement or
any post-effective amendment thereto or in any filing made in connection with the qualification of the offering under the securities or
other &ldquo;blue sky&rdquo; laws of any jurisdiction in which Registrable Securities are offered (&ldquo;<U>Blue Sky Filing</U>&rdquo;),
or the omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements therein
not misleading, (ii) any untrue statement or alleged untrue statement of a material fact contained in the Prospectus or the omission or
alleged omission to state therein any material fact necessary to make the statements made therein, in light of the circumstances under
which the statements therein were made, not misleading, (iii) any violation or alleged violation by the Company of the Securities Act,
the Exchange Act, any other law, including, without limitation, any state securities law, or any rule or regulation thereunder relating
to the offer or sale of the Registrable Securities pursuant to the Shelf Registration Statement or any New Registration Statement or (iv)
any violation by the Company of this Agreement (the matters in the foregoing clauses (i) through (iv) being, collectively, &ldquo;<U>Violations</U>&rdquo;).&nbsp;The
Company shall reimburse each Indemnified Person promptly as such expenses are incurred and are due and payable, for any reasonable and
documented out-of-pocket legal fees or other reasonable expenses incurred by them in connection with investigating or defending any such
Claim.&nbsp;Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this <U>Section 6(a)</U>:
(A) shall not apply to a Claim by an Indemnified Person arising out of or based upon a Violation which occurs in reliance upon and in
conformity with information furnished in writing to the Company by the Investor or such Indemnified Person expressly for use in connection
with the preparation of the Registration Statement, any New Registration Statement, the Prospectus or any such amendment thereof or supplement
thereto, if such in each case if the foregoing was timely made available by the Company; (B) with respect to use by an Indemnified Person
of any superseded prospectus, shall not inure to the benefit of any such Person from whom the Person asserting any such Claim purchased
the Registrable Securities that are the subject thereof (or to the benefit of any other Indemnified Person) if the untrue statement or
omission of material fact contained in the superseded prospectus was corrected in the revised prospectus, as then amended or supplemented,
if such revised prospectus was timely made available by the Company pursuant to <U>Section 3(c)</U> or <U>Section 3(e)</U>, and the Indemnified
Person was promptly advised in writing not to use the incorrect prospectus prior to the use giving rise to a violation; and (C) shall
not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the Company,
which consent shall not be unreasonably withheld.&nbsp;Such indemnity shall remain in full force and effect regardless of any investigation
made by or on behalf of the Indemnified Person and shall survive the transfer of the Registrable Securities by the Investor pursuant to
<U>Section 8</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>In connection with the Shelf Registration Statement, any New Registration Statement or Prospectus, the Investor agrees to indemnify,
hold harmless and defend, to the same extent and in the same manner as is set forth in <U>Section 6(a)</U>, the Company, each of its directors,
each of its officers who signed the Shelf Registration Statement or signs any New Registration Statement, and each Person, if any, who
controls the Company within the meaning of the Securities Act or the Exchange Act (collectively and together with an Indemnified Person,
an &ldquo;<U>Indemnified Party</U>&rdquo;), against any Claim or Indemnified Damages to which any of them may become subject, under the
Securities Act, the Exchange Act or otherwise, insofar as such Claim or Indemnified Damages arise out of or are based upon any Violation,
in each case to the extent, and only to the extent, that such Violation occurs in reliance upon and in conformity with written information
about the Investor set forth on <U>Exhibit A</U> attached hereto or updated from time to time in writing by the Investor and furnished
to the Company by the Investor expressly for inclusion in the Shelf Registration Statement or Prospectus or any New Registration Statement;
and, subject to <U>Section 6(d)</U>, the Investor will reimburse any reasonable and documented out-of-pocket legal or other expenses reasonably
incurred by them in connection with investigating or defending any such Claim; <U>provided</U>, <U>however</U>, that the indemnity agreement
contained in this <U>Section 6(b)</U> and the agreement with respect to contribution contained in <U>Section 7</U> shall not apply to
amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the Investor, which consent
shall not be unreasonably withheld; <U>provided</U>, <U>further</U>, <U>however</U>, that the Investor shall be liable under this <U>Section
6(b)</U> for only that amount of a Claim or Indemnified Damages as does not exceed the net proceeds to the Investor as a result of the
sale of Registrable Securities pursuant to such Registration Statement.&nbsp;Such indemnity shall remain in full force and effect regardless
of any investigation made by or on behalf of such Indemnified Party and shall survive the transfer of the Registrable Securities by the
Investor pursuant to <U>Section 8</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>Promptly after receipt by an Indemnified Person or Indemnified Party under this <U>Section 6</U> of notice of the commencement
of any action or proceeding (including any governmental action or proceeding) involving a Claim, such Indemnified Person or Indemnified
Party shall, if a Claim in respect thereof is to be made against any indemnifying party under this <U>Section 6</U>, deliver to the indemnifying
party a written notice of the commencement thereof, and the indemnifying party shall have the right to participate in, and, to the extent
the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume control of the defense thereof
with counsel mutually satisfactory to the indemnifying party and the Indemnified Person or the Indemnified Party, as the case may be;
<U>provided</U>, <U>however</U>, that an Indemnified Person or Indemnified Party shall have the right to retain its own counsel with the
fees and expenses to be paid by the indemnifying party, if, in the reasonable opinion of counsel retained by the indemnifying party, the
representation by such counsel of the Indemnified Person or Indemnified Party and the indemnifying party would be inappropriate due to
actual or potential differing interests between such Indemnified Person or Indemnified Party and any other party represented by such counsel
in such proceeding. The Indemnified Party or Indemnified Person shall cooperate with the indemnifying party in connection with any negotiation
or defense of any such action or claim by the indemnifying party and shall furnish to the indemnifying party all information reasonably
available to the Indemnified Party or Indemnified Person which relates to such action or claim.&nbsp;The indemnifying party shall keep
the Indemnified Party or Indemnified Person fully apprised as to the status of the defense or any settlement negotiations with respect
thereto.&nbsp;No indemnifying party shall be liable for any settlement of any action, claim or proceeding effected without its written
consent, provided, however, that the indemnifying party shall not unreasonably withhold, delay or condition its consent.&nbsp;No indemnifying
party shall, without the consent of the Indemnified Party or Indemnified Person, consent to entry of any judgment or enter into any settlement
or other compromise which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified
Party or Indemnified Person of a release from all liability in respect to such claim or litigation or which includes any admission as
to fault, culpability or failure to act on the part of such Indemnified Party or Indemnified Person.&nbsp;Following indemnification as
provided for hereunder, the indemnifying party shall be subrogated to all rights of the Indemnified Party or Indemnified Person with respect
to all third parties, firms or corporations relating to the matter for which indemnification has been made.&nbsp;The failure to deliver
written notice to the indemnifying party within a reasonable time of the commencement of any such action shall not relieve such indemnifying
party of any liability to the Indemnified Person or Indemnified Party under this <U>Section 6</U>, except to the extent that the indemnifying
party is prejudiced in its ability to defend such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>The indemnification required by this <U>Section 6</U> shall be made by periodic payments of the amount thereof during the course
of the investigation or defense, as and when bills are received or Indemnified Damages are incurred.&nbsp;Any Person receiving a payment
pursuant to this <U>Section 6</U> which person is later determined to not be entitled to such payment shall return such payment to the
person making it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>The indemnity agreements contained herein shall be in addition to (i) any cause of action or similar right (at law or in equity)
of the Indemnified Party or Indemnified Person against the indemnifying party or others, and (ii) any liabilities the indemnifying party
may be subject to pursuant to the law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">7.</TD><TD>CONTRIBUTION.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">To the extent any indemnification
by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum contribution with respect
to any amounts for which it would otherwise be liable under <U>Section 6</U> to the fullest extent permitted by law; provided, however,
that: (i) no seller of Registrable Securities guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities
Act) shall be entitled to contribution from any seller of Registrable Securities who was not guilty of fraudulent misrepresentation; and
(ii) contribution by any seller of Registrable Securities shall be limited in amount to the net amount of proceeds received by such seller
from the sale of such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">8.</TD><TD>ASSIGNMENT OF REGISTRATION RIGHTS.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Company shall not assign
this Agreement or any rights or obligations hereunder without the prior written consent of the Investor; provided, however, that any transaction,
whether by merger, reorganization, restructuring, consolidation, financing or otherwise, whereby the Company remains the surviving entity
immediately after such transaction shall not be deemed an assignment.&nbsp;The Investor may not assign its rights under this Agreement
without the prior written consent of the Company, other than to an affiliate of the Investor controlled by Jonathan Cope or Josh Scheinfeld,
in which case the assignee must agree in writing to be bound by the terms and conditions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">9.</TD><TD>AMENDMENT OF REGISTRATION RIGHTS.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">No provision of this Agreement
may be amended or waived by the parties from and after the date that is one (1) Business Day immediately preceding the initial filing
of the Initial Prospectus Supplement with the SEC. Subject to the immediately preceding sentence, no provision of this Agreement may be
(i) amended other than by a written instrument signed by both parties hereto or (ii) waived other than in a written instrument signed
by the party against whom enforcement of such waiver is sought. Failure of any party to exercise any right or remedy under this Agreement
or otherwise, or delay by a party in exercising such right or remedy, shall not operate as a waiver thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">10.</TD><TD>MISCELLANEOUS.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Notices</U></FONT>. Any notices, consents or other communications required
or permitted to be given under the terms of this Agreement must be in writing and will be deemed to have been delivered: (i) upon receipt
when delivered personally; (ii) upon receipt when sent by facsimile or email (provided confirmation of transmission is mechanically or
electronically generated and kept on file by the sending party); or (iii) one Business Day after deposit with a nationally recognized
overnight delivery service, in each case properly addressed to the party to receive the same. The addresses for such communications shall
be:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Cognition Therapeutics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">2500 Westchester Ave.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Purchase, NY 10577</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">E-mail:</TD><TD STYLE="text-align: justify">[***]</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.75in; text-align: left">Attention:</TD><TD STYLE="text-align: justify">[***]</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With a copy to (which shall
not constitute notice or service of process):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Goodwin Procter LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Rachael M. Bushey</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">2929 Arch Street Suite #1700<BR>
Philadelphia,&nbsp;Pennsylvania&nbsp;19104&nbsp;United States</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Telephone: &nbsp;(445) 207-7800</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Email: RBushey@goodwinlaw.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention: Rachael M. Bushey</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If to the Investor:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Lincoln Park Capital Fund, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">440 North Wells, Suite 410</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Chicago, IL 60654</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 1in; text-align: left">Telephone:</TD><TD STYLE="text-align: justify">[***]</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 1in; text-align: left">Facsimile:</TD><TD STYLE="text-align: justify">[***]</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 1in; text-align: left">E-mail:</TD><TD STYLE="text-align: justify">[***]</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 1in; text-align: left">Attention:</TD><TD STYLE="text-align: justify">[***]</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With a copy to (which shall
not constitute notice or service of process):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Katten Muchin Rosenman LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">525 W. Monroe St.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Chicago, IL 60661</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 1in; text-align: left">Telephone:</TD><TD STYLE="text-align: justify">(312) 902-5493</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 1in; text-align: left">E-mail:</TD><TD STYLE="text-align: justify">mark.wood@katten.com</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 1in; text-align: left">Attention:</TD><TD STYLE="text-align: justify">Mark D. Wood, Esq.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If to the Transfer Agent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">American Stock Transfer &amp; Trust Company, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">6201 15<SUP>th</SUP> Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Brooklyn, NY 11219</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 1in; text-align: left">Telephone:</TD><TD STYLE="text-align: justify">[***]</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 1in; text-align: left">Email:</TD><TD STYLE="text-align: justify">[***]</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 1in; text-align: left">Attention:</TD><TD STYLE="text-align: justify">[***]</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">or at such other address, email address and/or
facsimile number and/or to the attention of such other Person as the recipient party has specified by written notice given to each other
party three (3) Business Days prior to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient of
such notice, consent or other communication, (B) mechanically or electronically generated by the sender&rsquo;s facsimile machine or email
account containing the time, date, and recipient facsimile number or email address, as applicable, or (C) provided by a nationally recognized
overnight delivery service, shall be rebuttable evidence of personal service, receipt by facsimile or email or deposit with a nationally
recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>No Waiver</U></FONT> No failure or delay in the exercise of any power,
right or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege
preclude other or further exercise thereof or of any other right, power or privilege.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Governing Law</U></FONT>. All questions concerning the construction,
validity, enforcement and interpretation of this Agreement shall be governed by the internal laws of the State of New York, without giving
effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would
cause the application of the laws of any jurisdictions other than the State of New York.&nbsp;Each party hereby irrevocably submits to
the exclusive jurisdiction of and venue in the U.S. District Court for the Southern District of New York or, if that court does not have
subject matter jurisdiction, in any state court located in the City and County of New York for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not
to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such
suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper.&nbsp;Each
party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that such service shall
constitute good and sufficient service of process and notice thereof.&nbsp;Nothing contained herein shall be deemed to limit in any way
any right to serve process in any manner permitted by law.&nbsp;If any provision of this Agreement shall be invalid or unenforceable in
any jurisdiction, such invalidity or unenforceability shall not affect the validity or enforceability of the remainder of this Agreement
in that jurisdiction or the validity or enforceability of any provision of this Agreement in any other jurisdiction.&nbsp;<B>EACH PARTY
HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER
OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Integration</U></FONT>. This Agreement<B>,</B> the Purchase Agreement
and the other Transaction Documents constitute the entire understanding among the parties hereto with respect to the subject matter hereof
and thereof.&nbsp;There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein and
therein.&nbsp;This Agreement<B>,</B> the Purchase Agreement and the other Transaction Documents supersede all other prior oral or written
agreements between the Investor, the Company, their affiliates and persons acting on their behalf with respect to the subject matter hereof
and thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>No Third Party Benefits</U></FONT>. Subject to the requirements of
<U>Section 8</U>, this Agreement shall inure to the benefit of and be binding upon the permitted successors and assigns of each of the
parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Headings</U></FONT>. The headings in this Agreement are for convenience
of reference and shall not form part of, or affect the interpretation of, this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Counterparts</U></FONT>. This Agreement may be executed in two or more
identical counterparts, all of which shall be considered one and the same agreement and shall become effective when counterparts have
been signed by each party and delivered to the other party. Signatures transmitted by Adobe Sign, DocuSign, RightSignature, electronic
mail, or other digital or electronic means will be treated as original signatures for all purposes hereunder, each of which shall be of
the same legal effect, validity, and enforceability as a manually executed signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Further Assurances</U>. Each party shall do and perform, or cause to be done and performed, all such further acts and things,
and shall execute and deliver all such other agreements, certificates, instruments and documents as the other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>No Strict Construction</U>. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent and no rules of strict construction will be applied against any party. For the purposes of this Agreement, except
to the extent that the context otherwise requires: (i) when a reference is made in this Agreement to an Article, Section, Exhibit or Schedule,
such reference is to an Article or Section of, or an Exhibit or Schedule to, this Agreement unless otherwise indicated; (ii) headings
for this Agreement are for reference purposes only and do not affect in any way the meaning or interpretation of this Agreement; (iii)
whenever the words &ldquo;include,&rdquo; &ldquo;includes&rdquo; or &ldquo;including&rdquo; (or similar terms) are used in this Agreement,
they are deemed to be followed by the words &ldquo;without limitation&rdquo;; (iv) the words &ldquo;hereof,&rdquo; &ldquo;herein&rdquo;
and &ldquo;hereunder&rdquo; and words of similar import, when used in this Agreement, refer to this Agreement as a whole and not to any
particular provision of this Agreement; (v) the definitions contained in this Agreement are applicable to the singular as well as the
plural forms of such terms; (vi) references to a Person are also to its permitted successors and assigns; and (vii) the use of &ldquo;or&rdquo;
is not intended to be exclusive unless expressly indicated otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>No Third Party Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>IN WITNESS WHEREOF,</B> the parties have caused
this Registration Rights Agreement to be duly executed as of date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt"><U>THE
    COMPANY:</U></FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">COGNITION THERAPEUTICS,
    INC.</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-size: 10pt">/s/
Lisa Ricciardi</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Lisa
Ricciardi</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Chief
Executive Officer</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt"><U>THE
    INVESTOR:</U></FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">LINCOLN PARK
    CAPITAL FUND, LLC</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">BY: LINCOLN
    PARK CAPITAL, LLC</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">BY:</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/
Josh Scheinfeld</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Josh
Scheinfeld</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">President</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><U>Exhibit
A</U></FONT><U>&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Information About The Investor Furnished To
The Company By The Investor</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Expressly For Use In Connection With Each Registration
Statement and Prospectus</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Information With Respect to Lincoln Park Capital</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Immediately prior to the date
of the Purchase Agreement, Lincoln Park Capital Fund, LLC, beneficially owned zero (0) shares of Common Stock. Josh Scheinfeld and Jonathan
Cope, the Managing Members of Lincoln Park Capital, LLC, the manager of Lincoln Park Capital Fund, LLC, are deemed to be beneficial owners
of all of the Common Stock owned by Lincoln Park Capital Fund, LLC. Messrs. Cope and Scheinfeld have shared voting and investment power
over the shares being offered under the prospectus supplement filed with the SEC in connection with the transactions contemplated under
the Purchase Agreement. Lincoln Park Capital, LLC is not a licensed broker dealer or an affiliate of a licensed broker dealer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>cgtx-20230310.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaaJ6bOdzZR+yYkxtmB8bXmaTy0ov7tE3Cj/ov9G8Y0F -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:cgtx="http://cogrx.com/20230310" elementFormDefault="qualified" targetNamespace="http://cogrx.com/20230310">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://cogrx.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="cgtx-20230310_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="cgtx-20230310_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>cgtx-20230310_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>cgtx-20230310_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://cogrx.com/role/Cover" xlink:href="cgtx-20230310.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://cogrx.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm239035d1_ex5-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm239035d1_ex5-1img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  V /0# 2(  A$! Q$!_\0
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A* "BBB@ HHHH **** "BBB@ HHHH *!110 M%%%,1__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139864810400192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 10, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 10,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cognition
Therapeutics,&#160;Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001455365<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-4365359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2500 Westchester Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Purchase<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">481-2210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CGTX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>tm239035d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cgtx-20230310.xsd" xlink:type="simple"/>
    <context id="From2023-03-10to2023-03-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001455365</identifier>
        </entity>
        <period>
            <startDate>2023-03-10</startDate>
            <endDate>2023-03-10</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-03-10to2023-03-10">0001455365</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-03-10to2023-03-10">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-03-10to2023-03-10">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-03-10to2023-03-10">2023-03-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-03-10to2023-03-10">Cognition Therapeutics,&#160;Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-03-10to2023-03-10">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-03-10to2023-03-10">001-40886</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-03-10to2023-03-10">13-4365359</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-03-10to2023-03-10">2500 Westchester Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2023-03-10to2023-03-10">Purchase</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-03-10to2023-03-10">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-03-10to2023-03-10">10577</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-03-10to2023-03-10">412</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-03-10to2023-03-10">481-2210</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-03-10to2023-03-10">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-03-10to2023-03-10">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-03-10to2023-03-10">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-03-10to2023-03-10">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-03-10to2023-03-10">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-03-10to2023-03-10">CGTX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-03-10to2023-03-10">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-03-10to2023-03-10">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2023-03-10to2023-03-10">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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ML0(  .(,   -    >&PO<W1Y;&5S+GAM;-U7;6O;,!#^*T(_8&YB:N*1&+9
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M8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0
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M3R54&*!\4YFHO/93;#GICEYG>O\P>=0>6N=6RKV'5[+E&''\GN4/4$L#!!0
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ML;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( '4^:E8'04UB@0   +$    0
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MPPP  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !U/FI6EXJ[',     3 @
M"P              @ &?#P  7W)E;',O+G)E;'-02P$"% ,4    " !U/FI6
MJL0B%C,!   B @  #P              @ &($   >&PO=V]R:V)O;VLN>&UL
M4$L! A0#%     @ =3YJ5B0>FZ*M    ^ $  !H              ( !Z!$
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ =3YJ5F60
M>9(9 0  SP,  !,              ( !S1(  %M#;VYT96YT7U1Y<&5S72YX
8;6Q02P4&      D "0 ^ @  %Q0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm239035d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cogrx.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm239035d1_8k.htm">tm239035d1_8k.htm</File>
    <File>cgtx-20230310.xsd</File>
    <File>cgtx-20230310_lab.xml</File>
    <File>cgtx-20230310_pre.xml</File>
    <File>tm239035d1_ex10-1.htm</File>
    <File>tm239035d1_ex10-2.htm</File>
    <File>tm239035d1_ex5-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm239035d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2021q4": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "tm239035d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cgtx-20230310_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cgtx-20230310_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cgtx-20230310.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cgtx",
   "nsuri": "http://cogrx.com/20230310",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm239035d1_8k.htm",
      "contextRef": "From2023-03-10to2023-03-10",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://cogrx.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm239035d1_8k.htm",
      "contextRef": "From2023-03-10to2023-03-10",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cogrx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001104659-23-030852-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-23-030852-xbrl.zip
M4$L#!!0    ( '4^:E8WA":,. ,  .P+   1    8V=T>"TR,#(S,#,Q,"YX
M<V2U5MMRVC 0?6YG^@^J7S/R!9H+!)))DY*A0YH.)&F2EXZPA:/&EAQ)!M.O
MK^0+$# ND)8G:?><HUWMKDSK- D#,,9<$$;;AF/:!L#491ZA?MNX'<"SP7FW
M:X#3DP_O@?JU/D((.@0'7A-<,!=VZ8@=@V\HQ$UPB2GF2#)^#.Y0$&L+ZY
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MS5'^MV'70-:W1LO*--7R#U!+ P04    " !U/FI6]_V"=_\*  !LAP  %0
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MQ+2EE.=">\,BZBE@J9A$7'9/S]F8%H>R"'\0?&W=;5ER;DG\C2ZK^.+0R%T
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M;DL[BFC1NH8$M&N"TA(&!0OD#@2F"-#<Y"'>H?D7P6(8,C6E'V!:5NVX5+(
M83&]]:&B]-Y F6V$:#B'>Q]8ZNQF;H_9ZKXNH L"EAYSK;N]A;P!B\?>Z()E
M2;93S^-=;]9+(BP%;$M<\0&9TUR8Z4'P )@R.2AD2.E0(?16^_JN LO4@Y!@
MD4R96PKL)ILD-#4!T6 U!A"QU^;/I7JC8B9;*8'IG,5D^Q/9@65KZ=QR =AL
M@F&( B+#[@Q HQ2C7(VDW!L<MR)98[%;)%%/M]$6NL4#,MKDPU0%! A@#2"D
M5*/%?.:[5[G'VWDL@4T>DN+Y\AY20+U;8'IL-[D!Q 'AT^T0H$@&H6:4;YCF
M+.+BF=<>EYCQC6P,=S,>PR.6GBBW8 TJ0A.OSI" (!OB$T"M$?JA>*8%<34W
M*,\ J1R\47<>Q_)@I>6?JX21*7@,K%JWA'78;7)E$09$$^P.8*A4?M ?D(I!
M-RPD<([>4-PC_^ <#07G*&APCMX#SOTK#PB<XS<4]]@_.,=#P3D.&ISC=X$C
M*]][FS.3'V_$/7^U/? -*KU@T[9JA68O"P^9EK<^8%2 &M^H$-^HY(.M&W$K
M^$O"(G@8#<F]0 .8MI)C:,/#QVZPCZ%JD*SC?(-4#M9[ORQ:YJ>U:9JT-S6%
M)CQ0FL9Z&YE"[1N+6YYFF/X[>>X\2;>+O2!B-6P%I:$,#Q>;O3YHBA@D@WR=
M=)?8JAL@UNEJ1KJ[*<<66_LIQ[7$($"P.6I/.2ZNKA0B'U6M6!4$ RU#,]E9
M15M,5?5<2PNCFMN&6K6<?[^EQM<76JTL0V\?.8,?+FA+7-4V9$[7N)D>1*T#
MILR:SV4HUWF\<J]6N$CM37DMS5E/;]JI.G:=$$0-FVY:W;9.]U"COX@DDWN?
M\?5ZP\H[0[9G$ &=JYKNM*EKW2H*@H N9R8-I18UQ1[06'":1$F6L-7/\N14
M)-A6,IO(%12P04U$6Q$$#J MDX6]$&FE!Q!N!5$P$ED9^81#M<B1N'EXL/;^
M76)78/0;UH# RB! Z;5G B,#QE$M A4A*(_QC\X\33=$O D@2X@GC$#S $PM
M?8A(029[P2H"??.U(-%&]I>[Z='R/LFH[<2S+7'6/P'FJM[)2 ^"#\"4R4.>
MAO@#FA[]>?D7I*,\('#-[P56B]HN=NLEI\!*6%:5*Q Z+&H6+)(@<(!]F41<
M<U1*4:'UM5)6P["E2$:Z*PBLMG3U-Q*#J'B;HU8CT*AOC\W_Q39ZE,8(,-G!
M+G/=#=A,FEU!71,$!AW&6B<KI11IK:_)#OLN;-4_*%AY&Q2L>@8%JQ '!:NA
M@X*5UT&!WG6Q3(ELHVZ6-%EA8-'$3K5K,#HLFXQ8I$'A OL#VXXJ!.UC?*RV
MF2^[IEXE(-:YATOYP5)20.=LO<TNF]6"FS91$)QT.6LMN5DLA%<3(Z7VP<8F
M3C(2%X8N$X99E&!:+=UHNWK>'^*,F('F*WAZ]&%P-,QD"ZDB3*^Q6 7NE^'T
M<=F]>(CC%T+I3XR_L@7!*6<D+JZWV.XN=>O=/G738[OYX T@#@*I(0Z!QV]4
MT/A)12$=5EXM\T;35TXW+,,BG\,N;"T4H'-+#V"S28TA"H@6NS. DDJ,"K6_
M2>'%ZA75P*MX9Q)82$CN>(IXIVECIKA5&Q WG0:A>>/EFB/[\7(1Y7$Z9T;4
MNRZ2%_(99[CT!Y89DKN>P-EEVIRY:=,&A%&G07"N9A6CEJO!FBNOR]:(F1Q^
MK7C'T^>&ROWB-2V+[?5K*DE B-A\=:QB(Y#6>N-AL<:4?MJD"2,IW"D9*K<\
M6"TV>6A( N+!Y@O@(9<BK?7&P\6:B)7L[GX4_#5[+->0!<L'J-WRT6FYR8E5
M&A O7?X ;G0(*F+TLK_^ -KN%T O5H"$2VN1.D8'-&MPT]*%! UDKD4,)9&Z
M'G/-,W3/T9>4H.R1H(ORM7KUE>N+?'R^)26*U(2+8K3.8BQL&'6)G;\Q!33<
M>F]*2QD$3+WVX'>H5!%(AW@@YT:R+.KG>+F1>4;6X$R*_A!7% TUKUGJTP=!
MU$"3)E=Y6//$.P]$*M+WJDKU!?GA85]#Y'BT;#%H#)9KBB X 6U!0^7Z^PW\
MK>>W6=(DNJ0<PU=A&AK'J_BU[1D+^.T% 5'0=@4MVY<+4:[TQL GS)[$YCF+
M=K>"1X2HI[72JN7JNT8W,-HM-V\J4I.H0:$!L?86OP"%^RQ0+8\/M=[+]P4_
M]3"Z6F&.1T^+1RP/XLTF2U6/*LW!5\P[@QS?BAA0 ..&1$=$0/@-L G=G,@C
M41[Z 17!J!;M\;PMW:].2.)/NSOR0(2:TW!/MMDGN;.GCC./ ;&NS^H&%\<\
MR>L-# +$M[J%3@%35,\ +=5S9F46Z%>5"<ISL;VGO;[I2GZ2F_4F^6N)4R*W
M_!=02P,$%     @ =3YJ5J6<PR)3!P  NU@  !4   !C9W1X+3(P,C,P,S$P
M7W!R92YX;6S-G-]WVC84Q]]WSOX'CST# ;IUH<EZ$AIZ.$V;+-!VVTN/L 7H
M1):8) ?X[R?9F/+#DF]>>I.'A-A7TOU^KI!]+<D7;]<ICYZHTDR*RT:G==:(
MJ(AEPL3\LO%YW+P:#T:C1J0-$0GA4M#+AI"-MW_^_%-D?RY^:3:C(:,\Z4?O
M9-P<B9E\$WTB*>U'[ZF@BABIWD1?",_<$3EDG*IH(-,EIX;:$T7#_>BW5N<U
MB9I-0+U?J$BD^OPPVM6[,&:I^^WV:K5J"?E$5E(]ZE8L4UB%8T-,IG>UG:W/
MMC]%\0O.Q&/?_9H232/+2^C^6K/+AFMWV^RJUY)JWNZ>G77:?W^\'<<+FI(F
M$XY;3!ME*5=+5;G.^?EY.S];FIY8KJ>*EVWTVJ4[NYKM61:PW_-$L[[.W;N5
M,3%YV&N;B;P6[K]F:=9TAYJ=;K/7::UUTBCAYP25Y/2!SB+WUT9OUVHLYVKM
MHM5V9]H#:7NC=3,OLU!T=MF(YV9MJ^[VSGJ=,U?QKP=&9K.TO5(SUZD:4?N@
MT:6BF@J3Z[RU!PZ*T+6Q?8DF946N?9!;AAEGN>TFG:CI^E26VH;LQ\)RZT7I
M!Y?Q0=/<L9='.LM^G!/6-&[-Y5,[H<R2[G;^>^4^-HN/.03[[[>\L:NI-HK$
MIJR-DRGE>1O?K,V12?L'>582F=A:JQT[M#CV:S]R5RJ.I$JHLLS+NHB*#^)U
MVC6W%NTE4;:B9KQ@?!?JF9*IC]"6AO0XN@_+-O'CB%Y9'Q+GQY"3>372(Q,@
MTPX&U$HUF%3?41TKMG1L:N >6 (9=U$95VA#0%U^CQ[HG#F?G3ONXDO=P? 8
MX2D"A-_#'#6":A&C<"5$1O@#74I5 __0$LC\%2;S*FV(J/_*B#)4\0V$]HDQ
M$/AOF, ]"A&93Q01FCE&$.BGUD#JOZ/>D'@T(F(?+RCG+L$C M3;J^R!Z%]C
MHO?K?"'P;Y[<==]>;N#\]XH 0_#'2PG!B5K$*-Q3Q61B+_4*P/_$&$C^').\
M1R$Z\QN10(GO3,$Y$C[P(WF(N(=,QX077@WM,1U&7F$.Q8Z2F];*1$?_#R4*
M#'[/&(H=)5VMD8@ ?9 I=>!0<(3Q6T.QHR2J=2(1N-\(P\S&S19\RM+I]P>O
MA[Q/K:"<49)3GR@TON63"6'<1$B(\;$EE#-*3AH2A\9Z8#4IPD<BH>L/=!."
M?6(*I8V2BP;EH>&^5RPE:C-F<?T <FH+!8Z2@88%HA&?D/4HL<K8C!73BO7@
MO46@_%'23Y!<M#",1"S54NX];A[(S'XW-P.9!(?XFH+0D*#DI<^0CA:8JR2Q
MR/3VSRT3M!,*1Z4Y>*X)+P@!F2\(??=YZ+MP]"CY:JW,%X2^]SST/3AZE)RU
M5B8V^H']>*<F<N69U?8:0[&CY*PU$K&AYU>?.W6OY!,K5EW5D3\I <6/F,J&
MQ6+'8'OQA_3ZTA+*'#&MK1:'S?I>:D/XOVQ9=Y=9;0_ECIC@AH1B/)@LXN\>
M<OB6*QV90!FCY+25<C"PND@K2OS=^- ""A4E4:T2@\#T5KHYE(44P6>YIU90
MMB@9IT\4QD#L5C%K[S"P=QJ\6@YEF#V6@8#RJV+&>C&0:9J)[7,=SPR;QQ2*
M&"5-#,I#P#V6G,7,,#'_:.\@%2.\FG65'10T2E+H%X9 ^5Y1%W%J;\WS-6-N
MRX.ZF\U\(W'('DH=)2>L%XI/?Z1U1M5S8U!1"AH)E/00*AICS*%Q9H?!3:<[
MG;A=/)X1Y\0*RALE-?2)0N#[24X4<;L'QYMT*KE_JTJE(90R2B(8D(8 ^L"7
M:L1')E"X*!E@I1S$\>%F'2^(F%/_RHAJ2RADE(PP) YU+)Z#QN+Y,\=BE,S0
M)PJ1;[$^W7Z[[J:<S8E_AUNP 'C?#R;U@%2,O87Y-B2WUUREN2]#^Z$:O<<4
M"AUG"V=('@;N+&&&)H5;0R:(B&WJM=MSY\GDZTM!@X"SQQ,H&FV*X"OE_(.0
M*S&F1$M!DR(=",T2>(M (X$X)UDC%RT,7R3/+"F5+T!5GN^"QQ2*'7$NTB,/
M;[UGL:AZ=STJ7C(2HNXK 86/."D9%HNX%LY0YS=[HN^((5LO0S'PE8#& '&"
M,BP6=0V_&MB+T5R&Y^*/#*'$$9?@5DI# SU.">?7F6:"ZN X<V0(!8VXUK92
M&AKHFY2JN1WDWBNY,HOM_M,0<$\!*'C$%;5!J7@!6'_?]U[LS0O2K[ &OU$!
M$;U7).8K0^+8+=0HKO B(<I#/F0/98^Z\=,O%('^G5E0M7]OE3LTLOE=:$%%
M?2EH)%#26JAHO.OMWML'@I?; SLH<\0$MDH8WCZN;,I9/.22!._;#\R@C!&S
MU0I9:(BOB7A4V=+$FWLE8TK=-(S>??, 21.P FA8$//89Z' >[0@T]1M<)+Q
MXWAAA>N[S.3O9[4^!A\P!,M!PX.YR10@'/'N2'_?@$:3Z\T#G5'EED!,Z-I<
MV\8>PS=+@.+0&*&^&0F,H2)4%^T37;?V@'L+;W'&_7)OFK5'_@=02P,$%
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MDTU2=^#6+Z73J9%;+ODJZ7);J,YGJGRK4GB46O1$\G#7$@/>EQU?T17'=<H
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MKMY>=KH/ZY-_B\I>M=*R'/(%4CLP5&*6@JEE/Z!;4F^F/NYIAO9,?FO&E/I
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M:MG+''G!.\";3>"'!89'2M 94[/+8.+*:;Y("DP[O(/S6V)NU6R63W/XN%K
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M),4C+N-H,BIPT,'U15+F_Y'0,9A4R2('N=.?E%5Y;YHTEV!O7>5P(*8Q)SC
M0BGR%G]QE=7P5.O#2(6J04!R. +!LZ=T:D)GP"[7^%%6B!K:_W?O7O0\SXKT
MA^A-<I$]AN?_N<2-!<.,[MT3;,B/SU[\%D)7'-T/!&*_P<\F8)MFM?[L:9'
MLA[!>S=5D:<P  ^MT8G?_O@U/#/P^$F=)>_N33(0/1CC@L9L#^F;P(APF#=]
MI#4Q7^/,\&1LY6)NO[0-VKS9-MN\'V3ZVK[@9[6 Y90'M>_E9<7-[;ARG02P
M?*W]8'0TRZ'0$)@TG OL?S:G+\ A%Z.!C?6L:?ARM,<?'![^79U6'_@2E%;I
M>0M[$C>(&[^2V('X!C>*,H.D]$;MT$0@"(,:AR<QA+Q)&,?@9'*=6R;V+?>-
M#0#KE'#X =.T!<$DT,3NM:'XH6_8/T(5-U\6;0Y'+\\@FBQ#!F2TH?T(QHQO
M0*;+6D5<Q/&J-@M'DE_B.&F;6XCCT7!,I>NL!"_S#;)APW-GI=S:N3&[ ^?&
M1QP?9E]^JB.$-,)PG@ZA2R9B\N#P[SLS^_8$^.(."/"'2*[KYW\VZ4TLRZ'G
M7**#$1^I8H";!2XDJH\N<%9C..DCK*G-DVYK(AHX"G2E^:Q608#-#OI/[=6K
ML=S(K8]V7OUG53>7=UK=I SPA>W;:QANJ&G6W F5#OD2X33\=!C:(IH%#,B\
M69/A6PMH&8^"/QY&M=CNAG8-X#MVTAQM1.#.*UQFT &<\SSJB<6/1RIL:+\L
MZMPK$,QT[:1V--J:ZYW\9J33FS C*K^Y4Q2WIBCR.Z H>O1%M+'"^#CX3O#F
M5M1^&,KCZ9!/C>2!7;+1=MQMH5O;0G_<W2VT\0ZZ$<[GDQZZMP[YZ28"UXP_
MB/Y9\QO6/&N.1$NG])R)ZR _'Z8'7?2/4^BT4QNWIC;>W0&U\<'ZXB: H$]N
MHW\";% @1*V'V6.J,S*E$Z\NX&,#@=DD(M ).M^&\^!,F\8);.)YQ3I9<)/9
MV>BEYA7,%'HJ95MP)7*1X5W895DWN.Y+#*Y4TE@OH $JG 7! <+Z2>%;4733
M7":W@U_+  ,/HYK5M49:$^TYP]G',L!IL<3%Y5U3+5LK981R7A%:-6FY5FB"
M->G9;,:A*A'?)IG[Q1@"?;K!<1?T7XV'>8,[U1EM!G P57E3G;45)O=Y^.*C
M=D-I,.AGOQ^?J,E?>S@*/,?:>GW@')B0$#IGS8L,(N$"N24')_0_#(1S/6\X
M=!T8W&8;\=-"#0D%=R-DX8;JXM]K47#KS*$A!-CP&#8 QZW-;5) Y.;@N(W,
MR"!.[G^#$P:RNF;&-H/,;3QA0?3<>$3PN9N^[<V =/\C>_7?9J_^;P^0[J8'
MSR?#U*T56L'5_F68.A#;7?3]+\34W7\<O5X0P.,''*?87H^CWY#: ;[^/)"[
M+OO'XXA\C2;_3\9SN6GI><==,;?XZLD]>RK4)#R.SE<+N.2X3B;Y]''T"@P2
MGJA7%;[^?0=ZIWZ%W]S3CL<.'OA?M7$&?>+B#OC$'^L:?P!@</B.X]&-(M"W
M@QU$F"*"!S>*(\;1K<,(QZ./?*%/"",<CVY4K3Z]+1@A^%UK<(21#2/<2(X_
M&%'X$24I&R$*-_%J=; &9'>S..Z'V]4AR.$Z"W( ?CC\L)UM=VM'U'R;CZB/
M/)1N#$/\Q ?3#I'X&06YW&9!_C3R_$'@Q$^;[O](G.*ZP00QBQ]3 '*S8W0\
MNB'8)XZ"0,:;FAJAJ J<X9^W5'$75?F\"JNZ@PK+&?$DF;Z[J&&KIO?DY< -
M:K.O++568#( 3=-C)<L=UX$WPTNT^X<U&H&HD^X-AA58TO46YZP_!]PU<N?@
MXN0=FK=YB0^>3DDI^<P)!O3D@2,H'80[=YH4TV5!&F #&,1UM2S0L*:;>\HN
MS8K\*JO%=1J/#.%KUV%P/0.MS_S9BT,S:BG!Q'QZ[#I6E*Y)FO&(\BP8!4;M
M!3.;$#Q%)?G8WZ6\W^LRBWX&:4$_\7D^ ]OH'"YIR'G[V]$C9I8]L )E6[JM
M[[C>6=Q!O6,TBI'PE\EULYD-!"=MHUAAA:&X2*XY:0=?SS(DCBT02EQ=H6^.
M_VY:YKP !5;GL,?HPZ*:XG\P0 NK$'.(@!U:Y#9!BX,5'G\ #VGX3DO,$\.S
M4_Q/6V=P1<9?E6E2I_#/>EEP<AT&C]N10B!Q=+',<=>7E&8&Q0%/ ]71X.:#
M0<-__UBF%Z@Y\-5AH UFVO]8EE/Y?9I-0;4TE%K-VK9@3S]1^J8!HT4EYJ,D
M121GTR*)[E6&/X&;<RYU@;ELE+&&LC#)$C8W/ U>8E]SY-*[PX4<OB'M8-V0
M-12%@"8KSE2QU:' 6NJ-!>%&V.X:E W\R2,EU/>?2]!X:'0*B]Q%!0JQQ M@
ME&I8*V(=SA+0=TA:#^H\HT?!'3 $=YE<J7@+K"2GQ40>W!]*[A"5NZ590:C@
M1I-<8F'+A<J@L9A%8JS!36$YQ(@%7<<H/0X4;G!YKD$9.Q/LEA-;#W8Y+"N'
M]6"7P_K2]LB@N?#GG387KA)P:<GS[TE0Y=C*)"D*.#,V[WZ@ @L7<(Y>$"B(
M]#H<26PC<[IG@GF1=&ECEGQ;.A%43"=7(S"ZGAA+G[=CN3J[4^/6=D1]!W;$
MNHWQ-"G?U<M%.UVA'>UO"Q@UF(K1T5$<_7IP=@#"ES(\#RT5%282LYE,2S26
MR892"<,:C-9LAH*;9A.0Z68GC[<FC\T=D,<!0:2(244.V[+CT-DA$-UE9I:C
M=S7!7R[T+U77J_^;E,ND7D4/=,,K[>!0T"2MIDMV*. +:4K%&IJ2V&3LM-PQ
M9B>SMR:S[1V0V;6B:R'1.W*+FC)-5F[Y<B?U#UX>,:*2VF24LBVP_DVXEFF3
MNTCP3N$)9FQE(.($?5HV7Z:P?##!L%?PRYVPWYJP+^^ L/=+^:H(!-J">OD8
M]"KFPC"X\S8CHR"-^/<[Z;HUZ;JZR])U @Y.F]4;B1?Z9VE8R$ZP=]0LGZ(9
M"LKN16FUF]R)WJV)WO4VBUZ_S'4*([IA 95R;[+I$B/*TDR5#^16JC:*I&FI
MS COUN#=%FY=M/IU?\4-W+;.0%(M=(-_S4Y^;TU^WV^S_&XJS54Y0Z@'1K%
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M5V$^@HD="2>(I05@2[#UB@Z7&!NV"5@A=0Z%4Z2N$\LJ8+Z00ZD&@ZU;"8(
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M$A$SW"EDKW(O$"L4QN[D/AXD-.G6+^ \='[".+(,3Q$GE-9YTEN4(NN8ZG0
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MK!G T@.[U&)?W5HZN+CZ@:NTB?IPK9H@C#('-#PU(0U/TZQ DC1$%[':T H
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MT3WGG#HHMK)8!6G7P4NT6JK('$U65FYS0.,[KL^@AF#!:X9O&.@< +;) AG
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M$2LJ\MTN*O*E[9'!J,ATFZ,B \&188#V;<1)QJ,!,-SGB)-PDM%P2F-$:RB
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MI1-@*'R*R.";^#+K#T KJFJ<DK6+<Z,7"H5D;[#IAJ*S'X!7V]31V 5J_XI
M[?>[0*T5J/U^%ZC]TO;(8* VO0.!VBA4A SG%WH-[%MWB;^QR:6$:_WT&ZAL
M//\ONM7\ZI FYK&D7L72J=*)N/HE!7"X(KPMY"1G^\ID"ATA>=,L$5)=9QR#
M>!1_=W04?_/@.T5R[K7][#"<[IMR:[!_R9MW"Y\-176RL&N4%?>8&^]DBXOJ
MB)KHZ/N#[[__NP6 <1@)P*/5TZD9V0FR9 (+II1(MY"I9C$\FZ(N5%R(008\
M0[&:\0K6#L933:0^ PT\FJ!./8?]5NOM52MFJ0]U:_VL]:#R'8H;V.4QW@-Q
MC#5:'XC P@!'2V&&EK9*J^N^V<ABDA;L646PK"27DDSX00^//;UR&EP@?')O
MY=S?C@Z^_=Y;_5_ LYLOY]@FUF'81Y=#B&.<&D+59$SW&).&ZZ]GLWR*G915
M2(GMNW#E#'N+U.)+U>_G2++JL(AMT'=LAG52>X_VAP?1TWDL.#2%R?'&9N\
M$%FK)#,8G5!<KS+,CM[94][(-*^GRSGN$G32*8H/SM"B:OI_S(K";A%F=]BE
M'80N-]6J2K$BKRC7$L_MAO#*J;1E%W2E_BT)^X=B$R88#OISF6,-&[8G=;PR
ME.!>IQ9^C>$N\W/+I>5FK#T;([PCQ+?%9_(BT?M=Y54A4%6U6K5#S(NZ*K0
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MHW0'N9-!R!/#A!H3JO)*>G<M5G8M5EP#_[5#UG^\;"^IB2FC&4V0% 4R@LG
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M.:.T/XA.VR+'A$P##GN:+&CD6)\-SM4RT><H9NTE.(!OH!U]:FW6Z&TO+\,
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M>G4 @QEPBBS2=Z0"L=.^>O[Y)<Q#6 2ZZ5];2;GWP$AY. %LL2\&>+7R6B6
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M)'4LR/.OT4;\Z\:C.JD5?"O8:2DLU5Q?)$[)P7CT"COIJAO8H^'VU#PAL=4
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MT4<Z\<'N+UC=5@T(XJ0<OF:KCPM,=JRG&C7S5%0J7J?*W]<49<1.74<<*NS
M, ,A&];W<+&12[[!^"G7&*'>'[/(T9HU7K/"BB@"'1AKR^@B09E["DX0)HU/
M3E69A+..T1LY*8/<#*WB)N ("-_%N0F=OKA6U[ ZB$1H#%#![O+IT#L$6D1]
M>!%4H ##](/OA-2&%4=:N51J5DZ'S:"\G*%]P<@!OZJZ&WK2O&%=L;.E3@O*
MAPN0)XFN$!M!#6DJ6ZJZ[".F.I&+AVESVKA&*RU)&$KY'<X&GE58.L6/(#I&
M);EM-KTLZ;N\-#W()BO]%$,YR"'0:9'D\SA2D)#:[H,EB!+EV1%RIU7A1!IP
M&-LR'EF($4[:=L.1\;I%QOF4P$UP=?N752]EC,5XLL1Z5=<LZN#I$UY36WK=
MLENS_1"0LPMN;E&&\)M=AM#.$'ZSRQ!^:;MDT,DIMMK)61<-.BVO\KI2%OW+
MY'I3%X>J2+G E(L##,I:_09=&JO,6'I<8B$*TU[$"GL/UQ85'L6Z[MCVVWU\
MJ(6E09+3)4QL=)DE!3T9@P>SK)6\76;>CBLP_@/G)#;+H)AN]3Z?JEXD GF]
M3AH*;"VJHEBVB0"="!J-YB:U?]>([O#<:7PWMS_'P\M4?<",,%^[93M9C3Y-
M8PR-NV8W8MYM7-%]^L;>%77]R4,+*/VYB(2LARM-VUW\(OH]I*B<QN\VWHQU
MYU+%^W-)=&>Z\(?).,0^%L^."B^:2I4G;&JHNXY<V(_;V1*?7TO.MUE+!O3B
M.7+ ^8@)K[O-S=V[8<HY\AIGL#/ A5DP/HYK#VVG6G?M):V M^FGL).ZC 5%
MY_MOPLA $YJ@K6?C=C>A]H@56A)SH->756%M>RJB((I#4B<%U@N@)H&Q"9.H
MT]V">^@0%'4\,NJ6Z!#M*KND3!T^#[J D"WL1:OW0;PAUQ7A2W![$%5LIZ>$
MH9W^[S"P4<^(IETG-)=-IK(5*?V>,#2<(Z#/._<.4*1U1 ,_Y!?0U2E"#(L%
M4')@2LF3<:B$*=*[G!TKZGO$^1QDK"C14&TI96-W)<E ,!B/;4:P$3],C.*Z
M3M5NVO7XF(@Y;!'E,J,IMF.CG0.FK)R!!0&VW3GEO$%W4A$FC+]4HLYWD+Y>
MU#K9M(&W.\K1,Z3VK<O(T/<LVL"^-22UERBE3$?52%&*$31;^+3$11\N<#P;
MDV5>I*%<U*;;U]I:='L]-'JWC3BS2)7L'/B_Z- MM_G0[3][7Y3-DHZ"L"NB
M+,G@;L_QM]+6GO[)_0_  J\N2J(I-O@<+FYK<N[Y:&JO2-BE-H&S&,T[_I>J
MQDSF6)[0<.UFF5SH4F-[FPGP7J6/%_4R55CX*:PIS'JM05#&.B<=LKG* :V%
M5&6IS2J8EQHS5%D=6IF>0$$0045)K\M<3?>^ P P<!.5Y>>Z<S6 E0EX$O6P
M9./UW4 1PC;'T$/#X5!%.B7LT$2$/$#YYCV-&W$P@5-/:8-AZ83I5A4&H*U
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MKRLQC&+94KD^WORJHF>B =FNK",GQFTW70H\7QH7)$U.3IG\:%%=2\D5A\O
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M/@!BLB >9P& E97D@S X9 $..#^" ["]V5CK1O^PF58+50QI: D:]!VUEVN
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M5CM.+]%F9^;8,D%R9SM3JWPIG7-3Y<GJF(_[,GGV!";ZR)[1R62NTCGZ3@L
MWKUNG ^GB$<^V._4QM(&Z8==B\5Y!H[/I!"XR_6R;++B1M,8?:)91!Q10419
M">YI:L:%V4[-NUV6V+#:(KG!N*)I8>5!96EW<I["KTZTL@;/G_%B[*WVU8],
MZ20[O>J>.L?+/5N5>2HMR9:E;GI0=6;9HK,T:15D^H'ORVR%_U1KT&EL[O5C
M<-PY1PA")2^JX*5Q&)!H!4(+T-UX<%)AXF9*N/;*L^YU 8 =4+!SYO[<R#G)
MMD*J)FQ 0FD1LX1Y/.ILQM%Q!3< ]WO@88\5_($T*%?,.HE],X2^W)J]5KQ
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M*C';-#D@%/]SYA!8K^ZP;5!>\'EXF=?MZEZ3OX_V'GRSSZUJT83!LY9*P"U
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MU1UK[T)Y$MXZ_?U%-Q,ZNFOR]%TUMK*<@$&F>?3QN-'Y\@;,(7LBZC_=&Z_
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MENREVJ1C\LJ,%I:KC_PD("YRD*(-E8=5G\RB1$16KB^H8(L4EYLB0O&44]A
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M=FM4C;'Q=SMM1G[?P/MFNC:BI,S3/\/")AR#%K6'H2F]P7$_^)*9<DI8,.,
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M\F9)=5IXQR',5ZV-7XVQM#_O=OA[$V[9OHQJ9';046T@?+// KG6I!)31'"
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M6\2Q!J(N'*%&VM8'!9&J!C+)4Y,9L=D.P8_L(@VXGLHT +T(%K:,YZH#S(D
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M]HJ)=J,9,J-&O;.S,=VL8VBH ..F(7\V_W.64M?47#E>A!!=2#[>]<;^DF-
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MHA1F4N RMP!3LP#M) 8XA4G>J.RWBLI6X/H"CH5/\'Q?JHRJ"=2V4X.P]#E
M6/9\'L/HJ.X4 J1V-W6($\.^OP(&I2,-LW!4%@77H,(F$[%J"83,?&%EX6P
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M"@EN3UO/V,V("JK*,*G 70+GA@7--"MGG$]:D@[RB5+"^/*&HQD#Y:V#K12
MUG6L29"6KU0%8W.D19'JWZD,+'T@N2_44K2/CV(S403E;%KLQU6I3'7N*PK;
M+.3\L4JE@?L2^T%UCHK&H$O[2)B:,&I>XBNV_,0(U^.4Q"76(Z(=:%D%E0)3
M BYUN5:JSMJ>W<E$B%"F$+56%\&"*_;J5-VTEKI'7=&9JC!5D[Q([P.1G)9$
MYUI9IHBU4$&:1'@+Z1)8;;5*.7V5?5.QH\IGG-S22APAG )/J_5%Y7TAUYQ=
M8:+8@ALS2^0)]LV]:MD:3:]:"5G1.JN1Q7SUYG6_M_O>.^H=#S]W.^_[Q_TW
MG[W!\7'_C\/=WIO]S]ZGWN"/_HG7._C,0>_>8.A]Z'WVWO?^Z/OP\Y[7>W?<
MAS<.#H?>\- [[O_/Q_[)$!YY?_MX_-D;'@]Z^][;PV-O^+[O]?;^]G%OL,M!
M](=OJ=F]P<G1QV'?P\X_'NSUC[L=>'MPX.T>'AST=^E5?/9I,'SOP9/>\>!D
M</#.._Q(<?G#]X,3'@-'ZA]3H\/CWL%)CS_&Q%#]#T?[O6%_S^,I;ETI-OHA
MO^(-B)X#8*>GG _8$3R'S@V  ^[C7M-=4H$T]MU3.?/YB@PMAKTGU9ER&V-#
MLE!21)EDK#(UJV>I"+>5J/YJA2/.K^+(,:I0@XS%(K48QQ12ML8DY5PO(N51
MJG%,I U_NP@R&#;U210+AE50=L3<S7YREN:A7<D+P^VG(=60PE@^IN&4(JK@
M?^A!7&)%O7465%<!IHS/4A> ;')IQF4(=&IU*YN@*CY@ Z4K1?C@'U%F,KPP
M$V-6GQ-_QE0XB;PFQ7V^<H/NK39[MW-1?J,U9TC9QSEWY!NNC>V&XU;RB$B\
MK<KJ6B_EZS<+)^VUP:E*QRABJD*1L414M# $0@H*2VG&AYL3#I$JJ"I-<II4
MAPK=B].ZIH/OR8.#[X8=?$\>''QW[W8U\H+I7>0%5\D2WH<!$N*\(F*B+8@?
MZ'J7E@24<949;> 8<R)ODK;H)IAZ0*A(8JT?5>2#7&B69EDS@%;YR;V@[(UG
M[_0NGKTK.71DGH1MAR-1/7@-6<C0)3,NE9GS@O*(S8  =COH+R6.0:6U5(L^
M"]U3SXHEP&90RX$O4!W ]!9*CJ?"V($CWJM/J+"R=I]SY@Z[)[':4H(0D_HL
M-(9G+L^M\H*(-&25"0-Q"SX+"I"5<I7>0UF$>I,4!HW/?=(L^&_'R#CT1[[E
M/L?D=5'L&^?[)#JEZ$/'R4XY?7.=ZJ0 AE)PU:H4>%)$!D,S)*HE!6_.RVR>
MYF%N%]%1TEAEE5%&U,O*=7YY!7W/N$&H-IUK["&W'QP7+MZGMUP/YO[2@;.[
M30<^OGXKKM->GI<9@@?H4F]YE@>&C\<D5?HJL@0ZJN(#HO0]$W4MY05,(8N?
MD=E2^6=!R<WE[I(%@)56;E].C7WM3 ,"\-'JM@\R(,B;E%X<E]2D'<R=XM6Y
MPNW8Y?V0,ED%S5!+ G6=+)TD"%/>ZR##2F*E873*E#W&.F$QE<E#U4==KKIY
M4]$H)%WES,H$=!;:OI>\R?ER?R],=!<O3,.] 6WB1#D1C;^8[\Z07*#):8G2
M=YE;=<=[5FWQJC=B%(KO5#X<HTDLJ28OI<275%N>2'642=%4^XRB.:Z,^5"*
M)]-V:NN^R7.+#,2J>"NL[:U8^-O/MZK,14Z^HJ$T%QWK/PLKH;[8(W).PT4<
M.; $3\R*A45IZHO%N9%[J&$BD$ML&+[7_Y/J!B MPM3'F%O>%UB;TZSS/;T=
MCK7(2A[OIJ;@LYJ!I$QB N+I.:$MA/RXDBY,B=[=#CMM&X5O,SBSOECXG$F7
M[< QSBDWJ7^V$GWPDL%>G. L%$".=P$4+O=^CB>(R),J@/[/&?VS\G.N?H;.
MG"<P /5HPZJ!0@G;-FF.S6>>JAZ$"WK#.?93*@1HX!'.(!4&@IQU-%?I'"=X
MOEG_0&!'E4FQT5A^9+YC/2D9I\A?4#HY:A'OC\PNFLU3]"C3J6V9'^^KKD%D
M[3O!HL[2.%2.2\%PB"EL7&(72WQE,%>9ZB2<1DED& ?[.)OU/ -^U*9CV#OJ
M"T9T$2(B*Q>+7%RB<1LYMX&9THYBUW"N]9'EVZ1AL=A-G*?L <Y7F@)Y=:'%
MB*<C%75D*]),;U"D2F\6G,"83XI!>LA%%%H8+\Q%-)?S_G+1?]P?+EHW:H^C
M((N4'%K1*A%1H8Z$0L58%NH&%Y>(85%FX5W-,25NT7!.6<V10UCOB$&-*$BZ
M3FX!3U 1%=*0D*;YEIM;"J#>%>^NMK0.7O^O5ES)FNIQ]=;\_UX]'ER=L_K[
MI;6^? ;KIP^F^QLVW3]],-W?L7OUYO7@P/LT&![T3TZ\3PAO.7QK'/2:4F.F
M7C(F3*34C2JR1*+M,==<<=0!U)Q*V]84D-A"=1RF4885!B0VAH(=;KP\D\VH
MS374U&#%_?V)#HAU96OM5.\PG\*?U,$R-Z-."&J"A",<R&2987/XI6IQ]Q"G
M>/#7GYY\;=[R!B*S=#0@,0S?]WD$NX<?H///+RP;M+G0]W&Y+M_WO5V*RY^<
MW<-W!P,"W,$!.NX=]3\.![LG/@]I<+"[]4.LV\,1NJU+H<G]<XK+_^IEN31S
M4]VN[/7-XL72+I?+M2R!7FI(SU:/Z7'^N-O9C_( 9(0QJHV3Z$X<WDONTJJN
M2%#^+INS:B2X%]W.#[T90ZR=>CMV8_<L"J?=3I]D9#1['&)(!<:#WH%MN6<$
M_FZ)2[:@/3CXHW\R/#R^!Y+VPZFYUE.S#X+TX?X!!NS\792TWM%@B"$V'P_V
M)-78P\HU"5>?7WBR>CP,7$*U>C_.PJVQ3'=['1X(T ^W"E<\\^^EAJVE>E6*
M3O^(^W%[="_<C&[GQ]Z-[ZI\'65A3BCFRA);B0EOHX=W37?GLP=WYPV[.Y\]
MN#NOZ<Y<LK#N$FA$M3 ">3UM$D6/">Z+V*H77CF?AQD6T"0E6U"'W4[/5JX_
MZN%_O')HQ?<IR-9R"]Z\'B L1K#0O1'B^H96P+3WMLR2*#\+)]XP[7:&)GK:
M>[-PWOP^H^UK=!GB83_FV#_B?55>'2J 04AYVV$-3!C3_&@0^%&6$O"HS&]W
M8H?:!M'TCDWP>5-]K-L]I4L4,QG,9N$$X_+CA9N"$S$%%"+7G%/ ;UP64S;,
M%]C8..*LF1>(U_Q7F*7>QO8FQCYDC*Z&@SY+)67[EE>1K.D<_2U- DR6T.WL
MIO.0DPM\")+@%!'!'T),@DDM-8U'AD(88OR$<[VL&GD-J6NF0A/)<EH8"=F2
M9 =Z%C+7T6)%/ULP^#S/\BT/YT53M69.X!!:IHEWGNIZSQ$1 KICE,V/4W8R
MR)77E!,BI=,IQ6^9PM)S?1TQU<,\YHN*E94GG&Z!<H'U=RLYM/2C]M@-2;_5
M?$ZVVO=%X0P#+XZ ^B"X>)2E7ZAF<Q!SIL(@,9DC*!:_Y=U;#"U<4_!\_M([
MG-/JOO#V@[RX5NGSELHKC]\<[GU^C7]Y/_RP__K_ U!+ P04    " !U/FI6
MQHW3>%()  ">(@  %    '1M,C,Y,#,U9#%?97@U+3$N:'1MU5IM<]HZ%O[.
M#/]!R][M)K- @(3FC3*3]YN=O## O9U^VA&V +6VY4IV2/;7[W,D&QP"O6TW
MR32=%")9.N]ZSCER.K\/KZ^ZY5+G][.C4WPS^M<97@ZOSKJ=+?>-IUO9X\[Q
M[>DG-AA^NCK[4!FK*#E@S4:<L*$,A6$W8L;Z*N11U4U4V4!H.:Y@([;V\GTA
MUQ,9';!&I?LN&IGXL+/56UI"I&LS(2=3<!BIP#]DB;A/:CR0$^S4]."0%0B=
MW4_E2":L76\^I;:>X?#H^.J,G9Q=70UZ1R>7-Q<?*HV*'?>.3D_S\0_J>\AF
MTD^FM+3QCT.(KWVA:YX* AX;<<#RWRK6WIUA/V=P)W0B/1[D:B8JKF0^Z0Q/
M6?_V(Z2\^5!IST7*&.T1'VLS(_\KG(R5;N?R^H(-^B<?*DG8VMYO;+?]YG_$
M?;O6E.&DT:Q_CB<5=G0U_%!9V&5X6F"8,YG*1-1,S#V0CM1,\WBN8FLUY_/;
MF^$C7XYY*(.'@[\RW!-*%TKY,QFQGE9>(K23#=[I;!&+KA48'_T?-.6W-'LB
M0VN_Q8ZT-V6#1 N1L$&*0/M[<[?1Z!SW,Z*]J0RX+X)X*GF5]8Y8<[_9V'D5
M\0JN>VE6$^>-@,_JG@I?A>7SA=*_FFQC9Z>]B9C=K>WNP7LK8VC+8L+/0=;W
MH<.<&)8V'@.;)R)$>:5[S2G>FHTJA&UM/QNS9Y>^TCU1DT@F4D5L.!5PH4CA
M>JR^C+SZ,[)IM1L-]E&8Q)OB0VAV=">>DWXOA<&Y$55V\PG[V[N[O[+1^^+
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MQ?@]M7OK$'!KX_T *&J27Z>4_^NZ>OW;U"WZ^Q+W!R?T=RG_ U!+ 0(4 Q0
M   ( '4^:E8WA":,. ,  .P+   1              "  0    !C9W1X+3(P
M,C,P,S$P+GAS9%!+ 0(4 Q0    ( '4^:E;W_8)W_PH  &R'   5
M      "  6<#  !C9W1X+3(P,C,P,S$P7VQA8BYX;6Q02P$"% ,4    " !U
M/FI6I9S#(E,'  "[6   %0              @ &9#@  8V=T>"TR,#(S,#,Q
M,%]P<F4N>&UL4$L! A0#%     @ =3YJ5M>ZLWQ/(P  .[\  !$
M     ( !'Q8  '1M,C,Y,#,U9#%?.&LN:'1M4$L! A0#%     @ =3YJ5DB=
M.8,1J   EC0$ !4              ( !G3D  '1M,C,Y,#,U9#%?97@Q,"TQ
M+FAT;5!+ 0(4 Q0    ( '4^:E:'\#DBN$(  /:5 0 5              "
M >'A  !T;3(S.3 S-60Q7V5X,3 M,BYH=&U02P$"% ,4    " !U/FI6QHW3
M>%()  ">(@  %               @ ',) $ =&TR,SDP,S5D,5]E>#4M,2YH
8=&U02P4&      < !P#, 0  4"X!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
